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The utility of enantioenriched oxazolidinones in the preparation of small chiral building blocks 
has been investigated. Hard nucleophile induced ring opening reactions of oxazolidinones 
provided a series of enantioenriched α-hydroxy carbonyl compounds. Soft nucleophile induced 
ring opening reactions of oxazolidinones have been attempted. Aldol reactions and Mannich 
reactions of oxazolidinones afforded the addition products with good results. Additionally, the 
aldol addition products were able to be converted to enantioenriched α,β-dihydroxy carbonyl 
compounds with a quaternary chirality center at the α position. In addition, chiral diol was also 
obtained through the reductive ring opening reaction of oxazolidinone.       
 
        The synthesis of marineosin A, a structurally unique natural product exhibiting acute 
cytotoxicity, has been under investigation in our laboratory. The previously unreported 
spiroaminal structure consisting of tetrahydropyrrole ring and dihydropyran ring has been 
synthesized through a radical cyclization in model study. The 12-membered macrocyclic 
pyrrole core synthesis has been accomplished by Stetter reaction in model study. It is worth 
noting that this is the first time that Stetter reaction was used in macrocyclization reaction. Both 
the diene fragment and the dienophile fragment have been prepared successfully towards the 
synthesis of the densely functionalized tetrahydropyran ring in marineosin A. 
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 ENANTIOENRICHED OXAZOLIDINONES AS SYNTHESIS SCAFFOLDS 
 INTRODUCTION 
 Introduction of chiral α-functionalized carbonyl compounds 
Optically active α-functionalized carbonyl compounds, such as α-hydroxy acids and α-amino acids, 
are of great importance due to their application in “nearly all fields of organic chemistry”.1 For 
example, chiral α-functionalized carbonyl compounds are versatile building blocks and pivotal 
intermediates in organic synthesis. They also can be found in a number of natural compounds of 
biological importance. The significance of α-functionalized carbonyl compounds has led to an 
intensive effort in the development of new methodologies for the synthesis of these compounds by 
the application of asymmetric catalysis.2 At present, it still remains a popular yet challenging 
research field. 
 
1.1.1.1 Introduction of chiral α-hydroxyl carbonyl compounds The stereoselective synthesis of 
α-hydroxyl carbonyl compounds is of great importance in pharmaceutical industry due to the 
prevalence of the structural motif in many biologically active molecules. Compounds containing 
the unit are also useful synthons for the preparation of natural products such as antitumor agents, 
antibiotics, pheromones and sugars.3 Consequently, numerous researchers have aimed for the 
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synthesis of enantiomerically pure α-hydroxyl carbonyl compounds employing a number of 
strategies. In particular, enantioselective oxidation of enolates received the most attention. The 
method can be divided into two categories: stoichiometric chiral reagent induced reactions and 
asymmetric catalytic reactions of prochiral enolates.4 The latter, catalytic approach is more 
efficient and yet more challenging. Several general methods of this access have emerged during 
the past few decades including asymmetric epoxidation of enol ethers,5 asymmetric dihydroxylation 
of enol ethers,6 and aminoxylation of carbonyl compounds7 (Scheme 1). 
Scheme 1 General Methods of Preparation of α-Hydroxy Carbonyl Compounds 
 
1.1.1.2 Introduction of chiral α-amino acids Chiral α-amino acids represent an important source 
of chiral α-amino carbonyl compounds. Such compounds exhibit diverse biological functions and 
can be modified into various chiral intermediates with broad applications in biology and 
pharmaceutical science.8 Amino acids have many applications in the synthesis of enantioenriched 
heterocycles,9 utility as chiral auxiliaries,10 and as chiral catalysts in asymmetric transformations.11 
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The development of new reaction methodology to provide efficient routes to synthesize chiral α-
amino acids has progressed rapidly over the last few decades and continues to be an active area of 
investigation.8, 12 There are several main routes to obtain optically active α-amino acid including 
biotechnological methods, chemical synthesis using compounds from the chiral pool, resolution 
of a racemic mixture, and asymmetric synthesis. Among established methods, asymmetric 
synthesis is considered to be clearly advantageous over competing strategies. In the past decades, 
several general methods of chiral α-amino acids synthesis have been developed, such as the 
asymmetric Strecker reaction13, asymmetric hydrogenation of dehydroamino acids14, electrophilic 
amination of enolates15, derivatizations of glycine,8 and  reduction of α-azido acids16 (Scheme 2).  
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Scheme 2 General Methods of α-Amino Acids Synthesis 
 
1.1.1.3 Introduction of α,β-dihydroxy carbonyl compounds A wide range of important 
compounds in organic chemistry contain syn-α,β-dihydroxy carbonyl functionalities with a 
quaternary chirality center at the α-position. The motif occurs in carbohydrates as well as many 
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natural products.17 Meanwhile, the structure is thought as one kind of important synthon for the 
preparation of diol or glycerin frameworks in organic synthesis. For instance, the unique unit was 
found in TMC-95A 23, a proteasome inhibitor18 and fragenone A 2419 (Figure 1). In addition,  the 
motif is a key intermediate in the synthesis of bioactive molecules, such as variabilin A 25, an 
antibiotic from the marine sponge, Ircinia variabilis20 and antifungal agent 2721 (Figure 2).    
 
Figure 1 Selective Natural Product Containing syn-α,β-Dihydroxy Carbonyl Motif 
 
 
Figure 2 The Use of syn-α,β-Dihydroxy Carbonyl Compounds as Synthons in Total Synthesis 
By reason of the great importance, there is a particular demand for the development of 
efficient methods for the stereoselective synthesis of various chiral α,β-dihydroxy carbonyl 
compounds with a quaternary chirality center at α-position. At present, several different methods 
have been reported. The methods include: asymmetric dihydroxylation of α-substituted-α,β-
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unsaturated carbonyl compounds,22 the asymmetric aldol reaction of α-hydroxy carbonyl 
compounds with aldehydes,23 the asymmetric aldol reaction of furanones with α-keto esters,21 the 
tandem Wittig/aldol reaction24 and the three-component reaction of aryl diazoacetates, alcohol and 
aldehydes25 (Scheme 3).  
Scheme 3 General Methods for the Preparation of syn-α-β-Dihydroxy (2,3-dihydroxy) Carbonyl 
Functionalities with a-Quaternary Carbon 
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 Previous work 
One area of research in our group has focused on the rapid and economical preparation of optically 
active small molecule building blocks that relate directly to the complex stereochemical and 
structure motifs in natural products. Catalyzed enantioselective acyl halide-aldehyde 
cyclocondensation (AAC) reactions developed by our group provide convenient access to β-
lactones with high enantioselectivities under both Lewis acid-catalyzed and Lewis base-catalyzed 
conditions (Scheme 4).26 The versatility of the β-lactones derived from the AAC reaction is 
considerable. Enantioenriched lactones serve as templates for a diverse array of structures. When 
hard nucleophiles are used in the ring opening reaction of β-lactones, an addition-elimination 
reaction occurs at the carbonyl group, affording several kinds of chiral β-hydroxy compounds. For 
example, alkoxy anions provide β-hydroxy esters,26 amines afford the β-hydroxy amides,27 and 
enolates give β-hydroxy ketones.28  Soft nucleophiles, such as azides or organocopper reagents, 
perform SN2 reaction at the C-O bond to provide enantioenriched β-azido acids,29 β-alkyl acids or 
conjugated allenic acids,30 respectively (Figure 3). 
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Scheme 4 Previous AAC Reaction in Our Group 
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Figure 3 Ring opening of β-Lactone by Hard/soft Nucleophiles       
Based on the success of the AAC reactions as surrogates for asymmetric catalyzed aldol 
reactions, our group endeavored to extend this reaction to other enantioselective cycloaddition 
reactions. In 2007, our group reported catalytic asymmetric [4+2] cyclocondensation reaction of 
ketenes and N-thioacyl imines, which afford the chiral 4,5-cis-disubstituted 1,3-thiazin-6-one 
derivatives 54 as an alternative to traditional Mannich reactions (Equation 1).31 The utility of the 
enantioenriched [4+2] adducts was revealed through the ring opening process of thiazinone 
heterocycle 54. Amine-mediated ring opening of thiazinone with valine methyl ester provided the 
α,β-dipeptide derivative 55 (Equation 2), while hydride-mediated thiazinone reduction led directly 
to the optically active β-amino aldehyde derivative 56 (Equation 3). 
10 
 
 
 
Encouraged by the success of previous cyclocondensation work, we investigated the 
cinchona alkaloid-catalyzed ketene-oxaziridine cyclocondensation as a surrogate for enolate-
hydroxylation methodology (Equation 4). A series of chiral oxazolidinones with different 
substituents at the 5-position could be accessed with high yields and enantioselectivities. 
According to Evan’s mechanistic study in the metal enolate-oxaziridine reaction,32 we envision 
the reaction proceeding as outlined in Figure 4.  First, chiral ketene enolate is generated by addition 
of cinchona alkaloids (TMSQn or TMSQd) to the in situ formed ketene, ensuring the facial 
selectivity towards electrophiles. Next, the oxaziridine undergoes nucleophilic attack by chiral 
ketene enolate and generates the intermediate. Cyclization onto the carbonyl gives enantioenriched 
oxazolidinone as well as the regenerated catalyst to finish the catalytic cycle.    
11 
 
 
 
Figure 4 Proposed Mechanism of Acyl Chloride-Oxaziridine Cyclocondensations 
 
 Project design  
Group precedent suggested that these enantioenriched oxazolidinones would be subject to 
chemoselective ring opening reaction either at the carbonyl group or the C-O bond, when using 
hard or soft nucleophiles respectively. In previous work, when hard nucleophiles were used with 
chiral β-lactones, such as sodium methoxide or morpholine, the nucleophile selectively attacked 
the carbonyl group through an addition-elimination pathway. While soft nucleophiles, such as 
azides, sulfonamide anions, or Gilman reagents were employed, the C-O bond was broken by 
direct SN2 substitution (Figure 5).26, 29, 33 We anticipated that enantioenriched oxazolidinones 
would exhibit similar reactivity patterns due to the ring strain associated with oxazolidinones 
12 
 
because of bond length compression of the C–N/C–O bonds. Furthermore, ring opening at C5 
would liberate a highly stabilized anion very similarly to the intermediate derived from β-lactone 
opening. Therefore, by using hard nucleophiles in the ring opening process, we expected that the 
α-hydroxy carbonyl compounds would be obtained through the addition-elimination process. On 
the contrary, α-substituted acid or amide products would be anticipated from the direct SN2 
substitution pathway if soft nucleophiles were used in the ring opening reaction (Figure 6).  
 
Figure 5 Nucleophile-dependent β-Lactone Ring Opening Pathways 
 
 
Figure 6 Proposed Reaction Route of Hard/soft Nucleophile Induced Ring Opening Reactions of 
Oxazolidinones 
In addition to being an electrophile towards nucleophilic attack, the carbonyl moiety on 
oxazolidinone 59 may act as an enolate nucleophile in a series of transformations to construct 
useful structures. For instance, our oxazolidinones could be used as chiral nucleophiles to provide 
enantioenriched oxazolidinone derivatives through aldol or Mannich reactions. According to our 
13 
 
previous reaction design of hard nucleophile induced-ring opening reaction of our oxazolidinones, 
chiral α,β-dihydroxy carbonyl or α-hydroxy-β-amino carbonyl building blocks would be obtained 
after further hard nucleophile induced ring opening reaction of the aldol or Mannich addition 
products (Scheme 5).  
Scheme 5 Proposed Preparation of α,β-Dihydroxy Carbonyl or α-Hydroxy-β-amino Carbonyl 
Compounds from Enantioenriched Oxazolidinones 
 
 ENANTIOENRICHED OXAZOLIDINONES AS SYNTHESIS SCAFFOLDS 
 Hard nucleophile induced ring opening reactions of enantioenriched oxazolidinones 
The first goal of the project was to develop a methodology for the preparation of enantioenriched 
α-hydroxy carbonyl compounds. In our research, the benzyl substituted enantioenriched 
oxazolidinones 67 provided an approach to various α-hydroxy carbonyl compounds through facile 
ring opening reactions by different hard nucleophiles. When catalytic sodium methoxide was used 
in methanol, the α-hydroxy ester 68 was obtained in 89% yield and 99% ee from the 1:1 
diastereomeric mixture of oxazolidinone 67 (Table 1, entry 1). Ammonia in methanol provided the 
14 
 
α-hydroxy amide 69 in 94% yield (Table 1, entry 2). Since Weinreb amides provide access to 
functionalized ketones and aldehydes in organic synthesis, we also attempted using the N,O-
dimethylhydroxyamine as the hard nucleophile in our reaction and α-hydroxy Weinreb amide 70 
was obtained with satisfactory results (94% yield, 97% ee) (Table 1, entry 3). Reacting the 
oxazolidinone 67 with morpholine and catalytic amount of DMAP in THF afforded the α-hydroxy 
amide 71 in 85% yield and 97% ee. (Table 1, entry 4). Lithium hydroxide hydrolysis of 
oxazolidinone 67 resulted in α-hydroxy acid 72 in 79% yield and 98% ee. (Table 1, entry 5). In 
conclusion, we successfully developed a facile and efficient two-step method to obtain a collection 
of α-hydroxy carbonyl compounds with high yields and enantioselectivities.  
Table 1 Hard Nucleophile Induced Ring Opening Reaction of Oxazolidinones 
 
Entry Conditions Nu Yielda Eeb 
1 MeONa, MeOH MeO   68 89% 99% 
2 NH4OH, MeOH NH2   69 94% N.D. 
3 Me2AlCl, NHMe(OMe)•HCl,  
DCM    70  
94% 97% 
4 Morpholine, DMAP, THF 
    71 
85% 97% 
5 LiOH, MeOH, THF, H2O OH   72 79% 98% 
a isolated yield b ee values was determined by HPLC or GC.  
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 Soft nucleophile induced ring opening reaction of enantioenriched oxazolidinones 
Soft nucleophiles, such as azide, proved especially successful in SN2 ring opening reaction of β-
lactones, are expected to offer the best chance for realizing analogous reactivity patterns in 
enantioenriched oxazolidinones to provide the α-azido carbonyl compounds as equivalents for α-
amino acids. In this light, a multitude of reaction conditions and methods failed to facilitate 
breaking the C-O bond selectively through an SN2 pathway. Attempted methods included using 
different types of soft nucleophiles, (e.g. sodium azide, sodium cyanide, sodium thiocyanate, 
potassium phthalimide, Gilman reagents etc.);  using transition metal-azide complex nucleophiles 
instead of the high electron-density azide anion nucleophiles (such as Ti(Oi-Pr)2(N3)2, n-Bu3SnN3, 
VO(Oi-Pr)(N3)2, Ti(η-C5H5)2N3Cl, etc); activating azido-based soft nucleophiles (e.g. 
diphenylphosphoryl azid (DPPA)/4-dimethylaminopyridine (DMAP) system, 
tetramethylethylenediamine (TMEDA)/TMSN3 system, tris(2,4,6-trimethoxypehnyl)phosphine 
(TTMPP)/TMSN3 etc.); activating the aminal oxygen through protic acid or Lewis acid; and lastly, 
modifying the structure of oxazolidinones both electronically (increasing the electrophilicity of the 
C-O bond through inducing a strong electron withdrawing functional group on the 5-position) or 
sterically (increasing the steric hindrance of the substituent on the 2 position and the amide 
protecting group to shield the amide). However, under most of these reaction conditions, the 
nucleophiles attacked the carbonyl group instead of the C-O bond as a major reaction pathway, 
which meant the proposed SN2 reaction route was exceedingly difficult to accomplish. 
16 
 
Scheme 6 Attempted Soft Nucleophile Induced Ring Opening Reaction of Oxazolidinones 
 
 
 Alkylation of chiral oxazolidinones 
1.2.3.1 First attempts on the aldol reaction of oxazolidinones Our third goal was to develop a 
methodology for the synthesis of chiral α,β-dihydroxy carbonyl or α-hydroxy-β-amino carbonyl 
building blocks for complex natural product synthesis. In our previous attempts at soft nucleophile-
induced ring opening reactions (Scheme 6), oxazolidinone deprotonation and subsequent enolate 
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functionalization emerged as a common reaction pathway for 5-aryl substituted substrates, giving 
precedent for this endeavor. Accordingly, we examined conditions for optimizing the 
transformations of fuctionalization of oxazolidinone eonlates (Scheme 7). First, the two 
diastereomers of our oxazolidinone prepared from our methodology were separated through 
column chromatography and following recrystallization, isolating only the trans, enantiomerically 
pure product 83 as starting material. This is because the chirality center at the 2-position of 
oxazolidinone 83 was envisioned to control the enantioselectivity of the enolate functionalization 
reaction while our methodology provided a pair of diastereoisomers at the 2-position. 
Benzaldehyde, a commonly used electrophile in the study of aldol reaction, was used as the 
electrophile in our aldol reaction of our oxazolidinone. During the initial attempts, treatment of 
oxazolidinone 83 with 1.1 equivalent lithium diisopropylamide (LDA) in tetrahydrofuran (THF) 
at -78 oC followed by addition of benzaldehyde afforded the desired product 85 in only 18% 
isolated yield (Table 2, entry 1). Soft enolization conditions (Hünig’s base, Bu2BOTf) failed to 
provide any desired product probably because of the difficulty to form the boron enolates from the 
oxazolidinones due to the steric hindrance between substituents on 3, 5-position of oxazolidinone 
and boron moiety (Table 2, entry 2). Attempted enolate formation using Hünig's base and TiCl4 
gave the decomposition product likely owing to the incompatibility between the N, O-acetal and 
the strong Lewis acid (Table 2, entry 3). A detailed analysis of the product mixtures emerging 
from these reactions suggested that the retro-aldol reaction of our addition product may be the 
major factor for the poor yield under LDA conditions. Therefore, we planned further investigation 
into identifying whether the retro-aldol reaction of our addition product happen in our system.   
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Scheme 7 Proposed Reaction Pathway Using Oxazolidinones as Nucleophiles 
 
Table 2 First Attempts on the Aldol Reaction of Oxazolidinones 
 
a combined yield of diastereoisomers 
 
1.2.3.2 Retro-aldol study of addition products To test our assumption of the possible retro-aldol 
reaction, we planned to treat our aldol addition product 85 with excess sodium methoxide in 
methanol. The secondary alcohol was anticipated to be partially deprotonated by the excess sodium 
methoxide. If the retro-aldol reaction happened, the oxazolidinone 90 would be formed which 
would be further attacked by sodium methoxide to give α-hydroxy ester 87. If there were no retro-
aldol reaction, the sodium methoxide would directly attack the carbonyl and form the α,β-
dihydroxy ester 86.  Thus, the various reaction products would allow us to deduce whether the 
retro-aldol reaction was playing a significant role in these reactions. In a model experiment of 
treating aldol addition product 85 with excess sodium methoxide, all starting material diminished 
Entry Condition Solvent Temp Time Yielda 
1 LDA (1.1 equiv) THF -78 oC 1 h 18% 
2 DIPEA, Bu2BOTf DCM -78 oC 4 h N.R. 
3 DIPEA, TiCl4 DCM -78 oC 2 h Decomposition 
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on TLC after 10 min. The major products were confirmed to be α-hydroxy ester 87 and imine 66, 
indicating that the retro-aldol reaction happens easily in our system and almost certainly caused 
the low yield of the preceding reactions. A detailed mechanism based on the products obtained is 
proposed in scheme 8. The aldol addition product 85 was first partially deprotonated by the excess 
sodium methoxide to afford the anion 88, which underwent the retro-aldol reaction and provided 
enolate 89 and benzaldehyde. The tautomerization of enolate 89 in methanol afforded 
oxazolidinone 90. The oxazolidinone 90 was further attacked by sodium methoxide, which was 
proven in our previous hard nucleophile induced ring opening reaction of oxazolidinones, to afford 
α-hydroxy carbonyl compound 87.   
Scheme 8 Retroaldol Reaction Study 
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1.2.3.3 Reaction condition optimization The unexpected retro-aldol reaction necessitated finding 
another base instead of LDA in the aldol reaction of oxazolidinone with benzaldehyde because 
that the corresponding lithium aldolate was thought as the major reason for the retro-aldol reaction. 
The ideal base needed to possess sufficient basicity to deprotonate the α-position of carbonyl group 
while generating a conjugate acid that would protonate the aldolate alkoxide rapidly enough to 
prevent the retro-aldol reaction. Among common bases, DMAP attracted our attention due to 
observed epimerization of the 5-position of enantioenriched 2,5-diphenyloxazolidinone 83 in 
previous ring opening reactions attempts, indicating that DMAP can deprotonate our 
oxazolidinone and thus emerged as a potential alternative. Initial attempts using DMAP in THF at 
room temperature give product 85 in 78% yield after 96 h, although with poor selectivity (Table 
3, entry 1). We attributed the low selectivity to the possibility of an open transition state of the 
aldol reaction due to the lack of chelating group for two-point binding to enolate and aldehyde.  
With the aim of improving both efficiency and enantioselectivity, a metal-based Lewis acid 
was added with the anticipation of forming a closed transition state (Figure 7).   Fortunately, 
lithium chloride improved both reaction activity and selectivity remarkably. This reaction finished 
in 24 h with 73% yield and the selectivity increased to 86:6:8 (major isomer : minor isomer : ∑ of 
other isomers) (Table 3, entry 2). Treatment with lithium hypochlorite and lithium bromide led to 
similar yields and selectivities (Table 3, entry 3 and 4). Lithium iodide, however, failed to yield 
desired aldol addition product under similar reaction conditions. Instead, lithium iodide led to the 
decomposition of oxazolidinone. (Table 3, entry 5). Application of lithium triflate afforded 
comparable yield and selectivity albeit with longer reaction times (Table 3, entry 6). Conversely. 
commonly used Lewis acid magnesium bromide ethyl etherate (MgBr2•OEt2) resulted in a 
significant decrease in both yield (29% yield) and selectivity (72:18:10) (Table 3, entry 7), which 
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may be caused by the moderate solubility of magnesium bromide ethyl etherate in THF. Cerium 
chloride only afforded trace product probably due to the bad solubility of CeCl3 in THF (Table 3, 
entry 8). Trace product was obtained when using boron trifluoride ethyl etherate as Lewis acid. 
(Table 3, entry 9). No reaction took place with strong Lewis acid such as tin(IV) chloride and zinc 
bromide (Table 3, entry 10 and 11). This is most likely due to the formation of the unreactive 
adduct between DMAP and these strong Lewis acids as boron trifluoride ethyl etherate, tin (IV) 
chloride and zinc bromide. The yield improved to 85% by increasing the amount of Lewis catalyst 
to 3 equivalents however no increase in selectivity was observed (Table 3, entry 12).   
 
Figure 7 Open transition state vs. closed transition state of aldol reaction 
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Table 3 Screen of Lewis Acid 
 
Entry Lewis acid Time Yielda A:B:other isomersb 
1 None 96 h 78% 52:41:7 
2 LiCl 24 h 73% 86:6:8 
3 LiClO4 24 h 65% 86:6:8 
4 LiBr 24 h 67% 86:5:9 
5 LiI 24 h Decomposition N.D. 
6 LiOTf 48 h 75% 85:8:7 
7 MgBr2•Et2O 96 h 29% 72:18:10 
8 CeCl3 96 h Trace N.D. 
9 BF3•Et2O 96 h Trace N.D. 
10 SnCl4 48 h N.R.  
11 ZnBr2 48 h N.R.  
12 LiCl  (3.0 equiv) 24 h 85% 86:6:8 
a combined yield of diastereoisomers b determined by 1H NMR 
 
Since the base played a decisive role in our aldol reaction, we next screened several 
commonly used organic bases in the aldol reaction of oxazolidinone 83 with benzaldehyde using 
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3.0 equivalent LiCl as Lewis acid in THF at room temperature to determine whether there were 
better alternatives to DMAP. N,N-diisopropylethylamine lowered the reaction efficiency and 
afforded only 23% yield of desired product 85 yet maintained selectivity comparable to the DMAP 
conditions (Table 4, entry 2). Treating oxazolidinone 83 with triethylamine led to similar results 
compared with DMAP, although a small decrease is observed in both yield (72%) and selectivity 
(83:5:12) (Table 4, entry 3). Both 1,8-diazabicyclo[5,4,0]undec-7-ene (DBU) and 1,1,3,3-
tetramethylguanidine (TMG) resulted in a quick decomposition probably due to competing 
reactions stemming from their moderate nucleophilicity (Table 4, entry 4 and 5). No reaction 
happened when 2,6-lutidine was used in our reaction. This is probably because that the 2,6-lutidine 
is not basic enough to deprotonate oxazolidinones. (Table 4, entry 6). Compared with other bases 
for which the reaction usually took 24 h or more, 1,4-diazabicyclo[2,2,2]octane (DABCO) 
exhibited quite high activity and the reaction finished in 5 h. However, the yield dropped to 50% 
and the selectivity is somewhat inferior compared with DMAP (79:6:15) (Table 4, entry 7). Overall 
the experiments suggested that the suitable base for this reaction should have sufficient basicity to 
deprotonate the α-position of oxazolidinone while the conjugated acid of the base can be 
deprotonated by the aldolate alkoxide. Besides, the base should have poor nucleophilicity to avoid 
attacking on carbonyl and decreasing the yield. In all, DMAP was confirmed as the most suitable 
base in our system.   
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Table 4 Screen of Base 
 
Entry Base Time Yielda A:B:other isomersb 
1 DMAP 24 h 85% 86:6:8 
2 DIPEA 96 h 23% 83:7:10 
3 Et3N 24 h 72% 83:5:12 
4 DBU 1 h Decomposition N.D. 
5 TMG 1 h Decomposition N.D. 
6 2,6-lutidine 48 h N.R.  
7 DABCO 5 h 50% 79:6:15 
a combined yield of diastereoisomers b determined by 1H NMR 
The choice of solvent is often crucial for selectivity in asymmetric catalysis and solvent 
effects are rather unpredictable as they can perform multiple roles in a reaction (e.g. coordination, 
shuttles for reactive intermediates and hydrogen bond acceptor/donor)34. Therefore, a solvent 
screen will assist in determining optimum condition. Diethyl ether afforded 59% yield and 
80:10:10 selectivity in 96 h and the low activity is probably due to the poor solubility of 
oxazolidinone 83 in diethyl ether (Table 5, entry 2). Use of DCM afforded poor yield (24%) and 
moderate selectivity (69:16:15) (Table 5, entry 3). Toluene led to good selectivity (82:11:7) but 
unsatisfactory yield (56%) (Table 5, entry 4). Replacing THF with 1,2-dimethoxyethane (DME) 
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or 1,4-dioxane led to a slight drop in both yield and selectivity (Table 5, entry 5 and 6). When 
methyl tert-butyl ether (MTBE) was used as solvent, the selectivity is good (83:12:5) though the 
reaction required longer time (48 h) and provided moderate yield (53%) (Table 5, entry 7).  
Consequently, THF was identified as the optimal solvent for the transformation. Increasing the 
temperature to 40 oC or 50 oC in THF gave no improvement in either the yield or the selectivity 
(Table 5, entry 8 and 9).   
Table 5 Screen of Solvent and Temperature 
 
Entry Solvent Temp Time Yielda A:B:other isomersb 
1 THF rt 24 h 85% 86:6:8 
2 Et2O rt 96 h 59% 80:10:10 
3 DCM rt 96 h 24% 69:16:15 
4 Toluene rt 96 h 56% 82:11:7 
5 DME rt 24 h 72% 84:7:9 
6 1,4-dioxane rt 24 h 63% 80:14:6 
7 MTBE rt 48 h 53% 83:12:5 
8 THF 40 oC 20 h 63% 84:8:8 
9 THF 50 oC 20 h 38% 71:11:18 
a combined yield of diastereoisomers b determined by 1H NMR 
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1.2.3.4 Substrate scope The substrate scope of this reaction was explored and the results are 
summarized (Table 6). para-Methoxybenzaldehyde provided the aldol addition product 102 in 68% 
yield and 73:13:14 selectivity (Table 6, entry 2). When the electron donating ability of the 
substituent of benzaldehyde decreased, both the yield (71%) and the selectivity (85:7:8) increased 
(Table 6, entry 3). The benzaldehyde with the electron withdrawing nitro group at para position 
further improved the reaction activity (85%) and provided good enantioselectivity (84:5:11) (Table 
6, entry 4). meta-Nitrobenzaldehyde afforded similar results (91% yield, 83:7:10 selectivity) 
compared with para-nitro substituted benzaldehyde (Table 6, entry 5). ortho-
Methoxybenzaldehyde still afforded excellent selectivity (83:9:8) while the yield decreased to 64% 
(Table 6, entry 6). 2-Nitrobenzaldehyde gave good yield (78%) but the selectivity dropped 
(72:8:20) (Table 6, entry 7). Other aromatic aldehydes such as 2-furylaldehyde and 2-
naphthaldehyde are also applicable in the reaction with good results. (90% yield, 85:8:7 selectivity 
and 71% yield, 78:8:14 selectivity respectively) (Table 6, entry 8-9). Aldol addition product 110 
was obtained with good regioselectivity (1,2-addition, exclusively) and enantioselectivity (82:10:8) 
when cinnamaldehyde was used (Table 6, entry 10). In addition, the reaction is not only limited to 
aryl or alkenyl aldehyde but can also be applied to alkyl aldehyde such as hydrocinnamaldehyde 
and butyraldehyde though the selectivity significantly decreased (Table 6, entry 11-12).  
  
27 
 
Table 6 Substrate Scope 
 
Entry Aldehyde Major Product Time Yielda A:B:other 
isomersb 
1 
84 
85a 
24h 85% 86:6:8 
2 
91 
102a 
48h 68% 73:13:14 
3 
92 
103a 
30h 71% 85:7:8 
4 
93 
104a 
18h 85% 84:5:11 
5 
94 
105a 
18h 91% 83:7:10 
6 
95 
106a 
48h 64% 83:9:8 
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7 
96 
107a 
24h 78% 72:8:20 
8 
97 
108a 
16h 90% 85:8:7 
9 
98 
109a 
48h 71% 78:8:14 
10 
99 
110a 
24h 65% 82:10:8 
11 
100 
111a 
48h 69% 48:31:21 
12 101 
(10 equiv) 112a 
24h 77% 51:34:15 
a combined yield of diastereoisomers b determined by 1H NMR 
 
1.2.3.5 Identification of chirality The stereochemistry of the major diastereomeric product from 
our aldol reaction of enantioenriched oxazolidinones was unambiguously confirmed by X-ray 
crystallography. The major isomer 104a was isolated from the mixture of isomers through column 
chromatography and the single crystal of 104a was obtained through vapor diffusion using a 
dichloromethane and hexane system. Figure 8 clearly illustrates that the two oxygen atoms at the 
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α and β positions of the carbonyl adopt the syn configuration whereupon the absolute configuration 
of α-position of carbonyl is S-configuration while β-position of carbonyl is R-configuration.  
 
Figure 8 Structure and ORTEP Illustration of 104a with Thermal Ellipsoids Drawn at the 50% 
Probability Level (Hydrogen Atoms have been Omitted for Clarity) 
A rationalization for the stereochemical outcome of the aldol reaction of enantioenriched 
oxazolidinones to aldehydes is detailed in Scheme 9. Among all the four possible transition states, 
transition states TS1 and TS2 are kinetically favored compared with TS3 and TS4 for reason that 
the aldehyde approaches the enolate through the less hindered Si face. In the first two transition 
states, TS1 is more favored than TS2 due to the steric interactions between the R on the aldehyde 
and the phenyl group at the C5 position in TS2.  
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Scheme 9 Stereochemical Outcome of the Aldol Reaction of Oxazolidinones to Aldehydes Affording 
Diastereoisomeric Mixture of Products 
 
 
1.2.3.6 Attempts on Mannich reaction of oxazolidinones Based on the success of the aldol 
methodology, we pursued closely related Mannich additions as a potential route to α-hydroxy-β-
amino carbonyl compounds. A reaction employing N-tosyl imine 122 with 3.0 equiv LiCl in THF 
at room temperature afforded the Mannich addition product 123 in 78% yield and 65:26:9 
selectivity (Table 7, entry 1). N-Nosyl imine 66 gave similar results under the same reaction 
condition (82% yield, 65:22:13 selectivity) (Table 7, entry 2). Compared with aldol reactions, the 
decrease of the selectivity may be caused by the loose closed transition state due to the bulky group 
on the imine nitrogen. Limitations, however, were encountered in the Mannich reaction with in 
situ formed alkyl imines. This can be attributed to the quick imine-enamine tautomerization rate 
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compared with the Mannich reaction rate, which led to side reactions. In all, we successfully 
developed the Mannich reaction of our oxazolidinone with aromatic imines to afford α-hydroxy-
β-amino carbonyl compounds with moderate outcome.   
Table 7 Mannich Reaction of Oxazolidinones 
 
Entry Imine Product Time Yielda A:B:other isomersb 
1 
122 
123a 
24h 78% 65:26:9 
2 
66 
124a 
18h 82% 65:22:13 
a combined yield of diastereoisomers b determined by 1H NMR 
 
1.2.3.7 Ring Opening Reaction of Aldol Product Hard nucleophiles induced ring opening 
reactions of enantioenriched oxazolidinones have already been proved to be successful. Herein, 
we anticipated that enantioenriched aldol products should provide a direct route to the preparation 
of chiral syn-α,β-dihydroxy carbonyl compounds through the same hard nucleophile induced ring 
opening reaction. We planned to use a series of hard nucleophiles including sodium methoxide, 
ammonium hydroxide, Weinreb amide and morpholine in the ring opening reaction of 85a, which 
gave excellent outcome in the hard nucleophile induced ring opening reaction of enantioenriched 
oxazolidinone 67. Nonetheless, problems were encountered during the exploratory reactions. 
Among these hard nucleophiles induced ring opening reaction of 85a, only the sodium methoxide 
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gave the desired ring opening product 86 and the best yield (34% yield) was obtained when 0.4 
equivalent sodium methoxide in MeOH solution was added in 2 portions at -20 oC in MeOH over 
48 hours. (Equation 4) The major byproduct was 87, which was formed by retro-aldol reaction of 
85a followed by sodium methoxide induced ring opening reaction of the forming oxazolidinone. 
All other hard nucleophiles including ammonium hydroxide, morpholine, and 
dimethylhydroxylamine failed to provide the desired ring opening product. Instead, retro-aldol 
reactions of 85a followed by ring opening reaction of the retro-aldol products were the major 
reaction pathway in these reactions. The failure of these hard nucleophiles in the ring opening 
reaction of 85a can be attributed to two reasons. First, the basicity of some hard nucleophiles 
caused the retro-aldol reaction by deprotonating the hydroxyl group on 85a. Second, the phenyl 
rings on the 2, 5-positions of oxazolidinone 85a shielded the Si-face of the amide while the alkyl 
group on the 5-position and the nosyl group shielded the Re-face of the amide group, which made 
the nucleophile hard to approach the amide group (Figure 9). 
 
 
Figure 9 The Shielded Carbonyl of Oxazolidinone 85a 
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 Other Derivations of Chiral Oxazolidinones 
4-Oxazolidinone heterocycles have garnered considerable interest due to the existence of this 
structural motif in many natural products displaying promising antimicrobial activity.35 Indeed, 
our methodology can access this important family of heterocycles by deprotecting the nitrogen 
functionality. According to the reported nosyl deprotection method36, removing the nosyl 
protecting group of the oxazolidinone 83 was accomplished by using thiophenol and sodium 
carbonate in dimethylformamide at room temperature with 74% yield, which gave a forthright 
method to provide unprotected, optically active 4-oxazolidinones (Equation 5). In addition, for 
some oxazolidinone derivatives such as 126 and 124a, in which the amide was shielded by the 
nosyl group and substituents on the 2 and 5 positions of oxazolidinones, simple sodium methoxide 
in methanol provided the unprotected oxazolidinone compounds with 77% and 83% yields 
respectively (Equation 6 and 7). In all, this methodology represents an efficient two-step method 
for accessing enantioenriched unprotected oxazolidinones. 
 
 
 
Chiral 1,2-diols are found in a vast assortment of natural, biologically active molecules and 
thus the pursuit of new synthetic methods to prepare enantioenriched 1,2-diols remains an 
interesting topic. Generally, enantioenriched 1,2-diols are prepared by the following routes: ring 
34 
 
opening reactions of chiral epoxides,37 asymmetric dihydroxylation of olefins,38 hydrogenation of 
α-hydroxy carbonyls,39 enzymatic reactions40 and the reduction of α-keto-esters.41 In consideration 
of the high activity of the carbonyl group in our oxazolidinone, we speculated that the compounds 
may serve as precursors to prepare chiral 1,2-diols as a useful synthon in organic synthesis through 
a reductive ring opening reaction. Sodium borohydride reduction of oxazolidinone 67 confirmed 
our assumption and afforded the 1,2-diol 129 with 93% yield and 97% ee (Equation 8) 
 
 
 CONCLUSION 
 
In all, our group has successfully developed a new methodology for synthesizing chiral 
oxazolidinones through the cinchona-alkaloid catalyzed cyclocondensation reaction of acyl 
chlorides and oxaziridines with excellent yields and enantioselectivities, which afforded an access 
to a wide variety of useful structures and synthons. Reacting oxazolidinone 67 with hard 
nucleophiles effected addition-elimination to form a series of α-hydroxy carbonyl compounds. The 
proposed SN2 substitution route was proven to be exceedingly difficult to accomplish. Aldol 
reaction and Mannich reaction of our oxazolidinones provided the addition product with good 
results. Additionally, the aldol addition products can be converted into enantioenriched α,β-
dihydroxy carbonyl compounds with a quaternary chirality center at the α position as useful 
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synthons in natural product synthesis. The unprotected chiral oxazolidinones can be easily 
obtained by removing the nosyl protection group. Furthermore, chiral diol building blocks can also 
be obtained through the reductive ring opening reaction of our oxazolidinones.
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 EFFORTS TOWARDS THE TOTAL SYNTHEISI OF MARINEOSIN A 
     INTRODUCTION 
 Marineosin 
Marine actinomycetes are among the most fertile sources of structurally unique secondary 
metabolites. Some of the known compounds have potent biological activities and broad 
applications in the field of pharmaceutical drug development.42 Streptomyces, a diverse group of 
soil bacteria highly prolific in the production of microbially-derived antibiotics, belongs to the 
antinomycete family.43 A family of compounds known as prodigiosins display various structural 
substitutions of a common pyrrolylpyrromethene core (Figure 10). Of particular interest, 
marineosins A 136 and B 137, related to the prodigiosin class of polypyrrole bacterial pigments,44 
were isolated from a marine-derived streptomyces-related actinomycete collected by Fenical and 
coworkers in 2008 (Figure 11).45 Due to previously unreported unique structure and acute 
structure-dependent cytotoxiticy, marineosins are attractive targets both in medicinal and synthetic 
chemistry.   
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Figure 10 Representative Members of the Prodigiosin Family 
 
 
Figure 11 Marineosin A and Marineosin B 
Marineosin A and B exhibit several unique structural features. Spiroaminals, also called 
oxa-aza spirobicyclic frameworks, spiroaminoketals or spiro-N,O-ketals, are substructures 
existing in many biologically active compounds.46 The marineosins, which have a poly-pyrrole 
structure, possess 4-methoxy-2-pyrrolylazacyclopentene chromophores in addition to a previously 
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unknown spiroaminal constellation formed by adjacent tetrahydropyran and dihydropyrrole 
rings.47 The two different configurations adopted by the spiro-tetrahydropyran-dihydropyrrole 
aminals in marineosin A and B can be rationalized through stability effects. A plausible 
explanation of why marineosin A is more favorable than marineosin B invokes the stabilizing 
anomeric effect available to marineosin A.48 
Marineosin A displays human colon carcinoma HCT-116 inhibition with an IC50 of 0.5 
µM. Testing in the NCI 60 cell line panel demonstrated considerable selectivity against melanoma 
and leukemia cell lines. Marineosin A and marineosin B possess opposite configurations at the C7 
and C8 stereocenters and, as a result, marineosin B exhibits substantially decreased activity in all 
of the assays.45 
 
 Previous work on the total synthesis of marineosin A 
2.1.2.1   Lindsley’s synthesis In 2010 Lindsley reported the first synthetic efforts towards 
marineosin A 136 and marineosin B 137, which were described by evaluation of the proposed 
biosynthesis (Figure 12).49 The biosynthetic route proposed by the Fenical group was investigated, 
which featured an inverse-electron-demand hetero-Diels-Alder reaction as the key step to form the 
tetrahydropyran ring and the chiral spiroaminal structure in one single step. However, the proposed 
inverse-electron-demand hetero-Diels-Alder reaction from poly-pyrrole 139 could not be 
accomplished despite of various reaction conditions including thermal, microwave, photochemical, 
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Lewis acid catalysis and mineral acid catalysis. Herein, it was concluded that the proposed 
biosynthetic route was not viable under laboratory conditions.  
 
Figure 12 Retrosyntic Analysis of Marineosin A by the Lindsley Group 
In 2013, the Lindsley group also described the enantioselective construction of the 12-
membered macrocyclic pyrrole core 147 and spiroaminal structure 150 from the identical starting 
material 144, originally prepared from chiral oxazolidinone 142 and aldehyde 143 after several 
steps (Scheme 10).50 The alkene 145 was synthesized from 144 through a series of transformations. 
After a ring-closing metathesis reaction and Paal-Knorr pyrrole synthesis reaction, the desired 
macrocyclic pyrrole 147 was achieved from 145, with an overall 5.1% yield from the beginning 
starting material in 20 steps. Furthermore, the chiral spiroaminal moiety 150 was assembled in 38% 
yield from the same structure 144 through an acid-mediated cyclization strategy after a series of 
transformations.  
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Scheme 10  Lindsley’s Synthesis of Macrocyclic Pyrrole and Functionalized Spiroaminal Model 
        
 Meanwhile, the Lindsley group illustrated another enantioselective route to the 
spiroaminal structure in 9% overall yield (Figure 13).51 Grignard addition of 155 to chiral 
pyrrolidin-2,5-dione 154 followed by the treatment with p-toluenesulfonic acid generated the 
iminium salt 157, which was further attacked by the hydroxy group leading to the construction of 
spiroaminal 153. Removal of the 4-methoxybenzyl (PMB) protecting group using ceric 
ammonium nitrate resulted in the desired spiroaminal structure 151.  
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Figure 13 Lindsley’s Synthesis of Spiroaminal Moiety 
 
 
2.1.2.2   Snider’s synthesis Since the spiroaminal moiety of the marineosins consisting of 
tetrahydropyran and dihydropyrrole rings appeared to be unprecedented, Snider’s work focused 
on the synthetic route of the spiroaminal substructure 158 (Figure 14).47 The model enone 162, 
lacking the macrocyclic ring, was used as the starting material for the synthesis of the spiroaminal 
moiety. The alcohol protection and N-oxide cycloaddition afforded isoxazolinyl ketone 161, which 
underwent hydrogenolysis to afford the hemi-iminal 160.  Methylation of 160 gave methyl ether 
iminal 159. Treatment of 159 with aqueous hydrochloric acid hydrolyzed the protecting group and 
effected the loss of methanol to give the desired spiroaminal 158 as a mixture of diastereoisomers. 
 
Figure 14 Retrosynthetic Analysis of Spiroaminal Moiety of Marineosin A by the Snider Group 
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2.1.2.3    Shi’s work In 2013, the Shi group developed a new strategy to construct the spiroaminal 
fragment of marineosins A and B (Scheme 11).52 Treatment of 5-methyltetrahydrofuran-2-ol 163 
with 164 afforded the dihydropyrrol-2-one 165. N-acyliminium ion cyclization of 165 under acidic 
condition provided 166. A Pd/C reduction then provided isomers 167a and 167b with 64% and 
27% yield, respectively. The Tf2O mediated Vilsmeier-Haack type reaction with pyrrole provided 
the final product spiroaminal as a series of isomers. The anomeric effect and electronic repulsion 
between the two oxygen atoms of 168 was assumed to result in the formation of the undesired 
isomer. On the contrary, in the case of marineosin A or B, the fused macrocyclic ring will probably 
push the methoxy group away from it to form a more stable configuration.   
Scheme 11  Shi’s Work on the Formation of Spiroaminal Moiety 
 
The Shi group further reported the first total synthesis of marineosin A with 1.6% overall 
yield in 2016 (Scheme 12).53 Beginning from chiral pyranone 169, conjugated addition of Gilman 
reagent, aldol reaction and TBS protection afforded lactone 170. Ring opening reaction of 170 by 
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lithium thiazole, ketal formation and a three steps conversion from thiazole to aldehyde provided 
aldehyde 171. Reacting aldehyde 171 with (cyanomethyl)lithium, followed by the methylation of 
alcohol, nitrile reduction, alcohol deprotection and oxidation to ketone yielded amide 172, which 
was advanced to 1,4-diketone 173 via the Stetter reaction. Spirocyclization of 173 was 
accomplished using boron trifluoride ethyl etherate and the ring-closing metathesis followed by 
hydrogenation of alkene provided macrocycle structure 174. Conversion of 174 to the pyrrole with 
a microwave-assisted Paal-Knorr process followed by Vilsmeier-Haack type reaction gave the 
final product marineosin A 136. 
Scheme 12 The First Total Synthesis of Marineosin A by the Shi Group 
 
 
2.1.2.4 Sarli’s work The Sarli research group investigated the gold-catalyzed 
spiroamidoketalization of alkynyl amidoalcohols and provided an efficient method for the 
synthesis of spiro-aminol analogue of marineosin A (Scheme 13).54  Sonogashira cross-coupling 
reaction of amide 175 with an inseparable mixture of volatile alkenyl iodide 176 and 177 afforded 
alkynylamides 178 and 179 in a total of 64% yield. TBS deprotection and gold catalyzed 
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cyclization provided a mixture of spiroaminal structures 180, 181 and 182 in a total of 50% yield. 
The major isomer 181 was isolated and identified (more than 65% of the total spiroaminals).  
Scheme 13 Sarli's Spiroaminal Synthesis 
  
 
 EFFORTS TOWARDS THE TOTAL SYNTHESIS OF MARINEOSIN A 
 Retrosynthesis of marineosin A 
The molecule of marineosin A contains three challenging sites including the pyrrole-containing 
12-membered macrocycle ring, densely functionalized tetrahydropyran ring and previously 
unreported spiroaminal structure consisting of tetrahydropyran ring and dihydropyrrole ring. 
(Figure 15) Considering the molecule’s chemical sensitivity and recognizing its three challenging 
sites, the retrosynthetic analysis outlined in Figure 16 was chosen. Given the high sensitivity of 
the pyrrole units, we expected the pyrrole ring on the spiroaminal could be introduced by 
Vilsmeier-Haack reaction and the macrocyclic pyrrole could be synthesized by Paal-Knorr 
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reaction at a later stage, revealing intermediate 183 as a potential precursor. Inspired by the 
structural feature of 183 containing the 1,4-diketone motif, we decided to access the macrocycle 
through a Stetter reaction from enone 184, which has never been used in a macrocyclization 
reaction before. Considering the activity of hydrogen at the 2-position of tetrahedropyran ring, our 
approach towards the preparation of spiral aminal 184 would involve either a radical cyclization 
or a nitrene insertion and manipulation of protected alcohol from ester 186. An exo-selective 
asymmetric hetero-Diels-Alder reaction was expected to afford the chiral dihydro-2H-pyran ring 
186 between diene 187 and dienophile 188 followed by substrate-directed asymmetric 
hydrogenation of the olefin and methylation through oxocarbenium ion ensuring the correct 
configuration of stereocenter and methyl group.   
Construction of diene 187 was realized to come from the coupling reaction from trans-
vinyl triflate 189, which could be prepared using N-phenyltriflimide from β-keto ester 190 
followed DIBAL-H reduction and primary alcohol protection. The β-keto ester 190 would be 
prepared from diol 191 straightforwardly. The dienophile 188 would be set from 192 through the 
methylation and ozonolysis of the double bond. The oxidation of deoxyribose 194, a widely used 
chiral starting material, followed by the bromination with simultaneous acylation and zinc 
mediated elimination was anticipated to afford the desired allyl alcohol 192. 
 
Figure 15 Structural Analysis of Marineosin A 
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Figure 16 Retrosynthetic Analysis of Marineosin A 
 
 Model Study of spiroaminal structure of marineosin A 
2.2.2.1 Model Study of spiroaminal structure of marineosin A through nitrene insertion As 
depicted in Figure 16, both the macrocyclization and the spiro-aminal construction are both at a 
late stage in our synthesis. Herein, to determine the feasibility of the spiroaminal formation, a 
model study was carried out prior to the total synthesis. Towards this goal, we envisioned that the 
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acyl nitrene would potentially provide access to the structure at the beginning. As outlined in the 
model study (Scheme 14), the approach to the chiral spiroaminal relies upon the thermal or 
photolytic breakdown of the acyl azide 195 to deliver the corresponding acyl nitrene followed by 
the ideally positioned insertion across the C-H bond. While the use of nitrene insertion in natural 
products synthesis has already been reported,55 acyl nitrene insertion is relatively uncommon.56 It 
was proven that under some circumstances, the proximity of the two reacting sites would 
significantly accelerates the reaction by lowering the activation energy.57 Similarly, in our 
structure, the proximity of acyl nitrene and Csp3-H bond would strongly favor the insertion process. 
Additionally, the favorable entropy associated with 5-membered ring formation and the 
labilization of the axial C1-H bond resulting from the antiperiplanar alignment of the oxygen non-
bonding electron pair and σ*C-H should effectively enforce the desired regioselective C-H insertion. 
We were aware, however, that competing Curtius rearrangement could be problematic. 
Scheme 14  Proposed Nitrene Insertion Route to Construct Chiral Spiroaminal Structure 
 
Synthesis of a pyran derivative 195 possessing the relevant stereochemical relationships 
necessary to test the nitrene insertion was achieved by Swern oxidation of hydroxymethylenepyran 
198 to afford aldehyde 199. (Scheme 15) Chelation controlled addition of freshly prepared benzyl 
1-[(trimethylsilyl)oxy]vinyl ether 200 to aldehyde 199 provided β-hydroxy ester 201 possessing 
the correct C3-C4 syn stereochemistry in 46% yield after 2 steps. The Mukaiyama aldol product 
201 underwent the methylation by trimethyloxonium tetrafluoroborate and proton sponge to form 
the O-methylation product 202 in 92% yield. A three-step sequence of benzyl ester hydrolysis by 
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lithium hydroxide, acid to acyl chloride conversion by oxalyl chloride with DMF and sodium azide 
addition in acetone provided the desired acyl azide 195 in 50% yield.  
Scheme 15 Preparation of Acyl Azide in Model Study of Spiroaminal Synthesis 
 
Having access to nitrene precursor acyl azide 195, we next examined the reaction 
conditions of the acyl nitrene insertion. Different solvent may benefit to different conformation 
due to the solvent effect.58 Therefore, the direct nitrene insertion reaction was screened in different 
solvents in the anticipation that some solvents would strongly favor the conformation of 195 
beneficial to the C-H insertion reaction. Several common solvents were screened and in all cases, 
the Curtius rearrangement product was the only product. That is, the acyl azide decomposed into 
acyl nitrene, which underwent rearrangement to afford the isocyanate 204. The isocyanate 204 can 
be further attacked by the nucleophile as water or methanol to afford more stable products as amine 
205 and carbamate 206 for characterization (Scheme 16). This reaction was also screened under 
different temperature and solvent-free conditions. Nevertheless, only the Curtius rearrangement 
products were observed in all cases, which meant the direct nitrene insertion of our structure was 
hard to be accomplished under laboratory conditions.  
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Scheme 16  Study of Acyl Nitrene Insertion Reaction 
 
 
2.2.2.2 Model Study of spiroaminal structure of marineosin A through radical cyclization 
Since direct nitrene C-H insertion did not afford the direct insertion products, another route based 
on the radical cyclization illustrated by the Suárez group59 was proposed. In this event, treating 
amide 207, which was prepared directly from acid 203, with (diacetoxyiodo)benzene and iodine 
in acetonitrile under visible light afforded the anti-spiroaminal 197 as the only isomer in 56% yield. 
Comparing the spectrum of our product with the spectrum reported by the Lindsley group51, the 
configuration of 197 was conformed with the methoxy group of 197 adopting an anti-orientation 
relative to the ether oxygen (scheme 17). The mechanism was proposed as follows: first the 
reaction of (diacetoxyiodo)benzene with iodide provides the acetyl hypoiodite. Next the acetyl 
hypoiodite converts the amide 208 into the corresponding hypoiodite 209. Then the nitrogen 
radical 210 is formed through the homolytic cleavage of N-I bond. After the tandem hydrogen 
abstraction and single electron transfer, the oxocarbenium ion 212 produced is further attacked by 
intramolecular nucleophilic addition of amide to afford the spiroaminal structure 197.  Similar to 
the trend in  natural spiroketals prevalently possessing the optimal thermodynamically stable 
configuration,60 the configuration of  197 could be attributed to electronic repulsion between the 
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two oxygen atoms, rendering the anti-isomer as the lower energy isomer compared with the syn 
isomer (Figure 17). However, in the natural product marineosin A structure, the interaction 
between the fused macrocycle ring and the methoxy group will likely make the methoxy group 
stay away to ensure a more stable configuration (Figure 17). In view of this, we believe the radical 
cyclization in the model reaction should provide the desired configuration of the spiroaminal 
moiety in our total synthesis. 
Scheme 17  Synthesis of Spiroaminal 197 Through Radical Route and Proposed Mechanism 
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Figure 17 Configuration Analysis of Spiromainal Structure 
 
 
 Model study of the macrocyclization 
2.2.3.1 Model study of the macrocyclization through intramolecular acylation With the 
success of our spiroaminal moiety synthesis, we simultaneously pursued an investigation into the 
macrocyclization of the highly strained, 12-membered ring that would occur later in our synthesis. 
In addressing the synthetic objective, previously published intramolecular acylation 
macrocyclization influenced our initial efforts to construct the pyrrole-containing macrocycle.61 
To validate whether the proposed method was applicable in our structure, the pyrrolyl acid 217 
was prepared as displayed in Scheme 18. Pyrrole 212 was first protected with 4-tolunesulfonyl 
chloride in 65% yield. The Friedel-Crafts acylation of 1-tosylpyrrole 213 with monomethyl azelate 
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214 and trifluoroacetic anhydride (TFAA) followed by a selective reduction of carbonyl to 
methylene by using borane tert-butylamine and aluminum chloride afforded pyrrolyl ester 216 in 
56% yield. Hydrolysis of the resulting ester 216 afforded the desired acid 217 in 89% yield. At 
this point, we were ready to explore the key Friedel-Crafts macrocyclization. After several 
attempts, only the acid to acyl chloride conversion followed by the aluminum chloride mediated 
macrocyclization provided the ring-closing product 218. However, HR-MS analysis revealed that 
the ring-closed product was actually the dimer rather than desired macrocycle.    
Scheme 18 Preparation of Macrocycle Through Intramolecular Acylation Reaction 
 
 
The formation of the undesired macrocycle product 218 was attributed to the steric 
hindrance of the tosyl protecting group on pyrrole, which greatly increased the energy of the 12-
member ring and made it extremely hard for the acyl chloride to approach the 5-position of pyrrole 
by rounding the tosyl group (Figure 18). Therefore, the tosyl pyrrole was deprotected to diminish 
the impact of the steric hindrance of the protecting group in the anticipation of obtaining the desired 
macrocycle. Deprotection of 217 was accomplished with 5 N sodium hydroxide solution and 
methanol under reflux condition, providing the unprotected pyrrolyl acid 219 in 55% yield 
(Equation 9) Due to the significant nucleophilicity of the unprotected pyrrole, we used TFAA 
instead of the oxalyl chloride for the reaction. Unfortunately, pyrrolyl acid 217 directly reacted 
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with TFAA to afford product 220 rather than the desired macrocycle, which compelled us to 
explore alternatives for the macrocyclization. (Equation 10) 
 
Figure 18 Analysis of steric hindrance of the macrocyclization  
 
 
 
 
 
2.2.3.2 Model study of the macrocyclization through Stetter reaction Based on the instability 
exhibited by the pyrrole heterocycle in attempted macrocyclizations and the failure in our previous 
synthetic route with substrates containing pyrrole, we anticipated to prepare the macrocycle ring 
first without pyrrole followed by the microwave assisted Paar-Knorr reaction to assemble the 
desired pyrrole structure. Targeting a 1,4-diketone as a precursor to the requisite pyrrole allowed 
us to consider a Stetter reaction for the construction of the macrocycle. To the best of our 
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knowledge, the Stetter reaction had never been used as a macrocyclization reaction before. Since 
the pioneering work of Stetter in 1973, the N-heterocyclic carbene (NHC) -catalyzed addition of 
aldehydes to Michael acceptors, have enjoyed extensive utility in the synthesis of 1,4-dicarbonyl 
compounds that  would ordinarily require multistep operations for their synthesis.62 These 
umpolung conjugate additions are accepted to proceed by the activation of aldehyde 225  with the 
in situ formed carbene catalyst to  generate the nucleophilic Breslow intermediate 230. The 
Breslow intermediate undergoes an irreversible addition to the Michael acceptor, followed by the 
proton transfer and regeneration of the catalyst to produce the 1,4-dicarbonyl compound 226 
(Figure 20).  
 
Figure 19 Retrosynthetic Analysis of the Model Macrocycle Through Stetter Reaction 
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Figure 20 Stetter Reaction and Mechanism 
 
To evaluate the Stetter-based macrocycle synthesis, the requisite aldehyde-enone   239 was 
prepared as outlined in Scheme 19. The protection of 1,9-nonanediol 191 at one end with TBS 
protecting group followed by PCC oxidation of the unprotected hydroxy group provided aldehyde 
233 in 39% yield. Alkaloid-catalyzed ketene-aldehyde cycloaddition of 233 afforded the β-lactone 
234 in 73% yield. 26, 33, 63 Ensuing lactone ring opening with N,O-dimethylhydroxylamine  afforded 
β-hydroxy amide 235 in 81% yield, whereupon the hydroxy group was protected using tert-
butyldimethylsilyl triflate at low temperature to give 236 in 74% yield. Reacting Weinreb amide 
236 with DIBAL-H provided aldehyde 237 in 67% yield. Grignard addition reaction to 237 
followed by the selective deprotection of the terminal hydroxy group using pyridinium p-
toluenesulfonate (PPTS) gave the diol 238 as a mixture of two diastereoisomers in 66% yield after 
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two steps. At last, Dess-Martin Periodinane (DMP) oxidation of diol 238 provided the Stetter 
precursor 239 in 64% yield (Scheme 19).  
Scheme 19 The Synthesis of Enone 239 
 
With enone 239 prepared, we began to screen our proposed Stetter macrocyclization 
conditions. Based on the efficacy demonstrated in several total synthesis,64 Rovis catalyst 241 was 
screened first in our reaction. However, only trace product was obtained at 60 oC when 
triethylamine was used as base and toluene was used as solvent (Table 8, entry 1). The increase of 
temperature to 100 oC led to little improvement (Table 8, entry 2). The thizaolium-based catalyst 
242, which exhibited great activity in the intermolecular Stetter reaction in the synthesis of 
spirolide C attracted our attention.65 The previously reported  reaction conditions in the synthesis 
of spirolide C65 (catalyst 242 and K2CO3 in THF) showed no reaction activity. This is probably 
due to the bad solubility of potassium carbonate in THF and trace butylated hydroxytoluene (BHT) 
in THF, especially at a very low concentration (1.0 mmol/L) (Table 8, entry 3). Increasing the 
temperature and using Hünig’s base instead of the inorganic base did not afford any desired 
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product either. (Table 8, entry 4). Finally, changing the base into DBU, a more basic base than 
Hünig’s base, led to the desired macrocyclization product 240 in 35% yield (Table 8, entry 5). 
Despite the modest conversion, 239 was consumed completely according to the crude 1H NMR. 
One explanation for this moderate yield is the intrinsic polymerization characteristic of sterically 
unhindered enones.66 Indeed, scattered opaque white plastic was observed left in the syringe when 
a solution of 239 was added to the solution of catalyst 242 and base via a syringe pump in the 
macrocyclization.  It is worth noting that the reaction successfully generated a 12-membered 
macrocycle from a precursor that was devoid any preorganization or hindered rotational degrees 
of freedom. At last, the microwave assisted Paal-Knorr pyrrole synthesis delivered the desired 
macrocycle 243 in 72% yield (Equation 11), which proved our proposed macrocyclization is useful 
and promising.  
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Table 8 Investigation into the Stetter Macrocyclization Reaction 
 
Entry Catalyst Condition Temp Time Yield 
1 241 Et3N, toluene, 1.0 mmol/L 60 oC 24h trace 
2 241 Et3N, toluene, 1.0 mmol/L 100 oC 24h SM:Prod = 15:1a 
3 242 K2CO3, THF, 1.0 mmol/L 60 oC 24h N.R. 
4 242 DIPEA, toluene, 0.85mmol/L 80 oC 24h N.R. 
5 242 DBU, toluene, 1.0 mmol/L 100 oC 24h 35% 
a The ratio is determined by the crude 1H NMR. b isolated yield 
 
 
 Metal-chelated exo-selective hetero-Diels-Alder reaction 
 
With the success of our model reactions for the challenging spiroaminal structure and macrocycle 
preparation, we began our total synthesis towards marineosin A. Four stereocenters on the 
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tetrahydropyran ring posed a special challenge to construct stereospecifically. The hetero-Diels-
Alder (HDA) reaction, which provides a highly effective route in preparation of six-membered 
ring such as dihydropyrans and dihydropyrones,67 emerged as a prosperous strategy. However, the 
inverse-electron-demand hetero-Diels-Alder reaction was not applicable in the synthesis of 
marineosin A according to Lindsley’s work.49 Additionally, traditional Lewis acid catalyzed 
hetero-Diels-Alder reactions result in the formation of the endo product as the major isomer by 
reason of secondary orbital bonding interactions between the diene and dienophile.68 A chiral 
phosphoric acid catalyzed exo-selective HDA reaction69 failed to provide the chiral dihydropyran 
ring in our previous attempts. Inspired by the work of Danishefsky in chelation-controlled exo-
selective hetero-Diels-Alder reactions of chiral alkoxy aldehydes, we have been interested in 
constructing the tetrahydropyran ring through a similar exo-selective HDA reaction followed by 
substrate-directed hydrogenation and methylation (Figure 21). The exo selectivity is the result of 
approach of the diene on the less hindered face of the metal-chelated optically active aldehyde.   
 
Figure 21 Exo-selective Hetero-Diels-Alder Reaction 
In order to explore the proposed HDA reaction, the diene synthesis began with mono-TIPS 
protection of 1,9-nonanediol 101 followed by DMP oxidation to afford the aldehyde 244 in 44% 
yield. Reformatsky reaction of aldehyde 244 and ethyl bromoacetate followed by the DMP 
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oxidation of the resulting alcohol led to the beta-keto ester 190 in 62% yield. The trans isomer of 
the vinyl triflate 245 was prepared from 244 using N-phenyltriflimide and sodium hydride in DMF 
with 81% yield. Reducing the unsaturated ester 245 and TBS protection of the resulting allyl 
alcohol [(1) DIBAL-(H), THF; (2) TBSCl, imidazole] provided vinyl triflate 189 in 54% yield 
after two steps. Finally, Stille coupling of vinyl triflate 189 and freshly prepared organotin reagent 
gave the desired diene for the proposed HDA reaction (34% yield) (Scheme 20). 
Scheme 20 The Preparation of Diene 187  
 
 
Scheme 21 The Preparation of Dienophile 192 
 
 
The chiral dienophile 189 was readily obtained from the commercially available 2-deoxy-
L-ribose 194. Treatment of 194 with bromine in water gave 2-deoxy-L-ribonolactone 193 in 88% 
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yield. Bromination of the 5-position in acetic acid with simultaneous acylation of the other hydroxy 
groups followed by zinc mediated elimination, which further underwent basic hydrolysis process 
to remove the acyl group and subsequent esterification of the terminal acid in ethanol gave the 
chiral allyl alcohol 192 in 34% yield.70 Methylation of alcohol by proton sponge and 
trimethyloxonium tetrafluoroborate provided allyl ether 246 in 79% yield. Ultimately, the 
ozonolysis of the alkene afforded the desired aldehyde 188 as the dienophile in 75% yield (Scheme 
21).    
 FUTURE WORK 
Since both the diene 187 and the dienophile 188 had already been prepared, we planned to screen 
the metal-chelated exo-selective hetero-Diels-Alder reaction to optimize the outcome for the 
preparation of chiral dihydropyran ring 186 in the next step. The dihydropyran 186 will then 
undergo the substrate-directed hydrogenation and methylation through oxocarbenium ion to 
provide the desired core structure tetrahydropyran 185. Next, we will have the opportunity to apply 
our previous successful model reactions – the radical cyclization and the Stetter macrocyclization 
in the synthesis to prepare the spiroaminal structure and the macrocycle followed by the Vilsmeier-
Haack reaction to afford the final marineosin A structure (Scheme 22). 
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Scheme 22 Future Work towards the Total Synthesis of Marineosin A 
 
 
 SUMMARY 
 
In summary, in consideration of the challenging structural features of marineosin A, as well as the 
late-stage preparation of the challenging structures in our retrosynthetic analysis, we studied the 
model reactions to prepare the spiroaminal structure and the macrocycle structure. In the model 
system, the spiroaminal structure was obtained through a radical cyclization and the configuration 
analysis increased our confidence to obtain the isomer observed in marineosin A structure. A 
Stetter reaction gave us surprising results during the macrocyclization study. To the best of our 
knowledge, this is the first time that Stetter reaction was used in a macrocyclization reaction. In 
the total synthesis of marineosin A, both the diene and the dienophile has already been synthesized 
towards the preparation of dihydropyran ring through the proposed exo-selective HDA reaction.
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 EXPERIMENTAL FOR ENANTIOENRICHED OXAZOLIDINONES AS 
SYNTHESIS SCAFFOLDS 
General Information: Optical rotations were measured on a Perkin-Elmer 241 digital polarimeter 
with a sodium lamp at ambient temperature and are reported as follows: [α]λ(c = g/100 mL). 
Infrared spectra were recorded on a Nicolet Avatar 360 FT-IR spectrometer. NMR spectra were 
recorded on a Bruker Avance (1H: 300MHz; 13C: 75MHz), a Bruker Avance (1H: 400MHz, 13C: 
100MHz) or a Bruker Avance (1H: 500MHz, 13C: 125MHz) spectrometer with chemical shifts 
reported relative to residual CHCl3 (7.26 ppm) for 1H and CDCl3 (77.0 ppm) for 13C NMR spectra. 
Mass spectra were obtained on a VG-7070 or Fisons Autospec high resolution magnetic sector 
mass spectrometer.  
Unless otherwise stated, all reactions were carried out in dry glassware under a nitrogen 
atmosphere using standard inert atmosphere techniques for the manipulation of solvents and 
reagents. Anhydrous solvent (CH2Cl2, THF, DMF, diethyl ether and toluene) were obtained by 
passage through successive alumina and Q5 reactant-packed columns on a solvent purification 
system. N, N-diisopropylethylamine, triethylamine, pyridine, acetonitrile and diisopropylamine 
were distilled under nitrogen from calcium hydride. Benzaldehyde, 2-furaldehyde, 
cinnamaldehyde, butyraldehyde, hydrocinnamaldehyde, p-anisaldehyde and acetyl bromide were 
distilled before use. All the commercial chemicals are purchased from Aldrich Chemical Co or 
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Fisher Scientific Co. Flash chromatography was performed on EM silica gel 60 (230-240 mesh) 
unless noted otherwise.   
 
 
General Procedure A: Catalytic asymmetric ketene-oxaziridine cycloaddition: To a solution 
of O-trimethylsilylquinine (TMSQn) (0.2 equiv) in DCM was added N,N-diisopropylethylamine 
(2.0 equiv, 0.5 M). The resulting solution was cooled to −78 °C and stirred. The oxaziridine (1.0 
equiv) and the acyl chloride (2.0 equiv) were combined and dissolved in CH2Cl2 (0.3 M for the 
oxaziridine) in a separate flask and the resulting homogeneous mixture was then transferred into 
the previously made −78 °C solution via a syringe pump over 2h. Full consumption of the 
oxaziridine would be observed by TLC once the addition was complete. The reaction was stirred 
for another 0.5 h and quenched at the same temperature by adding Et2O and slurry usually formed. 
The heterogeneous mixture was then filtered through a short pad of celite, eluting with Et2O. The 
filtrate was concentrated and the crude material was purified by flash column chromatography. 
 
 (5S)-3-[(4-Nitrophenyl)sulfonyl)]-2,5-diphenyloxazolidin-4-one (83): 
General Procedure A was followed by employing 3.1 g of N-nosyl oxaziridine ±58 (10 mmol, 1.0 
equiv), 0.8 g of TMSQn (2 mmol, 0.2 equiv), 3.5 mL of N, N-diisopropylethylamine (20 mmol, 
2.0 equiv) and 2.6 mL of phenylacetyl chloride (20 mmol, 2.0 equiv). The product was purified by 
flash chromatography (SiO2, 5% ethyl acetate in hexane) to yield 3.3 g (78% yield) of the product 
as a mixture of two diastereomers. The two diastereomers were further separated by column 
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chromatography followed by recrystallization in hexane/ethyl acetate. Characterization of anti 
product: [𝛼]𝐷
20 -87.8, (c = 0.60, CHCl3), 1H NMR (400 MHz, CDCl3) 8.18 (d, J = 8.8 Hz, 2H), 7.74 
(d, J = 8.4 Hz, 2H), 7.49 (t, J = 6.8 Hz, 1H), 7.42-7.36 (m, 9H), 6.72 (s, 1H), 5.51 (s, 1H) ppm; 13C 
NMR (125 MHz, CDCl3) 168.6, 150.8, 142.9, 135.9, 133.7, 130.6, 129.5, 129.4, 129.0, 128.9, 
127.6, 126.1, 123.9, 91.3, 78.7 ppm. Characterization of syn product: [𝛼]𝐷
20 28.4, (c = 0.94, CHCl3), 
1H NMR (400 MHz, CDCl3) 8.16 (d, J = 8.8 Hz, 2H), 7.66 (d, J = 8.8 Hz, 2H), 7.47 (t, J = 6.8Hz, 
1H), 7.41-7.36 (m, 9H), 6.24 (s, 1H), 5.49 (s, 1H) ppm; 13C NMR (125 MHz, CDCl3) 168.4, 150.7, 
143.3, 135.4, 133.2, 130.8, 129.3, 129.1, 128.7, 128.6, 128.5, 126.2, 124.0, 90.7, 78.8 ppm. These 
compounds’ characterization data matched the data provided in the following literature: Guo, B. 
PhD dissertation, University of Pittsburgh, 2012.   
 
 
 (5S)-5-Benzyl-3-[(4-nitrophenyl)sulfonyl]-2-phenyloxazolidin-
4-one (67): General Procedure A was followed by employing 2.6 g of N-nosyl oxaziridine ±58 
(8.33 mmol, 1.0 equiv), 0.7 g of TMSQn (1.67 mmol, 0.2 equiv), 2.9 mL of N, N-
diisopropylethylamine (16.7 mmol, 2.0 equiv) and 2.5 mL of 3-phenylpropanoyl chloride (16.7 
mmol, 2.0 equiv). The product was purified by flash chromatography (SiO2, 5% ethyl acetate in 
hexane) followed to yield 2.4 g (66% yield) of the product as a mixture of two diastereomers. The 
two diastereomers were further purified by column chromatography followed by recrystallization 
in hexane/ethyl acetate for characterization. Characterization of anti product: [𝛼]𝐷
20 -80.2, (c = 1.44, 
CHCl3); 1H NMR (400 MHz, CDCl3) 8.13 (d, J  = 8.8 Hz, 2H), 7.54 (d, J = 8.8 Hz, 2H), 7.37 (t, J 
= 7.2 Hz, 1H), 7.21-7.14 (m, 7H), 6.75 (d, J = 8.4 Hz, 2H), 6.36 (s, 1H), 4.75 (t, J = 4.4 Hz, 1H), 
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3.21-3.19 (m, 2H) ppm; 13C NMR (100 MHz, CDCl3) 169.3, 150.6, 143.6, 135.2, 134.8, 130.5, 
130.1, 128.9, 128.6, 128.4, 128.2, 127.1, 123.8, 90.8, 78.4, 36.8 ppm; HRMS (ES+) m/z calculated 
for [M+H]+ C22H19N2O6S: 439.0964; found: 439.0977. Characterization of syn product:  [𝛼]𝐷
20 
25.8, (c = 0.51, CHCl3); 1H NMR (400 MHz, CDCl3) 8.15 (d, J = 8.8 Hz, 2H), 7.68 (d, J = 8.8 Hz, 
2H), 7.43 (t, J = 7.2 Hz, 1H), 7.34 (t, J = 7.6 Hz, 2H), 7.27-7.20 (m, 7H), 6.20 (d, J = 1.2 Hz, 1H), 
4.81 (td, J = 4.8, 1.2 Hz, 1H), 3.19 (dd, J = 14.4, 3.6 Hz, 1H), 3.09 (dd, J = 14.4, 5.2 Hz, 1H) ppm; 
13C NMR (100 MHz, CDCl3) 169.6, 150.8, 143.0, 136.5, 134.5, 130.4, 129.9, 129.3, 128.8, 128.5, 
127.3, 127.2, 123.9, 91.4, 78.0, 37.6 ppm; HRMS (ES+) m/z calculated for [M+H]+ C22H19N2O6S: 
439.0958; found: 439.0974. 
 
 
 Methyl (S)-2-hydroxy-3-phenylpropanoate (68): To a stirred solution of 
oxazolidinone 67 (87.7 mg, 0.2 mmol, 1.0 equiv) in 4 mL of MeOH was added 25% MeONa in 
MeOH solution (17µL, 0.08 mmol, 0.4 equiv) at 0 oC. The resulting mixture was stirred at this 
temperature for 2 hours and then warm up to ambient temperature and stirred overnight. After all 
the oxazolidinone 67 diminished on TLC, 2 mL of HCl in MeOH (5%) was added into the reaction 
to hydrolysis the imine byproduct. The resulting mixture was stirred for 10 min at ambient 
temperature and diluted with ethyl acetate and washed with water. The organic layer was separated 
and the aqueous layer was extracted ethyl acetate and the combined organic extracts were dried 
over MgSO4 and concentrated. The crude product was further purified by flash column 
chromatography (SiO2, 15% ethyl acetate in Hexane) to yield 32.2 mg (89% yield) of the title 
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compound as colorless oil. [𝛼]𝐷
20 -8.0, (c = 0.83, CHCl3), 1H NMR (300MHz, CDCl3) 7.25-7.12 
(m, 5H), 4.41-4.35 (m, 1H), 3.69 (s, 3H), 3.05 (dd, J = 13.8, 4.2 Hz, 1H), 2.89 (dd, J = 13.8, 6.6 
Hz, 1H), 2.61 (d, J = 5.7Hz, 1H) ppm, 13C NMR (100MHz, CDCl3) 174.6, 136.3, 129.5, 128.4, 
126.9, 71.3, 52.5, 40.6 ppm. Separating the enantiomers by GC [flow rate 1.0 mL/min, method: 105 
oC for 10 min, ramp @ 0.7 oC/min to 220 oC, hold for 10 min; Tr: 46.7 min (R), 48.4 min (S)] provided 
the enantiomer ratio S:R = 0.4 : 99.6 (99% e.e.). 
 
 
 (S)-2-Hydroxy-3-phenylpropanoic acid (72): Lithium hydroxide monohydrate 
(16.8 mg, 0.4 mmol, 2.0 equiv) was suspended in H2O/MeOH/THF = 0.4 mL/0.4 mL/1.2 mL and 
oxazolidinone 67 (87.7 mg, 0.2 mmol, 1.0 equiv) was added to the solution. The resulting solution 
was then stirred overnight at room temperature. After removal of the solvent under vacuo, the 
residue was then taken up in 5 mL of 1 M HCl and extracted with chloroform. The aqueous layer 
was extracted with chloroform (5 mL x 3). The combined organic layer was washed with brine, 
dried over sodium sulfate, filtered and concentrated. The crude residue was further purified by 
column chromatography (SiO2, 30% ethyl acetate in hexane) to afford 26.1 mg (0.16 mmol, 79% 
yield) of the desired product as a white solid. [𝛼]𝐷
20 -23.2, (c = 1.37, acetone), 1H NMR (500MHz, 
d6-acetone) 7.31-7.20 (m, 5H), 4.38 (dd, J = 8.0, 4.0 Hz, 1H), 3.12 (dd, J = 14.0, 4.0 Hz, 1H), 2.91 
(dd, J = 14.0, 7.5Hz, 1H), 2.08 (s, 1H) ppm; 13C NMR (125MHz, d6-acetone) 175.3, 138.9, 130.5, 
129.0, 127.3, 72.1, 41.3 ppm. E.e. 98%. The e.e. value was determined by converting it into the 
corresponding methyl ester then using GLC. 
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 (S)-2-Hydroxy-3-phenylpropanamide (69): To a stirred solution of oxazolidinone 
67 (87.7 mg, 0.2 mmol, 1.0 equiv) in 4 mL of MeOH was added 0.5 mL of ammonium hydroxide 
(28% - 30% NH3 in water) and the resulting mixture was kept stirring at room temperature for 10 
min. The mixture was concentrated under reduced pressure. The crude product was purified by 
column chromatography (SiO2, MeOH/DCM = 10:90) to provide 31.0 mg (94% yield) of the 
product as a white solid.  [𝛼]𝐷
20 -73.6, (c = 0.72, CHCl3), 1H NMR (400 MHz, CDCl3) 7.37-7.33 
(m, 2H), 7.30-7.26 (m, 3H), 6.36 (br, 1H), 5.43 (br, 1H), 4.34 (td, J = 8.4, 4.4 Hz, 1H), 3.26 (dd, J 
= 14.0, 4.0 Hz, 1H), 2.93 (dd, J = 14.0, 8.4 Hz, 1H), 2.38 (d, J = 4.0 Hz, 1H) ppm; 13C NMR (100 
MHz, CDCl3) 175.0, 136.6, 129.5, 128.9, 127.2, 72.8, 40.8 ppm.  
 
 
 (S)-2-Hydroxy-N-methoxy-N-methyl-3-phenylpropanamide (70): To a 0 oC 
solution of 39.0 mg of N,O-dimethylhydroxylamine hydrochloride (0.4 mmol, 4.0 equiv) in 1.0 
mL of CH2Cl2 was added 0.4 mL of dimethylaluminum chloride (0.4 mmol of 1M hexanes solution, 
4.0 equiv). Once addition was complete, the reaction was removed from the ice bath and warmed 
to ambient temperature where it was stirred for 0.5h. The resulting solution was cooled to 0 oC 
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whereupon 43.9 mg of oxazolidinone 67 (0.1 mmol, 1.0 equiv) was added. The resulting solution 
was cooled to 0 oC and allowed to warm slowly to ambient temperature. All starting material 
diminished on TLC overnight. The reaction was quenched with 1M HCl (1 mL) and diluted with 
10 mL of H2O and 10 mL of CH2Cl2. The layers were separated and the aqueous layer was 
extracted with CH2Cl2 (3 X 10 mL). The combined organic extracts were dried over Na2SO4 and 
concentrated. The crude product was further purified by column chromatography (hexane/ethyl 
acetate = 70:30) to afford 19.8 mg (94% yield) of desired product as a white solid. [𝛼]𝐷
20 -47.1, (c 
= 0.89, CHCl3), 1H NMR (500MHz, CDCl3) 7.31-7.28 (m, 2H), 7.24-7.22 (m, 3H), 4.63 (br, 1H), 
3.73 (s, 3H), 3.28-3.25 (m, 4H), 3.07 (dd, J = 13.5, 3.0 Hz, 1H), 2.85 (dd, J = 13.5, 7.5 Hz, 1H) 
ppm, 13C NMR (125MHz, CDCl3) 174.2, 137.3, 129.5, 128.3, 126.7, 69.7, 61.4, 41.0, 32.5 ppm.  
E.e. 97% HPLC (Daicel Chiralpak OD, hexanes/i-PrOH = 96:4, flow rate 1.0 mL/min, λ= 220 nm); 
major isomer: tR = 23.8 min, minor isomer: tR = 21.1 min 
 
 
 (S)-2-Hydroxy-1-morpholino-3-phenylpropan-1-one (71): To a stirred solution 
of 87.7 mg of oxazolidinone 67 (0.2 mmol, 1.0 equiv) and 12.2 mg of DMAP (0.1 mmol, 0.5 equiv) 
in 2 mL of THF was added 0.17 mL of morpholine (2.0 mmol, 10.0 equiv) dropwise at ambient 
temperature. The reaction was stirred at ambient temperature and monitored by TLC. After 24 
hours, all the starting material diminished on TLC and the reaction was diluted with 5 mL of DCM 
and quenched with 5 mL of saturated NH4Cl aqueous solution. The organic layer was separated 
and the aqueous layer was extracted with DCM (5 mL X 3). The combined organic layer was dried 
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over sodium sulfate and concentrated. The crude product was purified by flash column 
chromatography (hexane/ethyl acetate = 30:70 – 50:50) to afford 39.8 mg (85% yield) of desired 
product as a colorless oil. [𝛼]𝐷
20 +24.7, (c = 0.81, CHCl3), 1H NMR (500MHz, CDCl3) 7.32-7.29 
(m, 2H), 7.25-7.21 (m, 3H), 4.58 (t, J = 6.5Hz, 1H), 3.68-3.51 (m, 5H), 3.31-3.26 (m, 2H), 3.10-
3.03 (m, 1H), 2.95 (dd, J = 14.0, 7.0 Hz, 1H), 2.90 (dd, J = 14.0, 6.5 Hz, 1H) ppm; 13C NMR 
(125MHz, CDCl3)  172.5, 136.4, 129.4, 128.6, 127.0, 68.6, 66.6, 66.0, 45.4, 43.6, 42.4 ppm. E.e. 
97% HPLC (Daicel Chiralpak OD, hexanes/i-PrOH = 95:5, flow rate 1.0 mL/min, λ= 220 nm); 
major isomer: tR = 50.4 min, minor isomer: tR = 62.0 min 
 
 (2R,5S)-5-(4-Fluorophenyl)-3-[(4-nitrophenyl)sulfonyl]-2-phenyloxazolidin-
4-one: General Procedure A was followed by employing 4.3 g of N-nosyl oxaziridine ±58 (14 
mmol, 1.0 equiv), 1.1 g of TMSQn (2.8 mmol, 0.2 equiv), 4.9 mL of N,N-diisopropylethylamine 
(28 mmol, 2.0 equiv) and 3.8 mL of 2-(4-fluorophenyl)acetyl chloride (28 mmol, 2.0 equiv). The 
product was purified by flash chromatography (SiO2, 5% ethyl acetate in hexane) followed by 
recrystallization in hexane and ethyl acetate to yield 0.71 g (23% yield) cis-product as a white 
solid. [𝛼]𝐷
20 -26.1, (c = 1.42, CHCl3), 1H NMR (300 MHz, CDCl3) 8.19 (d, J =  8.7 Hz, 2H), 7.74 
(d, J = 9.0 Hz, 2H), 7.50-7.33 (m, 7H), 7.12 (t, J = 8.4 Hz, 2H), 6.72 (s, 1H), 5.49 (s, 1H) ppm; 13C 
NMR (100 MHz, CDCl3) 168.4, 163.3 (d, J = 247 Hz), 150.9, 142.8, 135.7, 130.7, 129.5, 128.9, 
128.1, 128.0, 127.5, 123.9, 116.1 (d, J = 21 Hz), 91.3, 78.1 ppm. This compound’s characterization 
data matched the data provided in the following literuature: Guo, B. PhD dissertation, University 
of Pittsburgh, 2012. 
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 (2S,5S)-5-(4-Methoxyphenyl)-3-[(4-nitrophenyl)sulfonyl]-2-
phenyloxazolidin-4-one: General Procedure A was followed by employing 2.1 g of N-nosyl 
oxaziridine ±58 (6.9 mmol, 1.0 equiv), 0.5 g of TMSQn (1.37 mmol, 0.2 equiv), 2.4 mL of N,N-
diisopropylethylamine (13.7 mmol, 2.0 equiv) and 2.1 mL of 2-(4-methoxyphenyl)acetyl chloride 
(13.7 mmol, 2.0 equiv). The product was purified by flash chromatography (SiO2, 5% ethyl acetate 
in hexane) followed by recrystallization in hexane and ethyl acetate to yield 0.53g (34% yield) 
trans-product as a light yellow solid. [𝛼]𝐷
20 75.4, (c = 0.59, CHCl3), 1H NMR (300 MHz, CDCl3) 
8.17 (d, J = 9.0 Hz, 2H), 7.67 (d, J = 9.0 Hz, 2H), 7.49 (t, J = 3.0 Hz, 1H), 7.38-7.36 (m, 4H), 7.32 
(d, J = 8.7 Hz, 2H) 6.90 (d, J = 8.7 Hz, 2H), 6.59 (d, J = 1.2 Hz, 1H), 5.43 (s, 1H), 3.79 (s, 3H) 
ppm; 13C NMR (125 MHz, CDCl3) 168.7, 160.3, 150.8, 143.4, 135.5, 130.8, 129.3, 128.6, 128.5, 
127.9, 125.3, 124.0, 114.2, 90.6, 78.9, 55.3 ppm. This compound’s characterization data matched 
the data provided in the following literuature: Guo, B. PhD dissertation, University of Pittsburgh, 
2012. 
 
 
 (S)-2,2-Dimethyl-3-[(4-nitrophenyl)sulfonyl]-5-phenyloxazolidin-4-one: General 
Procedure A was followed by employing 258 mg of 3,3-dimethyl-2-[(4-nitrophenyl)sulfonyl]-1,2-
oxaziridine (1.0 mmol, 1.0 equiv), 80 mg of TMSQn (0.2 mmol, 0.2 equiv), 0.35 mL of N,N-
diisopropylethylamine (2.0 mmol, 2.0 equiv) and 0.26 mL of phenylacetyl chloride (2.0 mmol, 2.0 
equiv). The product was purified by flash chromatography (SiO2, 10% ethyl acetate in hexane) 
followed by recrystallization in hexane and ethyl acetate to yield 222 mg (59% yield) of desired 
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product as a white solid. IR (thin film): 3109, 2980, 1754, 1607, 1534, 1497, 1373, 1087, 856, 739, 
683 cm-1;  1H NMR (400 MHz, CDCl3) 8.38 (d, J = 9.2 Hz, 2H), 8.29 (d, J = 8.8 Hz, 2H), 7.35-
7.34 (m, 5H), 5.26 (s, 1H), 1.99 (s, 3H), 1.93 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) 169.3, 
151.0, 143.6, 133.9, 130.2, 129.1, 128.7, 126.3, 124.2, 98.4, 28.7, 27.3 ppm; HRMS (ES+) m/z 
calculated for [M+H]+ C17H17N2O6S: 377.0807; found: 377.0817. 
 
 (2R,5S)-2-[2-(Methyl)phenyl]-3-[(4-nitrophenyl)sulfonyl]-5-phenyloxazolidin-4-
one: General Procedure A was followed by employing 1.6 g of 2-[(4-nitrophenyl)sulfonyl]-3-(o-
tolyl)-1,2-oxaziridine (5.0 mmol, 1.0 equiv),   0.4 g of TMSQn (1.0 mmol, 0.2 equiv), 1.8 mL of 
N,N-diisopropylethylamine (10.0 mmol, 2.0 equiv) and 1.3 mL of phenylacetyl chloride (10.0 
mmol, 2.0 equiv). The product was purified by flash chromatography (SiO2, 5% ethyl acetate in 
hexane) and further recrystallization in hexane and ethyl acetate to yield 0.21 g (19% yield) cis-
product as a white solid. [𝛼]𝐷
20 -29.6, (c = 1.14, CHCl3); IR (thin film): 3106, 3067, 2981, 1759, 
1607, 1533, 1495, 1350, 1228, 855, 740, 697 cm-1;  1H NMR (400 MHz, CDCl3) 8.22 (d, J = 8.8 
Hz, 2H), 7.82 (d, J = 8.8 Hz, 2H), 7.42 (s, 5H), 7.38-7.34 (m, 2H), 7.13-7.06 (m, 2H), 6.98 (s, 1H), 
5.41 (s, 1H), 2.46 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) 168.9, 150.9, 142.8, 137.6, 133.6, 
133.4, 131.5, 130.4, 129.6, 129.4, 129.0, 126.9, 126.2, 126.2, 124.0, 88.8, 78.3, 18.8 ppm; HRMS 
(ES+) m/z calculated for [M+Na]+ C22H18N2O6NaS: 461.0783; found: 461.0775. 
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 (2R,5S)-2-[2-(Benzyloxy)phenyl]-3-[(4-nitrophenyl)sulfonyl]-5-phenyloxazolidin-
4-one: General Procedure A was followed by employing  6.8 g of 3-(2-[benzyloxy)phenyl]-2-[(4-
nitrophenyl)sulfonyl]-1,2-oxaziridine (6.8 mmol, 1.0 equiv), 0.5 g of TMSQn (1.36 mmol, 0.2 
equiv), 2.4 mL of N,N-diisopropylethylamine (13.6 mmol, 2.0 equiv) and 1.8 mL of phenylacetyl 
chloride (13.6 mmol, 2.0 equiv). The product was purified by a quick flash chromatography (30% 
ethyl acetate in hexane) followed by recrystallization in ethyl acetate and hexane to yield 0.18 g 
(10% yield) cis-product as a light yellow solid. [𝛼]𝐷
20 -17.2, (c = 2.40, CHCl3); IR (thin film): 3110, 
3032, 2925, 1708, 1601, 1531, 1496, 1349, 1229, 1088, 854, 740, 697 cm-1;  1H NMR (300 MHz, 
CDCl3) 8.11 (d, J = 9.0 Hz, 2H), 7.80 (d, J = 9.0 Hz, 2H), 7.44-7.30 (m, 11H), 7.23 (s, 1H), 7.05-
6.96 (m, 3H), 5.38 (s, 1H), 4.98 (s, 2H) ppm; 13C NMR (100 MHz, CDCl3) 168.9, 157.6, 150.8, 
143.2, 136.1, 133.4, 132.0, 129.6, 128.9, 128.6, 128.6, 128.2, 127.6, 126.4, 123.9, 120.9, 112.7, 
78.7, 70.6 ppm; HRMS (ES+) m/z calculated for [M+H]+ C28H23N2O7S: 531.1226; found: 
531.1236. 
 
2-Azido-2-phenylacetic acid: 2-Bromo-2-phenylacetic acid (118 mg, 0.55 mmol, 1.0 
equiv) and sodium azide (54 mg, 0.83 mmol, 1.5 equiv) were mixed in 2 mL of dry DMF and 
stirred at room temperature. The reaction was stopped after 24 h by removing the DMF in vacuo. 
The crude product was purified by flash column chromatography (10% MeOH in DCM) to yield 
41 mg (42% yield) of 2-azido-2-phenylacetic acid as a white solid. 1H NMR (300 MHz, CDCl3): 
7.42 (app, s, 5H), 5.03 (s, 1H) ppm. 3.90-3.20 (br, 1H) ppm.71 
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2-Azido-N-[(4-nitrophenyl)sulfonyl]-2-phenylacetamide: DMAP (293 mg, 2.4 
mmol, 2.4 equiv) was added to a suspension of EDCI∙HCl (249 mg, 1.3 mmol, 1.3 equiv) in 2.5 
mL of DCM. The mixture was stirred at room temperature until all the solids dissolved and then 
was cooled to 0 oC. 2-azido-2-phenylacetic acid (177 mg, 1.0 mmol, 1.0 equiv) was added followed 
by p-NsNH2 (243 mg, 1.2 mmol, 1.2 equiv) and the reaction was stirred at room temp for 20 h. 
Diethyl ether (5 mL) was added and the organic mixture was washed with 2N HCl (8 mL). The 
aqueous layer was extracted with ethyl acetate (3 x 10 mL). The combined organic layer was 
washed with brine, dried over magnesium sulfate, filtered and concentrated. The crude product 
was further purified by flash column chromatography (SiO2, 10% methanol in DCM) to afford 195 
mg (54% yield) of 2-azide-N-[(4-nitrophenyl)sulfonyl]-2-phenylacetamide as a white solid. 1H 
NMR (300 MHz, CDCl3) 8.88 (br, 1H), 8.36 (d, J = 9.0 Hz, 2H), 8.25 (d, J = 9.0 Hz, 2H), 7.42 (m, 
3H), 7.26-7.24 (m, 2H), 5.06 (s, 1H) ppm; HRMS (ES+) m/z calculated for [M+Na]+ 
C17H11N5O5SNa: 384.0379; found: 384.0383. 
 
 
General Procedure B: Direct azide induced ring opening reaction of oxazolindinone: To a 
solution of azide source compound (1.1 – 5.0 equiv) in solvent was added a solution of 
oxazolidinone (1.0 equiv) in solvent. The resulting solution was kept stirring at different 
temperature and monitored by TLC. After all the starting material diminished on TLC, the mixture 
was quenched with saturated NaHCO3 solution. The aqueous layer was extracted with EtOAc and 
the combined organic layer was dried over sodium sulfate and concentrated. The crude mixture 
was further purified by flash column chromatography.  
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General Procedure C: Transition metal azide complex induced ring opening reaction of 
oxazolidinone: To a solution of freshly prepared transition metal azide complex (1.2 equiv) in 
solvent was added a solution of oxazolidinone (1.0 equiv) in solvent. The resulting solution was 
kept stirring at different temperature and monitored by TLC. The mixture was quenched with 
saturated NaHCO3, extracted with EtOAc and the combined organic layer was dried over sodium 
sulfate and concentrated. The crude mixture was further purified by flash column chromatography. 
 
 
General Procedure D: Hydrazoic acid induced ring opening reaction of oxazolidinone: To a 
solution of oxazolidinone (1.0 equiv) in dry solvent was added TMSN3 (2.0 equiv) and MeOH. 
The mixture was warmed up and monitored by TLC. After all the starting material diminished on 
TLC, the mixture was quenched with saturated NaHCO3.  The aqueous layer was extracted with 
EtOAc and the combined organic layer was dried over sodium sulfate and concentrated. The crude 
product was further purified by flash column chromatography. 
 
 
General Procedure E: Lewis acid catalyzed azide induced ring opening reaction of 
oxazolidinone: To a dry solution of Lewis acid (1.5 equiv) in solvent was added a solution of 
oxazolidinone (1.0 equiv) followed by tetrabutylammonium azide (1.5 equiv). The mixture was 
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kept stirring at room temperature and monitored by TLC. After all the starting material diminished 
on TLC, the mixture was quenched with saturated NaHCO3 solution.  The aqueous layer was 
extracted with EtOAc and the combined organic layer was dried over sodium sulfate and 
concentrated. The crude product was further purified by flash column chromatography. 
 
 
General Procedure F: Lewis base activated azide induced ring opening reaction of 
oxazolidinone: To a solution of azide nucleophile (1.5 equiv) was added Lewis base (1.5 equiv) 
and the mixture was kept stirring at room temp for 10min, then a solution of oxazolidinone (1.0 
equiv) was added. The mixture was kept stirring at different temperature and monitored by TLC. 
After all the starting material diminished on TLC, the mixture was quenched with saturated 
NaHCO3 solution.  The aqueous layer was extracted with EtOAc and the combined organic layer 
was dried over sodium sulfate and concentrated. The crude product was further purified by flash 
column chromatography. 
 
4-Nitro-N-({(2R)-3-[(4-nitrophenyl)sulfonyl]-4-oxo-2,5-diphenyloxazolidin-5-
yl}(phenyl)methyl)benzenesulfonamide (124a): [𝛼]𝐷
20 -14.6, (c = 1.50, CHCl3), IR (thin film): 
3311, 3108, 2923, 1754, 1532, 1350 cm-1; 1H NMR (300 MHz, CDCl3) 8.30 (d, J = 9.0 Hz, 2H), 
7.94 (t, J = 8.7 Hz, 4H), 7.60 (d, J = 9.0 Hz, 2H), 7.37-7.30 (m, 2H), 7.22-7.18 (m, 4H), 7.04 (t, J 
= 7.5 Hz, 5H), 6.91 (t, J = 6.9 Hz, 2H), 6.79 (d, J = 7.5 Hz, 2H), 6.38 (s, 1H), 6.18 (d, J = 10.2 Hz, 
1H), 4.78 (d, J = 10.5 Hz, 1H) ppm; 13C NMR (125 MHz, CDCl3) 168.9, 151.2, 149.6, 145.1, 
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142.2, 136.0, 135.0, 134.1, 130.4, 129.7, 128.7, 128.5, 128.4, 128.3, 128.1, 128.1, 127.7, 127.5, 
125.3, 124.4, 123.7, 91.7, 86.8, 64.6 ppm. HRMS (ESI) m/z calculated for [M+H]+ C34H27N4O10S2: 
715.1163; found: 715.1148. 
 
N-({(2S)-5-(4-Methoxyphenyl)-3-[(4-nitrophenyl)sulfonyl]-4-oxo-2-
phenyloxazolidin-5-yl}(phenyl)methyl)-4-nitrobenzenesulfonamide: [𝛼]𝐷
20  -3.0, (c = 1.21, 
CHCl3), IR (thin film): 3120, 3025, 2932, 1711, 1609, 1535, 1512, 1380, 1250, 1107, 1034, 856, 
736, 682 cm-1; 1H NMR (400 MHz, CDCl3): 8.27 (d, J = 8.7 Hz, 2H), 7.97 (d, J = 8.7 Hz, 2H), 
7.87 (d, J = 8.7 Hz, 2H), 7.60 (d, J = 9.0 Hz, 2H), 7.34 (t, J = 7.5 Hz, 1H), 7.19 (t, J = 7.8 Hz, 2H), 
7.12-7.06 (m, 3H), 7.01-6.96 (m, 4H), 6.85 (d, J = 7.5 Hz, 2H), 6.54 (d, J = 9.0 Hz, 2H), 6.27 (s, 
1H), 5.85 (d, J = 10.5 Hz, 1H), 4.75 (d, J = 10.5 Hz, 1H), 3.68 (s, 3H) ppm; 13C NMR (125 MHz, 
CDCl3) 169.1, 159.7, 151.2, 149.6, 145.3, 142.3, 136.0, 134.4, 130.4, 129.7, 128.5, 128.5, 128.3, 
128.2, 127.7, 127.6, 127.0, 126.7, 124.4, 123.7, 113.4, 91.7, 86.4, 64.7, 55.1 ppm. HRMS (ES+) 
m/z calculated for [M+H]+ C35H28N4O11S2Na: 767.1094; found: 767.1119. 
 
N-({(2R)-5-(4-Fluorophenyl)-3-[(4-nitrophenyl)sulfonyl]-4-oxo-2-
phenyloxazolidin-5-yl}(phenyl)methyl)-4-nitrobenzenesulfonamide (54): [𝛼]𝐷
20 6.3, (c = 0.75, 
CHCl3), IR (thin film): 3308, 3108, 2928, 1606, 1537, 1508, 1351, 855, 837, 738, 701 cm-1; 1H 
NMR (400 MHz, CDCl3): 8.32 (d, J = 8.8 Hz, 2H), 7.97 (d, J = 8.8 Hz, 2H), 7.96 (d, J = 8.8 Hz, 
2H), 7.62 (d, J = 8.8 Hz, 2H), 7.36 (t, J = 7.2 Hz, 1H), 7.22 (t, J = 8.0 Hz, 2H), 7.16-7.13 (m, 2H), 
7.04-7.00 (m, 3H), 6.90 (t, J = 7.6 Hz, 2H), 6.73-6.69 (m, 4H), 6.48 (s, 1H), 5.85 (d, J = 10.4 Hz, 
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1H), 4.74 (d, J = 10.8 Hz, 1H) ppm; 13C NMR (100 MHz, CDCl3) 168.9, 162.7 (d, J = 247 Hz), 
151.3, 149.7, 145.0, 142.1, 135.9, 133.8, 130.8 (d, J = 3 Hz), 130.6, 129.8, 128.6, 128.5, 128.3, 
128.2, 127.6, 127.4, 127.3, 124.5, 123.8, 115.1 (d, J = 22 Hz), 91.7, 86.6, 64.6 ppm; HRMS (ESI) 
m/z calculated for [M-H]- C34H24N4O10FS2: 731.0923; found: 731.0922. 
 
 
General Procedure G: Aldol reaction of oxazolidinone: To a flame dried 2 dram vial was added 
oxazolidinone (0.1 mmol, 1.0 equiv), DMAP (0.12 mmol, 1.2 equiv) and lithium chloride (0.3 
mmol, 3.0 equiv), then 2 mL of solvent was added through a syringe followed by aldehyde (0.2 
mmol, 2.0 equiv). The mixture was kept stirring at room temperature and monitored by TLC. After 
all the starting material diminished on TLC, 10 mL of NH4Cl solution (aq) was added to quench 
the reaction and aqueous layer was extracted with EtOAc (10 mL X 3). The combined organic 
layer was dried over sodium sulfate and concentrated. The crude product was further purified by 
column chromatography to afford the desired product. 
 
 General Procedure G was followed by employing 42.4 
mg of oxazolidinone 83 (0.10 mmol, 1.0 equiv), 14.7 mg of DMAP (0.12 mmol, 1.2 equiv), 12.7 
mg of LiCl (0.30 mmol, 3.0 equiv) and 20 µL of benzaldehyde (0.20 mmol, 2.0 equiv). The product 
was purified by flash chromatography (SiO2, hexane/ethyl acetate = 85:15) to yield 45.3 mg (85% 
yield) of product as a mixture of diastereomers. (major isomer/minor isomer/∑ of other isomers = 
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86:6:8). The major isomer and the minor isomer were further separated by column chromatography 
for characterization.  
 
(2S,5S)-5-[(R)-Hydroxy(phenyl)methyl]-3-[(4-nitrophenyl)sulfonyl]-2,5-
diphenyloxazolidin-4-one (85a): [𝛼]𝐷
20 -26.6, (c = 0.95, CHCl3),  1H NMR (500MHz, CDCl3) 8.19 
(d, J = 9.0 Hz, 2H), 7.80 (d, J = 9.0 Hz, 2H), 7.45-7.38 (m, 3H), 7.34-7.29 (m, 4H), 7.22-7.14 (m, 
4H), 7.10 (t, J = 7.5 Hz, 2H), 7.02 (d, J = 7.5 Hz, 2H), 6.89 (s, 1H), 5.27 (d, J = 3.5 Hz, 1H), 2.31 
(d, J = 3.5 Hz, 1H) ppm; 13C NMR (125MHz, CDCl3) 170.7, 150.8, 143.2, 137.0, 136.9, 135.4, 
130.4, 129.7, 128.5, 128.4(2C), 128.3, 128.0, 127.8, 127.7, 125.4, 123.9, 92.3, 87.2, 80.9 ppm. 
HRMS (ESI) m/z calculated for [M+H]+ C28H23N2O7S: 531.1220; found: 531.1226.  
 
(2S,5S)-5-[(S)-Hydroxy(phenyl)methyl]-3-[(4-nitrophenyl)sulfonyl]-2,5-
diphenyloxazolidin-4-one (85b): [𝛼]𝐷
20 -1.2, (c = 0.31, CHCl3), 1H NMR (500MHz, CDCl3) 8.11 
(d, J = 9.0 Hz, 2H), 7.66-7.64 (m, 2H), 7.56 (d, J = 9.0 Hz, 2H), 7.48-7.37 (m, 9H), 7.27-7.23 (d, 
J = 8.5 Hz, 2H), 7.08 (d, J = 7.0 Hz, 2H), 5.92 (s, 1H), 5.20 (d, J = 4.0 Hz, 1H), 2.09 (d, J = 4.0 
Hz, 1H) ppm; 13C NMR (125MHz, CDCl3) 168.6, 150.7, 142.8, 136.6, 136.3, 135.6, 130.4, 129.4, 
129.0, 128.9, 128.8, 128.5 (2C), 128.1, 127.8, 125.7, 123.9 ppm. HRMS (ESI) m/z calculated for 
[M+H]+ C28H23N2O7S: 531.1220; found: 531.1209.  
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 General Procedure G was followed by 
employing 42.4 mg of oxazolidinone 83 (0.10 mmol, 1.0 equiv), 14.7 mg of DMAP (0.12 mmol, 
1.2 equiv), 12.7 mg of LiCl (0.30 mmol, 3.0 equiv) and 24 µL of p-anisaldehyde (0.20 mmol, 2.0 
equiv). The product was purified by flash chromatography (SiO2, 15% ethyl acetate in hexane) to 
yield 38.1 mg (68% yield) of product as a mixture of diastereomers. (major isomer/minor isomer/∑ 
of other isomers = 73:13:14). The major isomer and the minor isomer were further separated by 
column chromatography for characterization.  
 
(2S,5S)-5-[(R)-Hydroxy(4-methoxyphenyl)methyl]-3-[(4-
nitrophenyl)sulfonyl]-2,5-diphenyloxazolidin-4-one (102a): [𝛼]𝐷
20 -41.5, (c = 0.53, CHCl3),  1H 
NMR (500 MHz, CDCl3) 8.19 (d, J = 9.0 Hz, 2H), 7.81 (d, J = 9.0 Hz, 2H), 7.40-7.32 (m, 8H), 
7.21-7.20 (m, 2H), 6.95 (d, J = 8.5 Hz, 2H), 6.88 (s, 1H), 6.63 (d, J = 8.5 Hz, 2H), 5.22 (d, J = 3.0 
Hz, 1H), 3.69 (s, 3H), 2.25 (d, J = 3.0 Hz, 1H) ppm; 13C NMR (125 MHz, CDCl3) 170.8, 150.8, 
143.2, 136.9, 135.5, 130.4, 129.7, 129.2, 129.0, 128.5(2C), 128.4, 128.2, 128.0, 125.3, 123.8, 
113.2, 92.3, 87.2, 80.5, 55.1 ppm; HRMS (ESI) m/z calculated for [M+Na]+ C29H24N2O8NaS: 
583.1146; found: 583.1131.  
 
(2S,5S)-5-[(S)-Hydroxy(4-methoxyphenyl)methyl]-3-[(4-
nitrophenyl)sulfonyl]-2,5-diphenyloxazolidin-4-one (102b):  [𝛼]𝐷
20 -17.8, (c = 0.28, CHCl3),  1H 
NMR (500 MHz, CD2Cl2) 8.14 (d, J = 9.0 Hz, 2H), 7.62 (d, J = 9.0 Hz, 2H), 7.56-7.54 (m, 2H), 
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7.42 (t, J = 7.0 Hz, 1H), 7.33-7.25 (m, 7H), 7.14 (d, J = 7.5 Hz, 2H), 6.80 (d, J = 9.0 Hz, 2H), 6.08 
(s, 1H), 5.09 (s, 1H), 3.83 (s, 3H), 2.18 (br, 1H) ppm; 13C NMR (125 MHz, CDCl3) 168.7, 160.1, 
150.7, 142.8, 136.5, 135.7, 130.4, 129.4, 129.0, 128.8, 128.6, 128.5 (2C), 128.0, 125.7, 123.8, 
113.8, 91.3, 87.8, 79.5, 55.4 ppm. HRMS (ESI) m/z calculated for [M-H]- C29H23N2O8S: 559.1170; 
found: 559.1190.  
 
 General Procedure G was followed by 
employing 42.4 mg of oxazolidinone 83 (0.10 mmol, 1.0 equiv), 14.7 mg of DMAP (0.12 mmol, 
1.2 equiv), 12.7 mg of LiCl (0.30 mmol, 3.0 equiv) and 37.0 mg of p-bromobenzaldehyde (0.20 
mmol, 2.0 equiv). The product was purified by flash chromatography (SiO2, 15% ethyl acetate in 
hexane) to yield 43.4 mg (71% yield) of product as a mixture of diastereomers. (major 
isomer/minor isomer/∑ of other isomers = 85:7:8). The major isomer and the minor isomer were 
further separated by column chromatography for characterization.  
 
(2S,5S)-5-[(R)-(4-Bromophenyl)(hydroxy)methyl]-3-[(4-
nitrophenyl)sulfonyl]-2,5-diphenyloxazolidin-4-one (103a): [𝛼]𝐷
20 -25.2, (c = 0.85, CHCl3), 1H 
NMR (500 MHz, CDCl3) 8.19 (d, J = 9.0 Hz, 2H), 7.78 (d, J = 9.0 Hz, 2H), 7.45-7.42 (m, 1H), 
7.38-7.36 (m, 2H), 7.33 (t, J = 7.5 Hz, 2H), 7.31-7.29 (m, 2H), 7.23-7.21 (m, 5H), 6.88 (s, 1H), 
6.87 (d, J = 8.0 Hz, 2H), 5.25 (d, J = 4.0 Hz, 1H), 2.48 (d, J = 4.0 Hz, 1H) ppm; 13C NMR (125 
MHz, CDCl3) 170.5, 150.8, 143.1, 136.7, 136.0, 135.1, 130.8, 130.4, 129.6, 129.4, 128.5(2C), 
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128.3, 128.2, 125.3, 123.9, 122.5, 92.3, 87.0, 80.2 ppm;  HRMS (ESI) m/z calculated for [M+H]+ 
C28H22BrN2O7S: 609.0326; found: 609.0299. 
 
(2S,5S)-5-[(S)-(4-Bromophenyl)(hydroxy)methyl]-3-[(4-
nitrophenyl)sulfonyl]-2,5-diphenyloxazolidin-4-one (103b): [𝛼]𝐷
20 -5.3, (c = 0.19, CHCl3), 1H 
NMR (500 MHz, acetone-d6) 8.42 (d, J = 9.0 Hz, 2H), 7.97 (d, J = 9.0 Hz, 2H), 7.44-7.42 (m, 3H), 
7.35 (t, J = 7.5 Hz, 2H), 7.31-7.24 (m, 7H), 7.02 (d, J = 8.5 Hz, 2H), 6.58 (s, 1H), 5.15 (d, J = 5.0 
Hz, 1H), 5.10 (d, J = 5.0 Hz, 1H) ppm; 13C NMR (100 MHz, CDCl3) 168.5, 150.8, 142.6, 136.3, 
135.5, 135.1, 131.4, 130.4, 129.5, 129.0, 128.5, 127.9, 125.7, 123.9, 123.0, 91.4, 87.4, 79.3 ppm; 
HRMS (ESI) m/z calculated for [M-H]- C28H20BrN2O7S: 607.0169; found: 607.0167. 
 
 
 General Procedure G was followed by 
employing 42.4 mg of oxazolidinone 83 (0.10 mmol, 1.0 equiv), 14.7 mg of DMAP (0.12 mmol, 
1.2 equiv), 12.7 mg of LiCl (0.30 mmol, 3.0 equiv) and 30.2 mg of p-nitrobenzaldehyde (0.20 
mmol, 2.0 equiv). The product was purified by flash chromatography (SiO2, 15% ethyl acetate in 
hexane) to yield 48.9 mg (85% yield) of product as a mixture of diastereomers. (major 
isomer/minor isomer/∑ of other isomers = 84:5:11). The major isomer was further separated by 
column chromatography for characterization.  
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 (2S,5S)-5-[(R)-Hydroxy(4-nitrophenyl)methyl]-3-[(4-
nitrophenyl)sulfonyl]-2,5-diphenyloxazolidin-4-one (104a): [𝛼]𝐷
20 -37.2, (c = 0.83, CHCl3), 1H 
NMR (500 MHz, CDCl3) 8.19 (d, J = 9.0 Hz, 2H), 7.94 (d, J = 9.0 Hz, 2H), 7.76 (d, J = 9.5 Hz, 
2H), 7.47-7.43 (m, 1H), 7.37-7.35 (m, 2H), 7.32 (t, J = 8.0 Hz, 2H), 7.29-7.21 (m, 5H), 7.14 (d, J 
= 8.5 Hz, 2H), 6.92 (s, 1H), 5.41 (d, J = 4.0 Hz, 1H), 2.65 (d, J = 4.0 Hz, 1H) ppm; 13C NMR (125 
MHz, CDCl3)   170.0, 150.9, 147.8, 144.0, 143.0, 136.4, 134.7, 130.6, 129.6, 128.9, 128.6(2C), 
128.4, 128.3, 125.3, 123.9, 122.7, 92.4, 87.1, 79.8 ppm; HRMS (ESI) m/z calculated for [M+H]+ 
C28H22N3O9S: 576.1071; found: 576.1050. 
 
 
 General Procedure G was followed by 
employing 42.4 mg of oxazolidinone 83 (0.10 mmol, 1.0 equiv), 14.7 mg of DMAP (0.12 mmol, 
1.2 equiv), 12.7 mg of LiCl (0.30 mmol, 3.0 equiv) and 30.2 mg of m-nitrobenzaldehyde (0.20 
mmol, 2.0 equiv). The product was purified by flash chromatography (SiO2, 15% ethyl acetate in 
hexane) to yield 52.1 mg (91% yield) of product as a mixture of diastereomers. (major 
isomer/minor isomer/∑ of other isomers = 83:7:10). The major isomer and the minor isomer were 
further separated by column chromatography for characterization.  
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(2S,5S)-5-[(R)-Hydroxy(3-nitrophenyl)methyl]-3-[(4-
nitrophenyl)sulfonyl]-2,5-diphenyloxazolidin-4-one (105a): [𝛼]𝐷
20 -29.9, (c = 1.02, CHCl3), 1H 
NMR (500 MHz, CDCl3) 8.20 (d, J = 9.0 Hz, 2H), 8.01 (d, J = 8.0 Hz, 1H), 7.93 (s, 1H), 7.78 (d, 
J = 9.0 Hz, 2H), 7.44 (t, J = 7.0 Hz, 1H), 7.36 (d, J = 7.0 Hz, 2H), 7.32 (t, J = 8.0 Hz, 2H), 7.36-8-
7.23 (m, 5H), 7.16 (d, J = 8.0 Hz, 1H), 6.94 (s, 1H), 5.42 (d, J = 4.0 Hz, 1H), 2.66 (d, J = 4.0 Hz, 
1H) ppm; 13C NMR (125 MHz, CDCl3) 170.1, 150.9, 147.7, 143.0, 139.0, 136.4, 134.7, 133.6, 
130.5, 129.6, 128.9, 128.6, 128.4, 128.3, 125.3, 123.9, 123.2, 122.8, 92.4, 87.0, 79.7 ppm; HRMS 
(ESI) m/z calculated for [M+H]+ C28H22N3O9S: 576.1071; found: 576.1046. 
 
  (2S,5S)-5-[(S)-Hydroxy(3-nitrophenyl)methyl]-3-[(4-
nitrophenyl)sulfonyl]-2,5-diphenyloxazolidin-4-one (105b): [𝛼]𝐷
20 +5.3, (c = 0.19, CHCl3), 1H 
NMR (500 MHz, CDCl3) 8.24 (ddd, J = 8.0, 2.5, 1.0 Hz, 1H), 8.20 (t, J = 2.0 Hz, 1H), 8.12 (d, J = 
9.0 Hz, 2H), 7.66 (d, J = 7.5 Hz, 1H), 7.59 (d, J = 9.0 Hz, 2H), 7.54 (d, J = 8.5 Hz, 1H), 7.51 (dd, 
J = 8.0, 2.0 Hz, 2H), 7.41-7.32 (m, 4H) 7.22 (t, J = 8.0 Hz, 2H), 7.01 (d, J = 7.0 Hz, 2H), 6.13 (s, 
1H), 5.27 (d, J = 3.5 Hz, 1H), 2.42 (d, J = 3.5 Hz, 1H) ppm; 13C NMR (125 MHz, CDCl3) 168.3, 
150.9, 148.0, 142.5, 138.5, 135.8, 134.5, 133.9, 130.5, 129.5, 129.2, 129.1, 128.6, 128.5, 127.9, 
125.8, 123.9, 123.8, 123.0, 91.4, 87.0, 79.1 ppm; HRMS (ESI) m/z calculated for [M+H]+ 
C28H22N3O9S: 576.1071; found: 576.1076.  
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 General Procedure G was followed by 
employing 42.4 mg of oxazolidinone 83 (0.10 mmol, 1.0 equiv), 14.7 mg of DMAP (0.12 mmol, 
1.2 equiv), 12.7 mg of LiCl (0.30 mmol, 3.0 equiv) and 27.2 mg of o-anisaldehyde (0.20 mmol, 
2.0 equiv). The product was purified by flash chromatography (SiO2, 15% ethyl acetate in hexane) 
to yield 35.8 mg (64% yield) of desired product as a mixture of diastereomers. (major isomer/minor 
isomer/∑ of other isomers = 83:9:8). The major isomer and the minor isomer were further 
separated by column chromatography for characterization.  
 
 (2S,5S)-5-[(R)-Hydroxy(2-methoxyphenyl)methyl]-3-[(4-
nitrophenyl)sulfonyl]-2,5-diphenyloxazolidin-4-one (106a): [𝛼]𝐷
20 -22.0, (c = 0.86, CHCl3), 1H 
NMR (400 MHz, CDCl3) 8.20 (d, J = 9.2 Hz, 2H), 7.82 (d, J = 9.2 Hz, 2H), 7.43-7.40 (m, 3H), 
7.35-7.28 (m, 3H), 7.33-7.28 (m, 5H), 7.17-7.10 (m, 4H), 6.85 (s, 1H), 6.79 (t, J = 7.2 Hz, 1H), 
6.60 (d, J = 8.4 Hz, 1H), 5.73 (d, J = 5.2 Hz, 1H), 3.45 (s, 3H), 2.94 (d, J = 5.2 Hz, 1H) ppm;  13C 
NMR (100 MHz, CDCl3)  170.7, 156.6, 150.7, 143.2, 137.0, 135.2, 130.3, 129.6, 129.4, 128.5, 
128.3, 128.0, 127.5, 125.6, 125.2, 123.8, 120.2, 110.2, 92.2, 87.6, 75.0, 55.0 ppm; HRMS (ESI) 
m/z calculated for [M+NH4]+ C29H28N3O8S: 578.1592; found: 578.1570. 
 
(2S,5S)-5-[(S)-Hydroxy(2-methoxyphenyl)methyl]-3-[(4-
nitrophenyl)sulfonyl]-2,5-diphenyloxazolidin-4-one (106b): [𝛼]𝐷
20 -7.0, (c = 0.63, CHCl3), 1H 
NMR (500 MHz, CDCl3) 8.05 (d, J = 9.0 Hz, 2H), 7.56-7.54 (m, 2H), 7.50 (d, J = 9.0 Hz, 2H), 
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7.42-7.35 (m, 8H), 7.11 (dd, J = 8.0, 1.0 Hz, 2H), 6.99 (td, J = 7.5, 1.0 Hz, 1H), 6.89 (d, J = 7.5 
Hz, 1H), 6.25 (s, 1H), 5.53 (d, J = 6.5 Hz, 1H), 3.76 (s, 3H), 3.10 (d, J = 6.5 Hz, 1H) ppm; 13C 
NMR (100 MHz, CDCl3) 168.1, 157.2, 150.5, 143.2, 136.4, 136.0, 130.3, 130.0, 129.4, 129.3, 
128.4(2C), 128.3, 127.9, 125.9, 124.7, 123.7, 120.6, 110.7, 91.2, 87.6, 76.4, 55.3 ppm;  HRMS 
(ESI) m/z calculated for [M+NH4]+ C29H25N2O8S: 561.1326; found: 561.1308. 
 
 
 General Procedure G was followed by 
employing 42.4 mg of oxazolidinone 83 (0.10 mmol, 1.0 equiv), 14.7 mg of DMAP (0.12 mmol, 
1.2 equiv), 12.7 mg of LiCl (0.30 mmol, 3.0 equiv) and 30.2 mg of o-nitrobenzaldehyde (0.20 
mmol, 2.0 equiv). The product was purified by flash chromatography (SiO2, 15% ethyl acetate in 
hexane) to yield 45.1 mg (78% yield) of product as a mixture of diastereomers. (major 
isomer/minor isomer/∑ of other isomers = 72:8:20). The major isomer was further separated by 
column chromatography for characterization.  
 
(2S,5S)-5-[(R)-Hydroxy(2-nitrophenyl)methyl]-3-[(4-nitrophenyl)sulfonyl]-
2,5-diphenyloxazolidin-4-one (107a): [𝛼]𝐷
20  -20.3, (c = 0.83, CHCl3),  1H NMR (500 MHz, 
CDCl3) 8.20 (d, J = 9.0 Hz, 2H), 7.88 (dd, J = 8.0, 1.0 Hz, 1H), 7.79 (d, J = 9.0 Hz, 2H), 7.53-7.48 
(m 2H), 7.44 (t, J = 7.0 Hz, 1H), 7.34-7.21 (m, 8H), 7.15 (t, J = 7.5 Hz, 2H), 6.84 (s, 1H), 6.18 (d, 
J = 5.5 Hz, 1H), 3.16 (d, J = 5.5 Hz, 1H) ppm; 13C NMR (125 MHz, CDCl3) 169.8, 150.9, 149.1, 
142.9, 136.6, 134.1, 132.4, 131.2, 130.9, 130.5, 129.7, 129.1, 128.7, 128.6, 128.3, 128.2, 125.1, 
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123.9, 92.1, 87.1, 74.2 ppm;  HRMS (ESI) m/z calculated for [M+H]+ C28H22N3O9S: 576.1071; 
found: 576.1074. 
 
 General Procedure G was followed by employing 
42.4 mg of oxazolidinone 83 (0.10 mmol, 1.0 equiv), 14.7 mg of DMAP (0.12 mmol, 1.2 equiv), 
12.7 mg of LiCl (0.30 mmol, 3.0 equiv) and 17 µL of 2-furaldehyde (0.20 mmol, 2.0 equiv). The 
product was purified by flash chromatography (SiO2, 10% ethyl acetate in hexane) to yield 41.7 
mg (90% yield) of product as a mixture of diastereomers. (major isomer/minor isomer/∑ of other 
isomers = 85:8:7). The major isomer and the minor isomer were further separated by column 
chromatography for characterization.  
 
(2S,5S)-5-[(R)-Furan-2-yl(hydroxy)methyl]-3-[(4-nitrophenyl)sulfonyl)]-2,5-
diphenyloxazolidin-4-one (108a): [𝛼]𝐷
20 -5.8, (c = 0.48, CHCl3), 1H NMR (500 MHz, CDCl3) 8.21 
(d, J = 8.5 Hz, 2H), 7.84 (d, J = 8.5 Hz, 2H), 7.46-7.43 (m, 3H), 7.34 (t, J = 8.0 Hz, 2H), 7.29 (d, 
J = 7.0 Hz, 2H), 7.25-7.23 (m, 3H), 7.21 (d, J = 1.0 Hz, 1H), 6.82 (s, 1H), 6.15 (dd, J = 3.0, 1.5Hz, 
1H), 6.03 (d, J = 3.0 Hz, 1H), 5.3 (s, 1H), 2.6 (br, 1H) ppm;  13C NMR (125 MHz, CDCl3) 169.9, 
150.9, 150.1, 143.0, 142.5, 136.8, 134.9, 130.4, 129.7, 128.6, 128.5, 128.2(2C), 125.2, 123.9, 
110.3, 109.3, 92.3, 86.8, 74.5 ppm. HRMS (ESI) m/z calculated for [M+NH4]+ C26H24N3O8S: 
538.1279; found: 538.1292. 
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(2S,5S)-5-[(S)-Furan-2-yl(hydroxy)methyl]-3-[(4-nitrophenyl)sulfonyl]-2,5-
diphenyloxazolidin-4-one (108b): [𝛼]𝐷
20 -1.1, (c = 0.38, CHCl3), 1H NMR (500 MHz, CDCl3) 8.11 
(d, J = 9.0 Hz, 2H), 7.62-7.58 (m, 5H), 7.54 (d, J = 1.0 Hz, 1H), 7.44 (t, J = 1.5 Hz, 2H), 7.36-7.34 
(m, 3H), 7.29-7.27 (m, 1H), 7.12 (d, J = 8.0 Hz, 2H), 6.47 (dd, J = 6.0, 1.5 Hz, 1H), 6.45 (d, J = 
3.0 Hz, 1H), 6.22 (s, 1H), 5.22 (d, J = 6.5 Hz, 1H), 2.36 (d, J = 6.5 Hz, 1H) ppm; 13C NMR (100 
MHz, CDCl3) 168.0, 150.7, 150.2, 143.0, 142.9, 136.1, 135.2, 130.5, 129.4, 128.8, 128.5(2C), 
128.2, 125.5, 123.8, 111.0, 109.5, 91.1, 87.0, 74.2 ppm. HRMS (ESI) m/z calculated for [M+K]+ 
C26H20N2O8KS: 559.0599; found: 599.0589. 
 
 
 General Procedure G was followed by 
employing 42.4 mg of oxazolidinone 83 (0.10 mmol, 1.0 equiv), 14.7 mg of DMAP (0.12 mmol, 
1.2 equiv), 12.7 mg of LiCl (0.30 mmol, 3.0 equiv) and 31.2 mg of 2-naphthaldehyde (0.20 mmol, 
2.0 equiv). The product was purified by flash chromatography (SiO2, 15% ethyl acetate in hexane) 
to yield 41.0 mg (71% yield) of desired product as a mixture of diastereomers. (major isomer/minor 
isomer/∑ of other isomers = 78:8:14). The major isomer and the minor isomer were further 
separated by column chromatography for characterization.  
 
(2S,5S)-5-[(R)-Hydroxy(naphthalen-2-yl)methyl]-3-[(4-
nitrophenyl)sulfonyl]-2,5-diphenyloxazolidin-4-one (109a): [𝛼]𝐷
20 -16.3, (c = 0.98, CHCl3), 1H 
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NMR (400 MHz, CDCl3) 8.18 (d, J = 8.8 Hz, 2H), 7.81 (d, J = 8.8 Hz, 2H), 7.71-7.69 (m, 1H), 
7.65-7.63 (m, 1H), 7.56 (d, J = 8.8 Hz, 1H), 7.50 (s, 1H), 7.42-7.38 (m, 5H), 7.32-7.31 (m, 4H), 
7.21-7.16 (m, 3H), 7.12 (dd, J = 8.8, 1.6 Hz, 1H), 6.95 (s, 1H), 5.43 (d, J = 4.0 Hz, 1H), 2.49 (d, J 
= 4.0 Hz, 1H) ppm;  13C NMR (125 MHz, CDCl3) 170.7, 150.8, 143.1, 136.9, 135.4, 134.6, 133.1, 
132.6, 130.4, 129.6, 128.5, 128.4, 128.3, 128.1(2C), 127.5, 127.3, 127.2, 126.3, 126.0, 125.4, 
125.3, 123.8, 92.3, 87.3, 80.9 ppm. HRMS (ESI) m/z calculated for [M+NH4]+ C32H28N3O7S: 
598.1642; found: 598.1621. 
 
 (2S,5S)-5-[(S)-Hydroxy(naphthalen-2-yl)methyl]-3-[(4-
nitrophenyl)sulfonyl]-2,5-diphenyloxazolidin-4-one (109b):  [𝛼]𝐷
20 +10.7, (c = 0.28, CHCl3),  
1H NMR (500 MHz, CDCl3) 7.83 (d, J = 9.0 Hz, 2H), 7.81 (d, J = 8.5 Hz, 1H), 7.73 (s, 1H), 7.70 
(d, J = 8.0 Hz, 1H), 7.64-7.62 (m, 3H), 7.54 (ddd, J = 8.0, 7.0, 1.0 Hz, 1H), 7.52 (d, J = 9.0 Hz, 
2H), 7.48-7.46 (m, 1H), 7.42-7.38 (m, 1H), 7.37-7.35 (m, 3H), 7.29 (t, J = 8.0 Hz, 2H), 7.16 (d, J 
= 7.0 Hz, 2H), 6.07 (s, 1H), 5.28 (s, 1H), 2.13 (br, 1H) ppm; 13C NMR (125 MHz, CDCl3) 168.6, 
150.5, 142.1, 136.8, 135.7, 134.1, 133.3, 132.6, 130.3, 129.2, 128.9, 128.6, 128.1(2C), 127.7, 
127.6, 127.0, 126.5, 125.7, 125.0, 123.5, 91.4, 87.8, 79.9 ppm; HRMS (ESI) m/z calculated for 
[M-H]- C32H23N2O7S: 579.1220; found: 579.1214. 
 
 
 General Procedure G was followed by 
employing 42.4 mg of oxazolidinone 83 (0.10 mmol, 1.0 equiv), 14.7 mg of DMAP (0.12 mmol, 
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1.2 equiv), 12.7 mg of LiCl (0.30 mmol, 3.0 equiv) and 25 µL of cinnamaldehyde (0.20 mmol, 2.0 
equiv). The product was purified by flash chromatography (SiO2, 15% ethyl acetate in hexane) to 
yield 37.5 mg (65% yield) of desired product as a mixture of diastereomers. (major isomer/minor 
isomer/∑ of other isomers = 82:10:8). The major isomer and the minor isomer were further 
separated by column chromatography.  
 
(2S,5S)-5-[(R,E)-1-Hydroxy-3-phenylallyl]-3-[(4-nitrophenyl)sulfonyl]-2,5-
diphenyloxazolidin-4-one (110a): [𝛼]𝐷
20 -32.7, (c = 1.42, CHCl3), 1H NMR (500MHz, CDCl3) 
8.20 (d, J = 9.0 Hz, 2H), 7.84 (d, J = 9.0 Hz, 2H), 7.54 (dd, J = 8.0, 2.0 Hz, 2H), 7.46-7.44 (m, 1H), 
7.36-7.28 (m, 7H), 7.21-7.16 (m, 5H), 6.85 (s, 1H), 6.38 (d, J = 15.5 Hz, 1H), 6.02 (dd, J = 15.5, 
6.0 Hz, 1H), 4.88 (dd, J = 6.0, 3.5 Hz, 1H), 2.32 (d, J = 3.5 Hz, 1H) ppm; 13C NMR (125MHz, 
CDCl3) 170.5, 150.8, 143.1, 136.9, 135.6, 135.2, 134.6, 130.4, 129.7, 128.6, 128.5, 128.4, 128.2, 
128.1, 126.6, 125.2, 124.3, 123.9, 92.3, 87.3, 79.5 ppm. HRMS (ESI) m/z calculated for [M+NH4]+ 
C30H28N3O7S: 574.1642; found: 574.1675.  
 
(2S,5S)-5-[(S,E)-1-Hydroxy-3-phenylallyl]-3-[(4-nitrophenyl)sulfonyl]-2,5-
diphenyloxazolidin-4-one (110b): [𝛼]𝐷
20 -2.2, (c = 0.28, CHCl3), 1H NMR (500MHz, CDCl3) 
8.04 (d, J = 9.0 Hz, 2H), 7.76 (d, J = 9.0 Hz, 2H), 7.57-7.56 (m, 2H), 7.42-7.41 (m, 2H), 7.33-7.30 
(m, 9H), 7.20 (d, J = 7.0 Hz, 2H), 6.69 (s, 1H), 6.62 (d, J = 16.0 Hz, 1H), 6.31 (dd, J = 16.0, 7.0 
Hz, 1H), 4.69 (dd, J = 7.0, 4.0 Hz, 1H), 1.98 (d, J = 4.0 Hz, 1H);  13C NMR (125 MHz, CDCl3) 
168.9, 150.8, 142.8, 136.7, 135.7, 135.3, 135.1, 130.4, 129.6, 128.8, 128.7, 128.6, 128.4, 127.9, 
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126.7, 125.7, 123.9(2C), 91.8, 87.3, 79.6 ppm. HRMS (ESI) m/z calculated for [M+NH4]+ 
C30H28N3O7S: 574.1642; found: 574.1672. 
 
 
 General Procedure G was followed by 
employing 42.4 mg of oxazolidinone 83 (0.10 mmol, 1.0 equiv), 14.7 mg of DMAP (0.12 mmol, 
1.2 equiv), 12.7 mg of LiCl (0.30 mmol, 3.0 equiv) and 26 µL of hydrocinnamaldehyde (0.20 
mmol, 2.0 equiv). The product was purified by flash chromatography (SiO2, 15% ethyl acetate in 
hexane) to yield 37.5 mg (69% yield) of desired product as a mixture of diastereomers. (major 
isomer/minor isomer/∑ of other isomers = 48:31:21). The major isomer and the minor isomer were 
further separated by column chromatography for characterization.  
 
 
(2S,5S)-5-[(R)-1-Hydroxy-3-phenylpropyl]-3-[(4-nitrophenyl)sulfonyl]-2,5-
diphenyloxazolidin-4-one (111a): [𝛼]𝐷
20 -33.3, (c = 0.21, CHCl3), 1H NMR (500 MHz, CDCl3) 
8.19 (d, J = 9.0 Hz, 2H), 7.78 (d, J = 9.0 Hz, 2H), 7.45-7.42 (m, 2H), 7.36 (t, J = 8.0 Hz, 2H), 7.30-
7.28 (m, 5H), 7.22-7.19 (m, 3H), 7.18-7.15 (m, 1H), 6.98 (d, J = 7.0 Hz, 2H), 6.78 (s, 1H), 4.20 
(ddd, J = 10.0, 5.5, 2.0 Hz, 1H), 2.71 (ddd, J = 14.0, 9.5, 5.5 Hz, 1H), 2.48 (dt, J = 14.0, 8.0 Hz, 
1H), 2.02 (d, J = 6.0 Hz, 1H), 1.84-1.77 (m, 1H), 1.44-1.38 (m, 1H) ppm; 13C NMR (125 MHz, 
CDCl3) 171.0, 150.8, 143.0, 140.7, 136.8, 135.3, 130.4, 129.6, 128.6, 128.5, 128.4(2C), 128.2(2C), 
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126.1, 125.1, 123.9, 92.0, 88.2, 77.7, 31.7, 31.0 ppm; HRMS (ESI) m/z calculated for [M+H]+ 
C30H7N2O7S: 559.1534; found: 559.1473. 
 
(2S,5S)-5-[(S)-1-Hydroxy-3-phenylpropyl]-3-[(4-nitrophenyl)sulfonyl]-2,5-
diphenyloxazolidin-4-one (111b): [𝛼]𝐷
20 -2.1, (c = 0.64., CHCl3), 1H NMR (500 MHz, CDCl3) 
8.14 (d, J = 9.0 Hz, 2H), 7.76 (d, J = 9.0 Hz, 2H), 7.48-7.47 (m, 2H), 7.39 (t, J = 7.0 Hz, 1H), 7.29-
7.27 (m, 5H), 7.24-7.21 (m, 3H), 7.10-7.08 (m, 4H), 6.67 (s, 1H), 3.99 (ddd, J = 10.5, 5.0, 2.0Hz, 
1H), 2.86 (ddd, J = 14.0, 9.0, 5.0 Hz, 1H), 2.58 (ddd, J = 14.0, 9.0, 7.0 Hz, 1H), 1.94 (d, J = 4.5 
Hz, 1H), 1.93-1.88 (m, 1H), 1.70-1.64 (m, 1H) ppm; 13C NMR (100 MHz, CDCl3) 169.2, 150.9, 
142.7, 141.0, 136.4, 135.4, 130.3, 129.6, 128.7, 128.5, 128.4, 127.8, 126.2, 125.6, 123.9, 91.5, 
87.0, 77.6, 32.2, 32.0 ppm; HRMS (ESI) m/z calculated for [M+H]+ C30H7N2O7S: 559.1534; found: 
559.1482. 
 
 
 General Procedure G was followed by 
employing 42.4 mg of oxazolidinone 83 (0.10 mmol, 1.0 equiv), 14.7 mg of DMAP (0.12 mmol, 
1.2 equiv), 12.7 mg of LiCl (0.30 mmol, 3.0 equiv) and 80 µL of butyraldehyde (1.0 mmol, 10.0 
equiv). The product was purified by flash chromatography (SiO2, 15% ethyl acetate in hexane) to 
yield 38.2 mg (85% yield) of desired product as a mixture of diastereomers. (major isomer/minor 
isomer/∑ of other isomers = 51:34:15). The major isomer and the minor isomer were further 
separated by column chromatography.  
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(2S,5S)-5-[(R)-1-Hydroxybutyl]-3-[(4-nitrophenyl)sulfonyl]-2,5-
diphenyloxazolidin-4-one (112a): [𝛼]𝐷
20 -17.9, (c = 0.83, CHCl3), 1H NMR (500 MHz, CDCl3) 
8.24 (d, J = 8.0 Hz, 2H), 7.85 (d, J = 8.0 Hz, 2H), 7.53-7.49 (m, 3H), 7.38 (t, J = 8.0 Hz, 2H), 7.34-
7.33 (m, 5H), 6.79 (s, 1H), 4.23 (ddd, J = 10.5, 6.0, 2.5 Hz, 1H), 2.01 (d, J = 6.0 Hz, 1H), 0.98-
0.94 (m, 4H), 0.79 (t, J = 7.0 Hz, 3H) ppm; 13C NMR (125 MHz, CDCl3) 171.2, 150.8, 143.1, 
137.0, 135.5, 130.4, 129.7, 129.0, 128.6, 128.4, 128.1, 125.1, 123.9, 92.1, 88.1, 78.0, 31.6, 18.6, 
13.6 ppm; HRMS (ESI) m/z calculated for [M+H]+ C25H25N2O7S: 497.1382; found: 497.1352. 
 
(2S,5S)-5-[(S)-1-Hydroxybutyl]-3-[(4-nitrophenyl)sulfonyl]-2,5-
diphenyloxazolidin-4-one (112b):  [𝛼]𝐷
20 -6.9, (c = 0.41, CHCl3),  1H NMR (500 MHz, CDCl3) 
8.18 (d, J = 9.0 Hz, 2H), 7.73 (d, J = 9.0 Hz, 2H), 7.53-7.51 (m, 2H), 7.39 (t, J = 8.5 Hz, 1H), 7.30-
7.23 (m, 5H), 7.09 (dd, J = 8.0, 1.0 Hz, 2H), 6.72 (s, 1H), 4.00 (ddd, J = 10.5, 5.0, 2.0 Hz, 1H), 
1.86 (d, J = 5.0 Hz, 1H), 1.68-1.59 (m, 2H), 1.37-1.28 (m, 2H) ppm; 13C NMR (125 MHz, CDCl3) 
169.3, 150.9, 142.8, 136.4, 135.8, 130.3, 129.6, 128.6, 128.5, 128.3, 128.0, 125.7, 123.9, 91.5, 
87.2, 78.2, 32.7, 19.2, 13.8 ppm;  HRMS (ESI) m/z calculated for [M+H]+ C25H25N2O7S: 497.1382; 
found: 497.1352. 
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 General Procedure G was followed by employing 
42.4 mg of oxazolidinone 83 (0.10 mmol, 1.0 equiv), 14.7 mg of DMAP (0.12 mmol, 1.2 equiv), 
12.7 mg of LiCl (0.30 mmol, 3.0 equiv) and 28.5 mg of (E)-N-benzylidene-4-
methylbenzenesulfonamide (0.11 mmol, 1.1 equiv). The product was purified by flash 
chromatography (SiO2, 15% ethyl acetate in hexane) to yield 53.1 mg (78% yield) of product as a 
mixture of diastereomers. (major isomer/minor isomer/∑ of other isomers = 48:31:21). The major 
isomer was further separated by column chromatography for characterization.  
 
 4-Methyl-N-((R)-{(2S,5S)-3-[(4-nitrophenyl)sulfonyl]-4-oxo-2,5-
diphenyloxazolidin-5-yl}(phenyl)methyl)benzenesulfonamide (123a): [𝛼]𝐷
20 +12.6, (c = 0.70, 
CHCl3),  1H NMR (500 MHz, CDCl3) 8.37 (d, J = 9.0 Hz, 2H), 8.08 (d, J = 9.0 Hz, 2H), 7.37 (t, J 
= 7.5 Hz, 1H), 7.26-7.15 (m, 7H), 7.09 (t, J = 6.5 Hz, 1H), 7.04 (t, J = 7.5 Hz, 2H), 6.95 (t, J = 7.5 
Hz, 1H), 6.88 (d, J = 8.5 Hz, 2H), 6.83 (t, J = 7.5 Hz, 2H), 6.66 (d, J = 7.5 Hz, 2H), 6.48 (s, 1H), 
5.35 (d, J = 10.5 Hz, 1H), 4.69 (d, J = 10.5 Hz, 1H), 2.22 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) 
169.1, 151.3, 143.2, 142.3, 136.7, 136.3, 135.2, 134.6, 130.3, 130.0, 129.1, 128.6, 128.4, 127.9, 
127.8, 127.7, 127.6, 127.5, 127.0, 125.4, 124.5, 91.9, 87.2, 64.4, 21.3 ppm; HRMS (ESI) m/z 
calculated for [M+H]+ C35H30N3O8S2: 684.1469; found: 684.1476. 
 
Methyl (2S,3R)-2,3-dihydroxy-2,3-diphenylpropanoate (86): To a -20 oC solution 
of oxazolidinone 85a (35.6 mg, 0.067 mmol) in 2 mL of MeOH was added 3.1 µL of MeONa in 
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MeOH solution (25% w/w, 0.0134 mmol, 0.2 equiv) and the resulting mixture was kept stirring at 
this temperature for 24 hours. Then another 3.1 µL of MeONa in MeOH solution (25% w/w, 
0.0134 mmol, 0.2 equiv) was added again to this solution and the mixture was kept stirring at this 
temperature for another 24 hours. The reaction was quenched with 20 µL of saturated NH4Cl 
solution and the mixture was run through a plug of celite and concentrated. The product was 
purified by flash chromatography (SiO2, 20% ethyl acetate in hexane) to yield 6.2 mg (34% yield) 
of product as a white solid. [𝛼]𝐷
20 -11.9, (c = 0.67, CHCl3) 1H NMR (300 MHz, CDCl3) 7.49-7.47 
(m, 2H), 7.23-7.21 (m, 3H), 7.15-7.09 (m, 5H), 5.42 (d, J = 8.1Hz, 1H), 3.98 (s, 1H), 3.92 (s, 3H), 
2.86 (d, J = 8.1Hz, 1H) ppm; 13C NMR (100 MHz, CDCl3) 174.6, 138.0, 137.8, 128.1, 128.0, 
127.8(2), 127.6, 125.8, 82.0, 78.2, 53.8 ppm.23     
 
(2S,5S)-2,5-Diphenyloxazolidin-4-one (125): To a solution of oxazolidinone 83 (246 
mg, 0.58 mmol) in 4 mL of DMF was added potassium carbonate (241 mg, 1.74 mmol), followed 
by 77 µL of thiophenol (0.75 mmol) via a syringe. The resulting mixture was stirred at room 
temperature for 2 hours. The reaction was quenched by adding 10 mL of saturated NaHCO3 
solution and extracted with EtOAc. The combined organic layer was dried over Na2SO4 and 
concentrated. The crude product was further purified by flash column chromatography (neutral 
alumina, 20% EtOAc in hexane) to afford the title product (103 mg, 74% yield) as a white solid. 
[𝛼]𝐷
20 66.3, (c = 1.14, CHCl3), 1H NMR (500MHz, CDCl3) 7.48-7.35 (m, 10H), 7.28 (br, 1H), 6.32 
(d, J = 2.0 Hz, 1H), 5.43 (d, J = 2.0 Hz, 1H) ppm; 13C NMR (125MHz, CDCl3) 173.2, 138.3, 136.0, 
130.0, 129.0, 128.8, 128.7, 126.5, 126.3, 87.7, 78.4 ppm. 
 
96 
 
 (2S,5S)-3-[(4-Nitrophenyl)sulfonyl]-2,5-diphenyl-5-{(R)-
phenyl[(triethylsilyl)oxy]methyl}oxazolidin-4-one (126): To a -60 oC solution of oxazolidinone 
83 (25.0 mg, 0.047 mmol) in 2 mL of DCM was added 27 µL of 2,6-lutidine (0.235 mmol, 5.0 
equiv.) followed by 17 µL of TESOTf  (0.094 mmol, 2.0 euqiv.) through a syringe. The resulting 
solution was kept stirring at this temp for 3 hours. The reaction mixture was quenched with 
saturated Na2CO3 solution. The mixture was extracted with EtOAc and the combined organic layer 
was washed with saturated NH4Cl solution and dried over sodium sulfate. The crude product was 
further purified by column chromatography (SiO2, 10% EtOAc in hexane) to afford 28.9 mg of 
desired product (0.045 mmol, 95% yield) as a white solid. [𝛼]𝐷
20 -18.7, (c = 1.13, CHCl3),  1H 
NMR (500 MHz, CDCl3) 8.05 (d, J = 9.0 Hz, 2H), 7.51 (d, J = 9.0 Hz, 2H), 7.41-7.38 (m, 3H), 
7.27-7.26 (m, 2H), 7.21-7.18 (m, 5H), 7.12-7.09 (m, 1H), 7.04 (t, J = 7.5 Hz, 2H), 6.96 (d, J = 7.5 
Hz, 2H), 6.88 (s, 1H), 5.27 (s, 1H), 0.95 (t, J = 8.0 Hz, 9H), 0.66-0.57 (m, 6H) ppm; 13C NMR 
(125 MHz, CDCl3) 170.2, 150.5, 143.8, 137.5, 136.4, 135.8, 130.3, 129.0, 128.8, 128.3, 128.1(2C), 
127.9(2C), 127.1, 125.5, 123.8, 92.1, 88.2, 81.8, 6.8, 4.6 ppm; HRMS (ESI) m/z calculated for 
[M+H]+ C34H37N2O7SSi: 645.2085; found: 645.2085. 
 
(2S,5S)-2,5-Diphenyl-5-{(R)-phenyl[(triethylsilyl)oxy]methyl}oxazolidin-4-one 
(127): To a solution of 126 (22.9 mg, 0.036 mmol) in 2 mL of MeOH was added 20 µL of MeONa 
solution in MeOH (25% w/w, 2.5 equiv.) via a syringe. The mixture was kept stirring at room 
temperature and monitored by TLC. All starting material diminished on TLC after 1 hour. 
Saturated NH4Cl solution was added to quench the reaction. The reaction was extracted with 
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EtOAc and the combined organic layer was washed with brine, dried over sodium sulfate and 
concentrated. The crude product was further purified by column chromatography to afford 12.6 
mg of unprotected product (0.027 mmol, 76% yield) as a white solid. [𝛼]𝐷
20  -45.5, (c = 0.11, 
CHCl3), 1H NMR (500 MHz, CDCl3) 7.50-7.48 (m, 2H), 7.42-7.36 (m, 5H), 7.19-7.18 (m, 3H), 
7.08-7.03 (m, 5H), 6.46 (s, 1H), 6.13 (s, 1H), 5.27 (s, 1H), 0.93-0.89 (m, 9H), 0.59-0.55 (m, 6H) 
ppm; 13C NMR (125 MHz, CDCl3) 173.7, 138.7, 138.5, 137.5, 129.9, 128.6, 128.2, 127.6, 
127.4(2C), 127.0, 125.5, 88.2, 87.4, 80.9, 6.7, 4.8 ppm; HRMS (ESI) m/z calculated for [M+H]+ 
C28H34NO3Si: 460.2302; found: 460.2315. 
 
 
  (S)-3-Phenylpropane-1,2-diol (129): To a stirred solution of oxazolidinone 67 
(87.7 mg, 0.2 mmol, 1.0 equiv) in 2mL of THF was added 15.1 mg of NaBH4 (0.4 mmol, 2.0 equiv) 
at ambient temperature. The reaction was stirred at ambient temperature and monitored by TLC. 
All the starting material diminished on TLC after 1 hour. The reaction was quenched with 1M HCl 
solution. The mixture was concentrated and purified by column chromatography (SiO2, 60% 
EtOAc in Hexane) to yield 28.2 mg (93% yield) of the title compound as white solid. [𝛼]𝐷
20 -27.2, 
(c = 1.17, CHCl3), 1H NMR (300 MHz, CDCl3) 7.32-7.30 (m, 2H), 7.24-7.21 (m, 3H), 3.95-3.93 
(m, 1H), 3.69 (dd, J = 11.1, 2.7 Hz, 1H), 3.52 (dd, J = 11.1, 6.9 Hz, 1H), 2.79-2.75 (m, 2H), 2.21 
(br, 1H), 1.68 (br, 1H) ppm; 13C NMR (100MHz, CDCl3) 137.6, 129.3, 128.7, 126.7, 73.0, 66.1, 
39.8 ppm.  E.e. 97% HPLC (Daicel Chiralpak OD, hexanes/i-PrOH = 97:3, flow rate 1.0 mL/min, 
λ= 220 nm); major isomer: tR = 38.4 min, minor isomer: tR = 35.6 min.
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  EXPERIMENTAL FOR MARINEOSIN A SYNTHESIS 
         Tetrahydro-2H-pyran-2-carbaldehyde (199): To a -78 oC solution of oxalyl chloride 
(7.3 mL, 86.0 mmol) in 100 mL of DCM, DMSO (12.2 mL, 172.0 mmol) in 20 mL of DCM was 
added dropwise through a syringe pump. The mixture was kept stirring for 20 min at -78 oC and 
then a solution of tetrahydropyran-2-methanol (5.0 g, 43.0 mmol) in 30 mL of DCM was added 
dropwise. The mixture was kept stirring at this temperature for 30 min and then triethylamine (24.0 
ml, 172 mmol) was slowly added. The reaction was warmed up to room temperature, stirred for 1 
h and water was added. When the mixture became clear, it was extracted with DCM. The combined 
organic layer was washed with brine, dried over sodium sulfate, filtered and concentrated. The 
crude product was run a quick column (SiO2, 10% ethyl acetate in hexane) and used directly in 
next step without further purification.  
 
        syn-Benzyl 3-hydroxy-3-(tetrahydro-2H-pyran-2-yl)propanoate (201): To the 
solution of freshly prepared tetrahydro-2H-pyran-2-carbaldehyde (43.0 mmol) and magnesium 
bromide ethyl etherate (12.2 g, 47.3 mmol) in 100 mL of DCM at -78 oC, {[1-
(benzyloxy)vinyl]oxy}trimethylsilane (15.0 mL, 64.5 mmol) was added slowly via a syringe pump 
over 30 min. The reaction mixture was kept stirring at this temperature after 1 h, then warmed up 
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to 40 oC and kept stirring for 3 h. The mixture was quenched with buffer solution (pH=7) and the 
aqueous layer was extracted with DCM (100 mL x 3). The combined organic layer was washed 
with brine, dried over sodium sulfate, filtered and concentrated. The crude residue was purified by 
column chromatography (SiO2, 20% ethyl acetate in hexane) to afford 5.2 g (19.7 mmol, 46% 
yield in two steps) of the product as yellow liquid. IR (thin film): 3461, 3045, 2939, 2853, 1733, 
1089, 745, 690 cm-1;  1H NMR (500 MHz, CDCl3) 7.37-7.32 (m, 5H), 5.16 (s, 2H), 4.00 (dt, J = 
11.0, 2.0 Hz, 1H), 3.94 (dt, J1 = 12.5 Hz, J2 = 5.0 Hz, 1H), 3.41 (td, J = 11.5, 2.5 Hz, 1H), 3.22 
(ddd, J = 10.5, 5.0, 2.0 Hz, 1H), 2.59 (dd, J = 15.5, 7.5 Hz, 1H), 2.56 (dd, J = 15.0, 5.0 Hz, 1H), 
1.86-1.85 (m, 1H), 1.55-1.44 (m, 5H); 13C NMR (75 MHz, CDCl3) 171.9, 135.8, 128.5, 128.2, 
128.1, 79.4, 70.8, 68.5, 66.4, 38.1, 27.2, 25.8, 23.0 ppm; HRMS (ESI) m/z calculated for [M+Na]+ 
C16H17NO3Na: 287.1259; found: 287.1268. 
 
      syn-Benzyl 3-methoxy-3-(tetrahydro-2H-pyran-2-yl)propanoate (202): To a 
solution of syn-benzyl 3-hydroxy-3-(tetrahydro-2H-pyran-2-yl)propanoate 201 (33 mg, 0.12 mmol) 
in 4 mL of DCM at room temperature was added proton sponge (160 mg, 0.75 mmol) followed by 
trimethyloxonium tetrafluoroborate (110 mg, 0.75 mmol). The reaction mixture was kept stirring 
at room temperature and monitored by TLC. The reaction mixture was quenched with saturated 
ammonium chloride solution and separated. The aqueous layer was extracted with DCM (10 mL 
x 3). The combined organic layer was washed with brine, dried over sodium sulfate, filtered and 
concentrated. The crude residue was purified by column chromatography (SiO2, 5% ethyl acetate 
in hexane) to afford 32 mg (0.11 mmol, 92% yield) of product as yellow oil. IR (thin film): 2937, 
1737, 1099, 742, 698 cm-1;  1H NMR (300 MHz, CDCl3) 7.35-7.33 (m, 5H), 5.16 (d, J = 12.3 Hz, 
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1H), 5.13 (d, J = 12.3 Hz, 1H), 3.99 (dt, J = 7.2, 1.8 Hz, 1H), 3.65 (dt, J = 7.2, 4.5 Hz, 1H), 3.41-
3.34 (m, 5H), 2.66 (dd, J = 15.9, 5.1 Hz, 1H), 2.56 (dd, J = 15.9, 7.5 Hz, 1H), 1.87-1.85 (m, 1H), 
1.60-1.41 (m, 5H) ppm; 13C NMR (75 MHz, CDCl3) 171.8, 136.0, 128.5, 128.2, 128.1, 79.7, 78.3, 
68.8, 66.2, 58.7, 35.6, 26.6, 26.0, 23.2 ppm; HRMS (ESI) m/z calculated for [M+Na]+ 
C16H17NO3Na: 301.1416; found: 301.1427. 
 
syn-3-Methoxy-3-(tetrahydro-2H-pyran-2-yl)propanoic acid (203): Lithium 
hydroxide monohydrate (9 mg, 0.22 mmol) was suspended in H2O/MeOH/THF solution (0.4 
mL/0.4 mL/1.2 mL) and syn-benzyl 3-methoxy-3-(tetrahydro-2H-pyran-2-yl)propanoate (31 mg, 
0.11 mmol) was added to the solution. The resulting solution was then stirred overnight at room 
temp. After removal the solvent under vacuo, the residue was then taken up in 10 mL of 1 M HCl 
and extracted with chloroform. The aqueous layer was extracted with chloroform (10 mL x 3). The 
combined organic layer was washed with brine, dried over sodium sulfate, filtered and 
concentrated. The crude residue was purified by column chromatography (SiO2, 30% ethyl acetate 
in hexane) to afford 19 mg (0.10 mmol, 89% yield) of the desired product as yellowish liquid. IR 
(thin film): 3225, 2936, 1735, 1096 cm-1;  1H NMR (500 MHz, CDCl3) 10.96 (br, 1H), 4.03 (dt, J 
= 11.5, 2.0 Hz, 1H), 3.62 (dt, J =  7.5, 4.5 Hz, 1H), 3.45 (s, 3H), 3.44-3.40 (m, 2H), 2.71 (dd, J = 
16.5, 10.0 Hz, 1H), 2.57 (dd, J = 16.0, 7.0 Hz, 1H), 1.89-1.88 (m, 1H), 1.57-1.45 ( m, 5H) ppm; 
13C NMR (75 MHz, CDCl3) 176.6, 79.3, 78.4, 68.9, 58.8, 35.5, 26.6, 25.9, 23.1 ppm; HRMS (ES+) 
m/z calculated for [M-OH]+ C9H15O3: 171.1021; found: 171.1022. 
 
101 
 
      syn-3-Methoxy-3-(tetrahydro-2H-pyran-2-yl)propanoyl azide (195): Oxalyl 
chloride (128 μL, 1.50 mmol) was added to a stirred solution of syn-3-methoxy-3-(tetrahydro-2H-
pyran-2-yl)propanoic acid 203 (95 mg, 0.50 mmol) and 5 μL of DMF in 5 ml of DCM in an ice 
bath. After a period of 1.5 h the solution was concentrated to oil and dissolved in a mixture of 4 
mL of acetone and 1 mL of water and sodium azide was added. After stirring for 2 h, another 10 
mL of water and ethyl acetate was added. The layers were separated and the aqueous layer was 
extracted with ethyl acetate (10 mL x 3). The combined organic layer was washed with brine, dried 
over sodium sulfate, filtered and concentrated. The crude residue was further purified by column 
chromatography (SiO2, 10% ethyl acetate in hexane) to afford 63 mg (0.30 mmol, 59% yield) of 
the desired product as light yellowish liquid.   1H NMR (400 MHz, CDCl3) 10.96 (br, 1H), 4.01 
(dt, J = 11.2, 2.0 Hz, 1H), 3.65 (ddd, J = 8.4, 4.4, 4.0 Hz, 1H), 3.45 (s, 3H), 3.44-3.40 (m, 2H), 
2.64 (dd, J = 16.0, 10.0 Hz, 1H), 2.54 (dd, J = 16.0, 8.0 Hz, 1H), 1.89-1.88 (m, 1H), 1.57-1.45 ( m, 
5H) ppm; 13C NMR (75 MHz, CDCl3) 176.6, 79.3, 78.4, 68.9, 58.8, 35.5, 26.6, 25.9, 23.1 ppm. 
 
 
General Procedure H: Direct nitrene insertion of 195: To a 2 dram vial syn-3-methoxy-3-
(tetrahydro-2H-pyran-2-yl)propanoyl azide 195 was added under nitrogen, then solvent was added 
through a syringe. The mixture was kept stirring at different temperature under nitrogen. After all 
the starting material diminished on TLC, the solvent was removed on rotary evaporator and the 
product was confirmed directly through crude 1H NMR and 13C NMR. 
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syn-2-(2-Isocyanato-1-methoxyethyl)tetrahydro-2H-pyran (204): 1H NMR (300 
MHz, CDCl3) 4.00 (dt, J = 11.1, 1.8 Hz, 1H), 3.51 (s, 3H), 3.45-3.36 (m, 4H), 3.21 (dt, J = 9.0, 4.5 
Hz, 1H), 1.89-1.86 (m, 1H), 1.50-1.47 (m, 5H) ppm; 13C NMR (100 MHz, CDCl3) 124.6, 82.5, 
68.9, 59.3, 42.7, 26.9, 25.9, 23.2 ppm. 
 
syn-Methyl [2-methoxy-2-(tetrahydro-2H-pyran-2-yl)ethyl]carbamate (206): 
To a solution of isocyanate 204 in 2 mL of solvent, 2 mL of methanol was added and the mixture 
was kept stirring overnight. The solvent was removed through the rotary evaporator to provide the 
syn-methyl [2-methoxy-2-(tetrahydro-2H-pyran-2-yl)ethyl]carbamate as a colorless oil. IR (thin 
film): 3342, 2938, 1727, 1090 cm-1;  1H NMR (300 MHz, CDCl3) 5.18 (br, 1H), 4.02 (dt, J = 11.4, 
2.1 Hz, 1H), 3.66 (s, 3H), 3.56-3.51 (m, 1H), 3.44 (s, 3H), 3.42-3.36 (m, 2H), 3.28-316 (m, 2H), 
1.89-1.86 (m, 1H), 1.61-1.46 (m, 5H) ppm; 13C NMR (100 MHz, CDCl3) 157.2, 81.3, 78.9, 68.9, 
58.8, 52.0, 40.8, 27.2, 25.9, 23.2 ppm; HRMS (ESI) m/z calculated for [M+H]+ C4H20NO4: 
218.1392; found: 218.1390. 
 
 syn-3-Methoxy-3-(tetrahydro-2H-pyran-2-yl)propanamide (207): Oxalyl 
chloride (60 μL, 0.70 mmol, 1.2 equiv) was added to a stirred solution of syn-3-methoxy-3-
(tetrahydro-2H-pyran-2-yl) propanoic acid 203 (110 mg, 0.58 mmol, 1.0 equiv) and 1 drop of DMF 
in 5 mL of DCM in ice bath. The reaction mixture was removed from ice-bath after 15 min and 
allowed to warm to room temperature. After stirring for 2 h, ammonia gas was induced for 5 min, 
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then 5 mL of H2O was added and the layers were separated. The aqueous layer was extracted with 
DCM (10 mL x 3), washed with brine, dried over sodium sulfate and concentrated. The crude 
product was purified by column chromatography (SiO2, 40% ethyl acetate in hexane) to afford 77 
mg (0.41 mmol, 71% yield) of the desired product as white solid. IR (thin film): 3397, 3210, 2937, 
2851, 1681, 1097, 1048 cm-1;  1H NMR (400 MHz, CDCl3) 6.03 (br, 1H), 5.27 (br, 1H), 4.04-4.01 
(m, 1H), 3.54 (dt, J = 6.8, 4.8 Hz, 1H), 3.47 (s, 3H), 3.45-3.39 (m, 2H), 2.54 (dd, J = 14.8, 5.2 Hz, 
1H), 2.45 (dd, J = 14.8, 6.8 Hz, 1H), 1.88-1.87 (m, 1H), 1.56-1.48 (m, 5H) ppm; 13C NMR (75 
MHz, CDCl3) 173.8, 80.3, 78.6, 68.8, 58.8, 37.0, 27.0, 25.8, 23.1 ppm; HRMS (ESI) m/z calculated 
for [M+H]+ C9H18NO3: 188.1287; found: 188.1269. 
 
anti-4-Methoxy-6-oxa-1-azaspiro[4.5]decan-2-one (197): A solution of 87 mg of 3-
methoxy-3-(tetrahydro-2H-pyran-2-yl)propanamide (0.47 mmol, 1.0 equiv) in 8 mL of acetonitrile 
containing 381.0 mg of (diacetoxyiodo)benzene (1.19 mmol, 2.5 equiv) and 119 mg of iodine (0.47 
mmol, 1.0 equiv) was stirred under light at room temp and the reaction was monitored by TLC. 24 
h later, the reaction mixture was poured into 20 mL of sodium thiosulfate solution and extracted 
with DCM. The organic layer was combined, washed with brine, dried over sodium sulfate and 
concentrated. The crude product was further purified by flash column chromatography 
(hexane/ethyl acetate = 1:1 to 1:2) to afford 46 mg of desired product as a colorless oil.  1H NMR 
(400MHz, CDCl3) 6.48 (br, 1H), 3.76-3.65 (m, 3H), 3.36 (s, 3H), 2.70 (dd, J = 17.2, 5.6 Hz, 1H), 
2.31 (dd, J = 17.2, 1.2 Hz, 1H), 1.89-1.78 (m, 3H), 1.60-1.58 (m, 3H) ppm; 13C NMR (100MHz, 
CDCl3) 176.3, 91.3, 82.1, 62.8, 57.3, 35.4, 29.3, 25.1, 19.8 ppm. 51 
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 1-Tosyl-1H-pyrrole (213): A mixture of 10.0 mL of pyrrole (144 mmol, 1.0 equiv), 100 mL 
of DCM, 4.89 g of n-Bu4NHSO4 (14.4 mmol, 0.1 equiv) and 50 mL of NaOH solution (50% w/w) 
was made in a 500-mL round bottom flask. The stirred mixture was cooled in ice bath and 41.2g 
of TsCl (216 mmol, 1.5 equiv) was added. The mixture was kept stirring at room temp for 20 hours. 
The inorganic precipitate was collected on celite pad by vacuum filtration. The celite pad was 
washed by DCM till all the product was removed from celite pad. The solution was diluted with 
50 mL of water and separated. The aqueous layer was extracted with DCM and the combined 
organic layer was washed with water and brine, dried over sodium sulfate and concentrated. 
Hexane was added to form the crystal. The crude crystals were filtered and further recrystallized 
from MeOH to afford 20.7 g desired product (93 mmol, 65% yield) as a white solid 1H NMR 
(300MHz, CDCl3) 7.74 (d, J = 8.4Hz, 2H), 7.28 (d, J = 8.4Hz, 2H), 7.15 (t, J = 2.1Hz, 2H), 6.28 
(t, J = 2.1 Hz, 2H), 2.40 (s, 3H) ppm; 13C NMR (125MHz, CDCl3) 144.9, 136.2, 130.0, 126.8, 
120.7, 113.5, 21.6 ppm. 
 
 Methyl 9-oxo-9-(1-tosyl-1H-pyrrol-2-yl)nonanoate (215): To a solution of 0.69 
g of 1-tosyl-1H-pyrrole (3.12 mmol, 1.0 equiv) in 20 mL of DCE were added 1.85 g of 9-methoxy-
9-oxononanoic acid (85% w/w, 7.8 mmol, 2.5 equiv) and 1.76 mL of trifluoroacetic anhydride 
(12.47 mmol, 4.0 equiv). The resulting mixture was stirred at 40 oC overnight. Water was added 
until there is no bubbling observed. The mixture was washed successively with water, NaHCO3 
(aq) and brine. The organic layer was dried over sodium sulfate and concentrated. The crude 
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product was further purified by a quick flash column chromatography (hexane/ethyl acetate = 9:1) 
and used in next step directly.  
 
Methyl 9-(1-tosyl-1H-pyrrol-2-yl)nonanoate (216): A mixture of 52.2 mg of 
borane-tert-butylamine complex (0.60 mmol, 2.3 equiv) and 48.0 mg of AlCl3 (0.36 mmol, 1.4 
equiv) in 10 mL of dry DCM was stirred at room temp for 30 mins before cooled to 0 oC. A solution 
of freshly prepared 215 in 5 mL of DCM was added dropwise. After addition, the resulting solution 
was stirred for further 10 mins and then quenched with 5 mL of ice water. HCl (1 M, 10 mL) was 
added to help separating the two layers. The aqueous layer was extracted with DCM (10 mL X 3). 
The combined organic layer was washed with brine, dried over sodium sulfate and concentrated. 
The crude product was further purified by column chromatography (SiO2, hexane/ethyl acetate = 
9:1) to afford 56.4 mg of product (0.144 mmol, 56% yield in two steps) as a white solid.  1H NMR 
(400MHz, CDCl3) 7.63 (d, J = 8.4 Hz, 2H), 7.29-7.26 (m, 3H), 6.19 (t, J = 3.2 Hz, 1H), 5.97 (d, J 
= 1.2 Hz, 1H), 3.67 (s, 3H), 2.63 (t, J = 7.6 Hz, 2H), 2.40 (s, 3H), 2.30 (t, J = 7.6 Hz, 2H), 1.62-
1.50 (m, 4H), 1.30-1.26 (m, 10H) ppm;   13C NMR (100MHz, CDCl3) 174.3, 144.6, 136.6, 135.9, 
129.9, 126.7, 122.2, 111.7, 111.2, 51.4, 34.1, 29.2 (2C), 29.1 (2C), 28.6, 27.1, 24.9, 21.6 ppm.  
 
9-(1-Tosyl-1H-pyrrol-2-yl)nonanoic acid (217): Lithium hydroxide monohydrate 
(13.8 mg, 0.33 mmol, 3.0 equiv) was suspended in H2O/MeOH/THF (1 mL/1 mL/3 mL) and 43.0 
mg of methyl ester 216 (0.11 mmol, 1.0 equiv) was added to the solution. The resulting solution 
was then stirred overnight at ambient temperature overnight. After removal the solvent under 
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vacuo, the residue was then taken up in 10 mL of 1 M HCl and extracted with chloroform (10 mL 
x 3). The combined organic layer was washed with brine, dried over sodium sulfate, filtered and 
concentrated. The crude residue was further purified by column chromatography (SiO2, 40% ethyl 
acetate in hexane) to afford 37.1 mg of the desired product (0.098 mmol, 89% yield) as a white 
solid. IR (thin film): 3146, 2927, 2858, 1719, 1597, 1459, 813 cm-1; 1H NMR (400MHz, CDCl3) 
7.63 (d, J = 8.4 Hz, 2H), 7.29-7.26 (m, 3H), 6.19 (t, J = 3.2 Hz, 1H), 5.97 (d, J = 1.6 Hz, 1H), 2.63 
(t, J = 7.6 Hz, 2H), 2.40 (s, 3H), 2.35 (t, J = 7.6 Hz, 2H), 1.64-1.51 (m, 4H), 1.30-1.27 (m, 10H) 
ppm; 13C NMR (100MHz, CDCl3) 178.4, 144.6, 136.6, 135.9, 129.9, 126.7, 122.2, 111.7, 111.2, 
33.7, 29.2, 29.1(2C), 29.0, 28.6, 27.1, 24.6, 21.6 ppm. HRMS (ESI) m/z calculated for [M-H]- 
C9H18NO3: 376.1577; found: 376.1581. 
 
11,61-Ditosyl-11H,61H-1,6(2,5)-dipyrrolacycloicosaphane-2,7-dione (218): 
To a solution of 76.3 mg of acid 217 (0.20 mmol) in 50 mL of DCE at room temperature was 
added 52 µL of oxalyl chloride (0.60 mmol) and the mixture was kept stirring at room temperature 
for 0.5 h. The resulting solution was added to a 200 mL of DCE solution containing 13.4 mg of 
aluminum chloride (0.1 mmol) at 40 oC via a syringe pump over 4 hours. After the addition was 
completed, the mixture was further kept stirring at 40 oC for 0.5 h. 20 mL of water was added to 
quench the aluminum chloride. The two layers were separated and the aqueous layer was extracted 
with DCE (20 mL X 3). The combined organic layer was concentrated to ~40 mL, dried over 
sodium sulfate and concentrated. The crude product was further purified by column 
chromatography (SiO2, 10% ethyl acetate in hexane) to afford 21.1 mg of macrocyclization 
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product (0.029 mmol, 29% yield) as a white solid. 1H NMR (300MHz, CDCl3) 7.68 (d, J = 8.4 Hz, 
4H), 7.31 (d, J = 8.4 Hz, 4H), 7.27 (d, J = 3.3 Hz, 2H), 6.54 (d, J = 3.3 Hz, 2H), 3.07-3.02 (m, 2H), 
2.82-2.74 (m, 2H), 2.69-2.63 (m, 4H), 2.42 (s, 6H), 1.64-1.53 (m, 4H), 1.28-1.20 (m, 20H) ppm; 
13C NMR (100MHz, CDCl3) 197.9, 145.5, 140.7, 136.0, 130.2, 127.0, 125.0, 121.0, 111.3, 41.2, 
30.0, 28.9(2C), 28.8, 28.6, 25.5, 24.1, 21.6 ppm; HRMS (ES+) m/z calculated for [M+H]+ 
C40H51N2O6S2: 719.3189; found: 719.3173. 
 
9-(1H-Pyrrol-2-yl)nonanoic acid (219): To a stirred solution of 124 mg of 9-(1-Tosyl-
1H-pyrrol-2-yl)nonanoic acid 217 (0.33 mmol) in 10 mL of MeOH was added 2 mL of 5 N NaOH 
solution. The mixture was kept stirring under reflux for 48 hours. The solution was acidified with 
10 mL of 1 N HCl and extracted with chloroform. The combined organic layer was washed with 
brine, dried over sodium sulfate and concentrated. The crude product was further purified by 
column chromatography (SiO2, 2% MeOH in DCM) to afford 40.3 mg of desired product (0.18 
mmol, 55% yield) as a white solid. 1H NMR (400MHz, CDCl3) 10.03 (br, 1H), 7.90 (br, 1H), 6.66 
(dd, J = 4.0, 2.4 Hz, 1H), 6.13 (dd, J = 5.6, 2.4 Hz, 1H) 5.91 (s, 1H), 2.59 (t, J = 8.0 Hz, 2H), 2.35 
(t, J = 7.6 Hz, 2H), 1.65-1.60 (m, 4H), 1.35-1.26 (m, 10H) ppm; 13C NMR (100MHz, CDCl3) 176.6, 
132.8, 116.0, 108.3, 104.9, 33.8, 29.6, 29.2 (2C), 29.1, 29.0, 27.7, 24.6 ppm.  
 
9-[5-(2,2,2-Trifluoroacetyl)-1H-pyrrol-2-yl]nonanoic acid (220): To a solution of 
8.6 mg of 9-(1H-Pyrrol-2-yl)nonanoic acid 219 (0.038 mmol) in 150 mL of DCE was added 55 
µL of trifluoroacetic anhydride (0.038 mmol). The resulting mixture was stirred at 60 oC for 24 
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hours. Water (10 mL) was added to the mixture. The organic layer was separated and concentrated 
to ~50 mL. The mixture was washed successively with water, NaHCO3(aq) and brine. The organic 
layer was dried over sodium sulfate and concentrated. The crude product was further purified by 
column chromatography (SiO2, 2% MeOH in DCM) to afford 11.1 mg of product (0.035 mmol, 
91% yield) as a white solid. 1H NMR (300MHz, d4-MeOD) 7.10 (dd, J = 3.9, 1.8 Hz, 1H), 6.16 (d, 
J = 3.9 Hz, 1H), 2.68 (t, J = 7.5 Hz, 2H), 2.27 (t, J = 7.2 Hz, 2H), 1.70-1.57 (m, 4H), 1.42-1.31 (m, 
8H) ppm; 13C NMR (125MHz, d4-MeOD) 177.7, 169.4 (q, J = 35 Hz), 148.6, 126.0, 123.8 (q, J = 
3.75 Hz), 118.9 (q, J = 287.5 Hz), 111.8, 34.9, 30.3 (2C), 30.2 (2C), 28.6, 26.0 ppm.   
 
     9-[(tert-Butyldimethylsilyl)oxy]nonan-1-ol: A solution of 15.8 g of nonane-1,9-
diol (99 mmol, 1.0 equiv)) in 200 mL of THF was treated with 13.4 g of imidazole (198 mmol, 2.0 
equiv) and 14.9 g of tert-butyldimethylsilyl chloride (99 mmol, 1.0 equiv). The resulting mixture 
was stirred at ambient temperature overnight, then quenched with 100 mL of saturated NaHCO3 
solution and extracted with Et2O (100mL X 3). The combined organic layer was dried over sodium 
sulfate and concentrated. The crude product was further purified by column chromatography (SiO2, 
EtOAc/hexane = 15: 85) to afford 17.6 g of mono-protected product (54 mmol, 54% yield) as a 
colorless oil. 1H NMR (400MHz, CDCl3) 3.64 (t, J = 6.8 Hz, 2H), 3.59 (t, J = 6.8 Hz, 2H), 1.58-
1.49 (m, 4H), 1.30-1.26 (m, 10H), 0.89 (s, 9H), 0.04 (s, 6H) ppm. 
 
        9-[(tert-Butyldimethylsilyl)oxy]nonanal (233): A round bottom flask was 
charged with 0.90 g of pyridinium chlorochromate (4.2 mmol, 1.5 equiv), 0.90 g of Celite (1:1 
mass ratio to pyridinium chlorochromate) and 20 mL of DCM. Mono TBS-protected alcohol (0.76 
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g, 2.8 mmol, 1.0 equiv) was added to the stirred suspension at room temperature. All the starting 
material diminished on TLC after 2 hours. The solution was filtered through a pad of Celite and 
the pad of Celite was washed by DCM thoroughly. The combined solution was concentrated and 
the crude product was further purified by column chromatography (SiO2, ethyl acetate/hexane = 
5: 95) to afford 0.56 g of desired product (2.04 mmol, 73% yield) as a colorless oil.  1H NMR 
(400MHz, CDCl3) 9.76 (t, J = 2.0 Hz, 1H), 3.59 (t, J = 6.4 Hz, 2H), 2.42 (td, J = 7.6, 2.0 Hz, 2H), 
1.64-1.61 (m, 2H), 1.52-1.48 (m, 2H), 1.32-1.30 (m, 10H), 0.89 (s, 9H), 0.04 (s, 6H) ppm; 13C 
NMR (100MHz, CDCl3) 202.9, 63.3, 43.9, 32.8, 29.3, 29.2, 29.1, 26.0, 25.7, 22.1, 18.4, -5.3 ppm. 
 
 (S)-4-{8-[(tert-Butyldimethylsilyl)oxy]octyl}oxetan-2-one (234): To a stirred 
solution of 0.96 g of TMSQn (2.42 mmol, 0.1 equiv.) and 2.58 g of lithium perchlorate (24.2 mmol, 
1.0 equiv) in 30 mL of diethyl ehter was added 30 mL of DCM and the resulting solution was 
cooled to -78 oC. To the cooled solution was added 10.5 mL of diisopropylethylamine (60.5 mmol, 
2.5 equiv.) and a solution of 6.6 g of aldehyde 233 (24.2 mmol, 1.0 equiv.) in 10 mL of DCM. A 
solution of 3.6 mL of acetyl bromide (48.4 mmol, 2.0 equiv.) in 10 mL of DCM was added through 
a syringe pump over 1 hour and the mixture was kept stirring overnight at -78 oC. The mixture was 
quenched at -78 oC by adding 100 mL of diethyl ether. The resulting mixture was filtered through 
a pad of SiO2 eluting with diethyl ether. The solution was concentrated and the crude product was 
further purified by column chromatography (SiO2, 5% ethyl acetate in hexane) to afford 5.5 g of 
desired product (17.6 mmol, 73% yield) as a white solid. 1H NMR (400MHz, CDCl3) 4.53-4.47 
(m, 1H), 3.60 (t, J = 6.4 Hz, 2H), 3.50 (dd, J = 16.4, 5.6 Hz, 1H), 3.05 (dd, J = 16.4, 4.4 Hz, 1H), 
1.89-1.82 (m, 1H), 1.78-1.70 (m, 1H), 1.53-1.30 (m, 12H), 0.91 (s, 9H), 0.03 (s, 6H) ppm; 13C 
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NMR (100MHz, CDCl3) 168.3, 71.3, 63.2, 42.9, 34.7, 32.8, 29.4, 29.2, 29.1, 26.0, 25.7, 24.9, 18.4, 
-5.3 ppm. HRMS (ESI) m/z calculated for [M+H]+ C17H35O3Si: 315.2350; found: 315.2368. 
 
 (S)-11-[(tert-Butyldimethylsilyl)oxy]-3-hydroxy-N-methoxy-N-
methylundecanamide (235): To a 3 mL of DCM solution of 53.7 mg of N, O-
dimethylhydroxylamine hydrochloride (0.56 mmol, 2.0 equiv) was added 0.56 mL of 
dimethylaluminum chloride solution (1.0 M in hexanes, 0.56 mmol, 2.0 equiv). The resulting 
solution was cooled to -40 oC and a 1 mL of DCM solution of 86.0 mg of β-lactone 234 (0.28 
mmol, 1.0 equiv) was added. The reaction was kept stirring at -40 oC overnight. Saturated Rochelle 
salt solution (5 mL) and water (5 mL) was added and the reaction was warmed up to ambient 
temperature and stirred for extra 2 hours. The layers were separated and the aqueous layer was 
extracted with DCM (10 mL x 3). The combined organic layer was dried over sodium sulfate and 
concentrated. The crude product was used in next step without further purification.  
 
 (S)-3,12-Bis[(tert-butyldimethylsilyl)oxy]-N-methoxy-N-
methyldodecanamide (236): To a -60 oC solution of Weinreb amide 235 (0.28 mmol) from last 
step in 10 mL of DCM was added 48 µL of 2,6-lutidine (0.42 mmol, 1.5 equiv) followed by 97 µL  
of TBSOTf (0.42 mmol, 1.5 equiv). The resulting solution was kept stirring at -60 oC for 3 hours. 
Saturated NaHCO3 (10 mL) was added and the mixture was extracted with DCM (5 mL x 3). The 
combined organic layer was washed with 1M NaHSO4 solution, dried over sodium sulfate and 
concentrated. The crude product was further purified by column chromatography (SiO2, 5% ethyl 
acetate in hexane) to afford 101 mg of desired product (74% yield in two steps) as a colorless oil. 
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1H NMR (300MHz, CDCl3) 4.22 (td, J = 11.1, 5.7 Hz, 1H), 3.69 (s, 3H), 3.59 (t, J = 6.6 Hz, 2H), 
3.17 (s, 3H), 2.71 (dd, J = 14.4, 6.9 Hz, 1H), 2.38 (dd, J = 14.7, 5.4 Hz, 1H), 1.52-1.46 (m, 4H), 
1.37-1.28 (m, 10H), 0.89 (s, 9H), 0.86 (s, 9H), 0.06-0.03 (m, 12H) ppm; 13C NMR (125MHz, 
CDCl3) 172.6, 69.5, 63.3, 61.3, 39.6, 37.9,, 32.9, 31.9, 29.7, 29.6, 29.4, 26.0, 25.9, 25.8, 25.1, 18.4, 
18.0, -4.6, -4.7, -5.3 ppm. HRMS (ESI) m/z calculated for [M+H]+ C25H56NO4Si2: 490.3742; found: 
490.3740. 
 
 (S)-3,11-Bis[(tert-butyldimethylsilyl)oxy]undecanal (237): To a -78 oC solution 
of 101 mg of Weinreb amide 236 (0.21 mmol, 1.0 equiv) in 10 mL of dry DCM was added 0.25 
mL of DIBAL solution (0.25 mmol, 1.0 M in hexanes, 1.2 equiv) dropwise. The resulting solution 
was kept stirring at -78 oC  for 3 hours. Methanol (0.3 mL) was added and the mixture was warmed 
up to room temperature. The solution was filtered through a pad of celite and concentrated. The 
crude product was further purified by column chromatography (SiO2, 10% ethyl acetate in hexane) 
to afford 60 mg of product (0.14 mmol, 67% yield) as a colorless oil. 1H NMR (400MHz, CDCl3) 
9.81 (t, J = 2.4 Hz, 1H), 4.17(t, J = 6.0 Hz, 1H), 3.59 (t, J = 6.4 Hz, 2H), 2.51 (dd, J = 5.6, 2.4 Hz, 
2H), 1.52-1.49 (m, 4H), 1.31-1.27 (m, 10H), 0.89 (s, 9H), 0.87 (s, 9H), 0.07-0.05 (m, 12H) ppm. 
 
 (5S)-5,13-Bis[(tert-butyldimethylsilyl)oxy]tridec-1-en-3-ol: To a stirred 
solution of 60 mg of aldehyde 237 (0.14 mmol, 1.0 equiv) in 10 mL of dry THF was added 0.28 
mL of vinylmagnesium bromide (1.0 M in THF solution, 0.28 mmol, 2.0 equiv) slowly. The 
solution was stirred at this temperature for 1.5 h. The reaction was quenched by slow addition of 
0.1 mL of acetic acid followed by 10 mL of aqueous NH4Cl solution. The mixture was warmed to 
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room temperature and the organic phase was separated. The aqueous phase was extracted with 
Et2O and the combined organic layer was washed with brine, dried over sodium sulfate and 
concentrated. The crude product was used in next step without further purification.  
 
 (9S)-9-[(tert-Butyldimethylsilyl)oxy]tridec-12-ene-1,11-diol (238): To a 
solution of allyl alcohol from last step in 5 mL of MeOH was added 105.6 mg of pyridinium p-
toluenesulfonate (0.42 mmol, 3.0 equiv). The reaction was stirred at room temperature overnight 
and then saturated NaHCO3 was added to quench this reaction. The organic layer was separated 
and the aqueous layer was extracted with DCM. The combined organic extracts were dried over 
sodium sulfate and concentrated. The crude product was further purified by column 
chromatography (SiO2, 20% ethyl acetate in hexane) to afford 31.8 mg of product (66% yield in 
two steps, mixture of cis:trans isomers) as a light yellow oil. 1H NMR mixture of cis:trans isomers 
(~3:2) (CDCl3, 400MHz) 5.80-5.72 (m, 1H), 5.19-5.13 (m, 1H), 5.00-4.96 (m, 1H), 4.33 (br, 0.6H) 
4.17 (br, 0.4H), 3.87-3.82 (m, 1H), 3.54 (t, J = 6.4 Hz, 2H), 3.19 (br, 0.4H), 3.08 (br, 0.6H), 1.57-
1.40 (m, 4H), 1.28-1.12 (m, 12H), 0.80-0.78 (m, 9H), 0.02- -0.05(m, 6H) ppm; 13C NMR (CDCl3, 
100MHz) 141.3, 140.9, 114.0, 113.8, 72.8, 72.2, 71.2, 69.6, 63.1, 43.0, 38.0, 32.8, 29.7, 29.6, 
29.5(2C), 29.3, 25.8, 25.7, 25.5, 24.6, 18.0, -4.0, -4.7 ppm. 
 
 (S)-9-[(tert-Butyldimethylsilyl)oxy]-11-oxotridec-12-enal (239): DMP (148 mg, 
0.35 mmol, 3.0 equiv) was added to a solution of 40 mg of alcohol 238 (0.12 mmol, 1.0 equiv) in 
5 mL of DCM. The reaction was kept stirring at room temperature and monitored by TLC. All the 
starting diminished on TLC after 2 hours. Saturated NaHCO3 (2 mL) and Na2S2O3 (2 mL) was 
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added to this mixture. After all solids were dissolved, the mixture was extracted with DCM. The 
combined organic layer was washed with brine, dried over sodium sulfate and concentrated. The 
crude product was further purified by column chromatography. (SiO2, 15% ethyl acetate in hexane) 
to afford 25.4 mg of product (64 % yield) as a light yellow oil. The purified product was used in 
next step immediately after purification due to the intrinsic polymerization characteristic of the 
unhindered enone.  1H NMR (400MHz, CDCl3) 9.76 (t, J = 1.6 Hz, 1H) 6.36 (dd, J = 17.6, 10.4 
Hz, 1H), 6.21 (dd, J = 17.6, 1.2 Hz, 1H), 5.84 (dd, J = 10.8, 1.2 Hz, 1H), 4.22-4.16 (m, 1H), 2.80 
(dd, J = 14.8, 6.8 Hz, 1H), 2.58 (dd, J = 14.8, 5.2 Hz, 1H), 2.42 (td, J = 7.2, 2.0 Hz, 2H), 1.64-1.61 
(m, 2H), 1.48-1.43 (m, 2H), 1.31-1.26 (m, 8H), 0.83 (s, 9H), 0.08 (s, 3H), -0.01 (s, 3H) ppm;  13C 
NMR (100MHz, CDCl3) 202.9, 199.9, 137.5, 128.5, 69.2, 47.0, 43.9, 37.8, 29.4, 29.3, 29.1, 25.8, 
25.0, 22.0, 18.0, -4.6, -4.7 ppm.  
 
 (R)-6-[(tert-Butyldimethylsilyl)oxy]cyclotridecane-1,4-dione (240): To a solution 
of 42.8 mg of catalyst 242 (0.115 mmol, 1.5 equiv) and 35 µL of DBU (0.231 mmol, 3.0 equiv) in 
50 mL of toluene at 100 oC was added a solution of 25.4 mg of freshly prepared enone 239 (0.077 
mmol, 1.0 equiv) in 24 mL of toluene dropwise through a syringe pump over 8 hours. The resulting 
mixture was stirred at this temperature for another 16 hours then cooled to room temperature. The 
resulting mixture was concentrated and directly loaded on a silica gel column and purified (10% 
ethyl acetate in hexane) to afford 9.2 mg of product (35% yield) as a light yellow oil. 1H NMR 
(300MHz, CDCl3) 4.13-4.06 (m, 1H), 2.84-2.73 (m, 2H), 2.63 (dd, J = 15.3, 9.3 Hz, 1H), 2.55-
2.42 (m, 4H), 2.32-2.28 (m, 1H), 1.59-1.53 (m, 2H), 1.40-1.02 (m, 10H), 0.80 (s, 9H), 0.01 (s, 6H) 
ppm; 13C NMR (125MHz, CDCl3) 209.5, 208.0, 67.6, 51.8, 41.9, 37.8,36.6, 34.5, 26.2, 26.1, 25.6, 
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25.1, 21.8, 21.5, 18.2, -4.5(2C) ppm; HRMS (ESI) m/z calculated for [M+H]+ C19H37O3Si: 
341.2506; found: 341.2470. 
 
 (R)-3-[(tert-Butyldimethylsilyl)oxy]-11H-1(2,5)-pyrrolacyclodecaphane (243): 
To a solution of 8.0 mg of macrocyclic 1,4-diketone 240 (0.024 mmol, 1.0 equiv) in 2 mL of 
MeOH in a microwave vial was added 92 mg of NH4OAc (1.2 mmol, 5.0 equiv) and the vial was 
sealed and heated in a microwave reactor at 120 oC for 30 mins. The solution was cooled to room 
temperature, quenched with water and extracted with DCM. The combined organic layer was 
washed with saturated sodium bicarbonate solution, dried over anhydrous sodium sulfate and 
concentrated. The crude product was further purified by column chromatography (SiO2, 5% 
EtOAc in hexane) to afford 5.6 mg of desired product (0.017 mmol, 70% yield) as a light red oil.  
1H NMR (500 MHz, CDCl3) 8.23 (br, 1H), 5.79 (t, J = 2.5 Hz, 1H), 5.76 (t, J = 2.5 Hz, 1H), 4.00-
3.96 (m, 1H), 2.82 (dd, J = 14.5, 3.5 Hz, 1H), 2.73 (dd, J = 14.5, 8.0 Hz, 1H), 2.70-2.62 (m, 1H), 
2.50 (ddd, J = 14.5, 10.5, 4.0 Hz, 1H),  1.53-1.49 (m, 6H), 1.33-1.14 (m, 4H), 1.01-0.98 (m, 2H), 
0.94 (s, 9H), 0.12 (s, 3H), 0.11 (s, 3H) ppm. 13C NMR (100 MHz, CDCl3) 130.8, 128.8, 107.1, 
106.2, 72.1, 36.4, 36.0, 27.2, 26.0(2C), 24.7, 22.9, 22.3, 18.1, 17.7, -4.7, -4.8 ppm. HRMS (ESI) 
m/z calculated for [M+H]+ C19H36NOSi: 322.2561; found: 322.2564. 
  
 9-[(Triisopropylsilyl)oxy]nonan-1-ol: To a solution of 2.0 g of nonane-1,9-diol 
(12.5 mmol, 1.0 equiv.) in 20 mL of DCM and 2 mL of DMF were added 1.3 g of imidazole (18.7 
mmol, 1.5 equiv.) followed by 2.7 mL of TIPSCl (13.8 mmol, 1.1 equiv.). The mixture was kept 
stirring at room temp overnight and quenched by adding 20 mL of brine. The organic phase was 
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separated and the aqueous layer was extracted with DCM. The combined organic layer was dried 
over magnesium sulfate. The solvent was evaporated and the crude product was further purified 
by column chromatography (SiO2, 20% ethyl acetate in hexane) to afford 1.93 g of product (6.2 
mmol, 49% yield) as a light yellow liquid. 1H NMR (300MHz, CDCl3) 3.68-3.62 (m, 4H), 1.59-
1.51 (m, 4H), 1.38-1.31 (m, 10H), 1.19 (t, J = 5.4 Hz, 1H), 1.10-0.98 (m, 21H) ppm; 13C NMR 
(100MHz, CDCl3) 63.2, 63.1, 33.0, 32.8, 29.6, 29.4, 29.3, 25.8, 25.7, 18.0, 12.2 ppm.  
 
9-[(Triisopropylsilyl)oxy]nonanal (244): To a solution of 4.5 g of alcohol from last 
step (14.2 mmol, 1.0 equiv) in 100 mL of DCM was added 7.8 g of DMP (18.4 mmol, 1.3 equiv.). 
The resulting mixture was stirred at room temperature for 1.5 h. Saturated NaHCO3 (20 mL) and 
saturated Na2S2O3 solutions (20 mL) were added to this mixture. After all the solids were dissolved, 
the mixture was extracted with DCM. The combined organic layer was washed with brine, dried 
over sodium sulfate and concentrated. The crude mixture was further purified by column 
chromarography (SiO2, 5% ethyl acetate in hexane) to afford 4.0 g of product (12.7 mmol, 90% 
yield) as a light yellow oil. 1H NMR (300MHz, CDCl3) 9.76 (t, J = 1.8 Hz, 1H), 3.67 (t, J = 6.3 
Hz, 2H), 2.42 (td, J = 7.2, 1.8 Hz, 2H), 1.65-1.60 (m, 2H), 1.54-1.51 (m, 2H), 1.36-1.31 (m, 10H), 
1.07-1.05 (m, 21H) ppm; 13C NMR (100MHz, CDCl3) 202.9, 63.4, 43.9, 33.0, 29.3, 29.2, 29.1, 
25.7, 22.1, 18.0, 12.0 ppm. 
 
Ethyl 3-hydroxy-11-[(triisopropylsilyl)oxy]undecanoate: To a suspension of 
203 mg of zinc dust (3.1 mmol, 1,6 equiv.) in 30 mL of diethyl ether was added 292 µL of TMSCl 
and the mixture was kept stirring at room temperature for 15 min. Aldehyde 244 (600 mg, 1.9 
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mmol, 1.0 equiv) and ethyl bromoacetate (384 mg, 2.3 mmol, 1.2 mmol) were added to this 
suspension. The mixture was kept stirring at reflux for 3 hours. A solution of 2 M HCl (2 mL) was 
added to this mixture and the solution was kept stirring for 20 mins. The layers were separated and 
the aqueous layer was extracted with ethyl ether. The combined organic layer was washed with 
NaHCO3 solution, brine, dried over sodium sulfate and concentrated. The crude product was 
further purified by column chromatography (SiO2, 5% ethyl acetate in hexane) to afford 494 mg 
of desired alcohol (1.24 mmol, 65% yield) as a colorless oil. 1H NMR (400MHz, CDCl3) 4.17 (q, 
J = 7.2 Hz, 2H), 3.99 (br, 1H), 3.65 (t, J = 6.8 Hz, 2H), 2.92 (d, J = 4.0Hz, 1H), 2.50 (dd, J = 16.4, 
3.2 Hz, 1H), 2.39 (dd, J = 16.4, 8.8 Hz, 1H), 1.53-1.50 (m, 2H), 1.44-1.43 (m, 2H), 1.30-1.26 (m, 
13H), 1.07 (d, J = 6.0 Hz, 18H) ppm; 13C NMR(100MHz, CDCl3) 173.2, 68.0, 63.5, 60.7, 41.3, 
36.5, 33.0, 29.5 (2C), 29.4, 25.8, 25.5, 18.0, 14.2, 12.0 ppm.  
 
 Ethyl 3-oxo-11-[(triisopropylsilyl)oxy]undecanoate (190): To a solution of 
329 mg of alcohol from last step (0.82 mmol, 1.0 mmol) in 10 mL of DCM was added 451 mg of 
DMP (1.06 mmol, 1.3 equiv). The resulting mixture was stirred at room temperature for 1 h. 
Saturated NaHCO3 (5 mL) and saturated Na2S2O3 solutions (5 mL) were added to this mixture. 
After all the solids were dissolved, the mixture was extracted with DCM. The combined organic 
layer was washed with brine, dried over sodium sulfate and concentrated. The crude mixture was 
further purified by column chromatography (SiO2, 5% ethyl acetate in hexane) to afford 314 mg 
of desired product (0.78 mmol, 95% yield) as alight yellow oil. 1H NMR (300MHz, CDCl3) 4.20 
(q, J = 7.2 Hz, 2H), 3.66 (t, J = 6.6 Hz, 2H), 3.42 (s, 2H), 2.53 (t, J = 7.2 Hz, 2H), 1.61-1.50 (m, 
4H), 1.30-1.26 (m, 12H), 1.09-1.01 (m, 22H) ppm; 13C NMR (100MHz, CDCl3) 203.0, 167.3, 63.4, 
61.3, 49.3, 43.0, 33.0, 29.3, 29.3, 29.0, 25.8, 23.4, 18.0, 14.1, 12.0 ppm.  
117 
 
Ethyl (E)-3-{[(trifluoromethyl)sulfonyl]oxy}-11-[(triisopropylsilyl)oxy]undec-
2-enoate (245): A solution of 64.8 mg of ketone 244 (0.162 mmol, 1.0 equiv) in 1 mL of DMF 
was added dropwise to a mixture of 7.1 mg of sodium hydride (60% w/w, 0.178 mmol, 1.1 equiv) 
in 1 mL of DMF. The reaction was stirred for 10 minutes at room temperature and the solution 
turned clear. Then 63.6 mg of N-phenyltrifluoromethanesulfonimide (0.178 mmol, 1.1 equiv) was 
added and the solution was stirred at room temperature for additional 3 hours. The crude mixture 
was diluted with diethyl ether, and the organic layer was washed with saturated NH4Cl (aq), H2O 
and brine. The combined organic layer was dried over sodium sulfate and concentrated. The crude 
product was further purified by column chromatography (SiO2, 5% ethyl acetate in hexane) to 
afford 69.6 mg of desired product (0.131 mmol, 81% yield) as a colorless oil. 1H NMR (300M Hz, 
CDCl3) 5.93 (s, 1H), 4.22 (q, J = 7.2 Hz, 2H), 3.66 (t, J = 6.6 Hz, 2H), 2.91 (t, J = 7.2 Hz, 2H), 
1.64-1.51 (m, 4H), 1.33-1.28 (m, 13H), 1.07-1.01 (m, 21H) ppm; 13C NMR (100MHz, CDCl3) 
165.8,  164.1, 112.5, 63.4, 61.1, 33.0, 31.4, 29.2, 29.1, 28.8, 26.3, 25.7, 18.0, 14.1, 12.0 ppm.   
 
 (E)-1-Hydroxy-11-[(triisopropylsilyl)oxy]undec-2-en-3-yl 
trifluoromethanesulfonate: To a solution of 517 mg of vinyl triflate 245 (1.0 mmol, 1.0 equiv) 
in 15 mL of DCM at -60 oC was added 4.0 mL of DIBAL-(H) (1.0 M in hexanes) and the mixture 
was kept stirring at this temperature for 1.5 hours. The reaction was quenched by adding 2 mL of 
MeOH and warmed up to room temperature. Saturated Rochelle salt solution was added and the 
solution was kept stirring at room temperature for 2 hours. The organic layer was separated and 
the aqueous layer was extracted with DCM. The combined organic layer was dried over sodium 
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sulfate and concentrated. The crude product was directly used in next step without any further 
purification. 
 
 (E)-17,17-Diisopropyl-2,2,3,3,18-pentamethyl-4,16-dioxa-3,17-disilanonadec-
6-en-7-yl trifluoromethanesulfonate (189): To a solution of allylic alcohol from last step (1.0 
mmol, 1.0 equiv) from last step in 10 mL of DMF was added 136 mg of imidazole (2.0 mmol, 2.0 
equiv) and 301 mg of TBSCl (2.0 mmol, 2.0 equiv). The resulting mixture was kept stirring at 
room temperature for 2 hours. Saturated NaHCO3 was added to the solution followed by ethyl 
acetate. The layers were separated and the aqueous layer was extracted with ethyl acetate. The 
combined organic layer was washed with brine, dried over sodium sulfate and concentrated. The 
crude product was further purified by column chromatography (SiO2, 3% ethyl acetate in hexane) 
to afford 327 mg of desired product (0.54 mmol, 54% yield in 2 steps) as a colorless oil. 1H NMR 
(500 MHz, CDCl3) 5.66 (t, J = 7.0 Hz, 1H), 4.22 (d, J = 7.0 Hz, 2H), 3.66 (t, J = 6.5 Hz, 2H), 2.38 
(t, J = 7.5 Hz, 2H), 1.56-1.50 (m, 4H), 1.65-1.30 (m, 10H), 1.08-1.04 (m, 21H), 0.90 (s, 9H), 0.08 
(s, 6H) ppm; 13C NMR (125 MHz, CDCl3) 151.5, 121.2, 118.5 (q, J = 318 Hz),  63.4, 58.3, 33.0, 
30.4, 29.3, 29.2, 28.8, 26.2, 25.8, 18.0, 12.0, -5.3 ppm; HRMS (ESI) m/z calculated for [M+H]+ 
C27H56O5F3SSi2: 605.3315; found: 605.3334. 
 
 (E)-7-[(E)-2-Ethoxyvinyl]-17,17-diisopropyl-2,2,3,3,18-pentamethyl-4,16-
dioxa-3,17-disilanonadec-6-ene (187):  To a solution of 30.0 mg of vinyl triflate (0.050 mmol, 
1.0 equiv) in 2 ml of 1-methyl-2-pyrrolidinone was added 1.3 mg of 
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bis(acetonitrile)dichloropalladium(II) (0.005 mmol, 0.1 equiv), 1.9 mg of copper(I) iodide (0.010 
mmol, 0.2 equiv) and 3.1 mg of triphenylarsine (0.010 mmol, 0.2 equiv). A solution of 21.7 mg of 
(E)-tributyl(2-ethoxyvinyl)stannane (0.060 mmol, 1.2 equiv) in 1 ml of 1-methyl-2-pyrrolidinone 
was added and the reaction stirred for 24 h at room temperature under an atmosphere of nitrogen 
in dark. The reaction was diluted with ethyl acetate and the product was washed with aqueous KF 
solution. The combined organic layers were washed with brine, dried over sodium sulfate and 
concentrated. The product was purified by chromatography (SiO2, 5% ethyl acetate in hexane) to 
afford 9.0 mg of product (34% yield) as light yellow oil.     1H NMR (500 MHz, CDCl3) 6.52 (d, 
J = 13.0 Hz, 1H), 5.46 (d, J = 13.0 Hz, 1H), 5.34 (t, J = 6.5 Hz, 1H), 4.24 (d, J = 6.5 Hz, 2H), 3.79 
(q, J = 7.0 Hz, 2H), 3.66 (t, J = 7.0 Hz, 2H), 2.11 (t, J = 8.0 Hz, 2H), 1.54-1.52 (m, 2H), 1.30-1.27 
(m, 11H), 1.08-1.04 (m, 21H), 0.90 (s, 9H), 0.07 (s, 6H) ppm; 13C NMR (125 MHz, CDCl3) 146.6, 
137.2, 125.5, 109.4, 65.2, 63.5, 59.9, 33.0, 29.8, 29.5 (2C), 29.3, 27.8, 26.0, 25.8, 18.4, 18.0, 14.8, 
12.0, -5.0 ppm. HRMS (ESI) m/z calculated for [M+H]+ C30H63O3Si2: 527.4316; found: 527.4359.  
 
 (4R,5R)-4-Hydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one (193): To a 
solution of 0.51 g of 2-deoxy-L-ribose 194 (3.8 mmol, 1.0 equiv) in 10 mL of water was added 0.6 
mL of bromine (11.4 mmol, 3.0 equiv) and the resulting solution was kept stirring at ambient 
temperature in the dark for 24 hours. Sodium sulfite and sodium carbonate were added until red 
color diminished and pH = 7. The mixture was filtered through a pad of celite and concentrated. 
The concentrated solution was further filtered through a pad of celite. The crude product was 
further purified by column chromatography (SiO2, 10% MeOH in DCM) to afford 0.45 g of desired 
product (88% yield) as a light yellow solid. [𝛼]𝐷
20 4.7 (c = 1.21, MeOH); 1H NMR(400 MHz, D2O) 
4.66-4.62 (m, 2H), 3.95 (dd, J = 12.8, 2.4 Hz, 1H), 3.85 (dd, J = 12.8, 4.4 Hz, 1H), 3.14 (dd, J = 
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16.8, 6.8 Hz, 1H), 2.66 (dd, J = 16.8, 2.0 Hz, 1H) ppm; 13C NMR (100 MHz, D2O) 179.5, 88.9, 
68.2, 61.0, 37.8 ppm. 
 
     Ethyl (R)-3-hydroxypent-4-enoate (192): Lactone 193 (4.9 g, 37 mmol, 1.0 equiv) 
was stirred with 25 mL of HBr in acetic acid (33% w/w) at room temperature overnight. Excess 
acid was evaporated on a rotary evaporator and the resulting syrup was dissolved in 15 mL of 50% 
acetic acid solution (v/v). Zinc dust (15 g, 231 mmol, 6.0 equiv) was added in portions and the 
mixture was stirred at room temperature for 3 hours. To remove zinc salt and deacetylate the 3-
position OH, the residue was dissolved in water and pH was adjusted to 10 using KOH. A white 
precipitate of Zn(OH)2 was formed and removed by filtration. The filtrate was concentrated and 
the syrup was dissolved in ethanol and acidified with HCl. The KCl salt was removed by filtration. 
The mixture was kept stirring at 50 oC overnight and concentrated. The crude product was further 
purified by column chromatography (SiO2, 30% ethyl acetate in hexane) to afford 1.5 g of product 
(34% yield) as a colorless oil. [𝛼]𝐷
20 5.9, (c = 0.87, CHCl3); 1H NMR(500 MHz, CDCl3) 5.89 (ddd, 
J = 17.5, 10.5, 5.5 Hz, 1H), 5.32 (dt, J = 17.5, 1.5 Hz, 1H), 5.16 (dt, J = 10.5, 1.5 Hz, 1H), 4.54 
(ddd, J = 9.5, 5.5, 4.0 Hz, 1H), 4.18 (q, J = 7.0 Hz, 2H), 2.59 (dd, J = 16.0, 4.0 Hz, 1H), 2.52 (dd, 
J = 16.0, 8.5 Hz, 1H), 1.28 (t, J = 7.0 Hz, 3H) ppm; 13C NMR(125 MHz, CDCl3) 172.3, 138.8, 
115.4, 68.9, 60.8, 41.1, 14.2 ppm.  
 
     Ethyl (R)-3-methoxypent-4-enoate (246): To a solution of 1.20 g of alcohol 193 
(8.3 mmol, 1.0 equiv) in 50 mL of DCM at 0 oC was added 5.42 g of proton sponge (24.9 mmol, 
3.0 equiv) followed by 3.73 g of trimethyloxonium tetrafluoroborate (24.9 mmol, 3.0 equiv). The 
resulting solution was stirred at room temperature for 3 hours. The reaction was quenched by 
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addition of 20 mL of saturated NaHCO3(aq). The phases were separated and the aqueous layer was 
extracted with DCM. The combined organic layer was washed with citric acid solution (10% w/w) 
andbrine, dried over sodium sulfate and concentrated. The crude product was further purified by 
column chromatography (SiO2, 20% ethyl acetate in hexane) to provide 1.04 g of ethyl (R)-3-
methoxypent-4-enoate (79% yield) as a colorless liquid. [𝛼]𝐷
20  11.2, (c = 1.31, CHCl3); 1H 
NMR(400 MHz, CDCl3) 5.70 (ddd, J = 17.6, 10.4, 7.6 Hz, 1H), 5.29 (d, J = 17.2 Hz, 1H), 5.24 (d, 
J = 10.4 Hz, 1H), 4.15 (q, J = 7.2 Hz, 2H), 4.03 (td, J = 7.6, 5.6 Hz, 2H), 3.29 (s, 3H), 2.60 (dd, J 
= 15.2, 8.4 Hz, 1H) 2.45 (dd, J = 15.2, 5.2 Hz, 1H), 1.26 (t, J = 7.2 Hz, 3H); 13C NMR (100MHz, 
CDCl3) 170.9, 137.0, 118.0, 79.1, 60.5, 56.5, 41.0, 14.2 ppm.  
 
     Ethyl (R)-3-methoxy-4-oxobutanoate (188): To a -78 oC solution of 220 mg of 
ethyl (R)-3-methoxypent-4-enoate (1.39 mmol, 1.0 equiv) in 20 mL of DCM/EtOH (9:1) was 
bubbled with ozone for 10 min, then 0.3 mL of Me2S was added at this temperature and the mixture 
was allowed to warm up to ambient temperature and kept stirring at ambient temperature for 
another 2 hours. The solvent was removed under rotary evaporator. The crude mixture was further 
purified by column chromatography (SiO2, 20% ethyl acetate in hexane) to provide 167 mg of α-
methoxy aldehyde (75% yield) as a colorless liquid. [𝛼]𝐷
20 11.2, (c = 1.31, CHCl3); 1H NMR (400 
MHz, CDCl3): 9.78 (s, 1H), 4.16 (q, J = 7.2 Hz, 2H), 3.97 (dd, J = 6.8, 4.8 Hz, 1H), 3.51 (s, 1H), 
2.77 (dd, J = 16.4, 4.8 Hz, 1H), 2.67 (dd, J = 16.4, 6.8 Hz, 1H), 1.26 (t, J = 7.2 Hz, 3H) ppm; 13C 
NMR (125MHz, CDCl3) 202.2, 170.0, 81.8, 61.1, 58.7, 35.7, 14.1 ppm; HRMS (ESI) m/z 
calculated for [M+H]+ C7H13O4: 161.0808; found: 161.0814.
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APPENDIX   
X-RAY STRUCTURE OF 104a 
 
Figure 22 X-Ray Structure of 104a 
ORTEP structure of 104a. The molecular structure is drawn with 50% probability displacement 
ellipsoids; hydrogen atoms are drawn with an artificial radius. 
 
 
 
 
123 
 
Table 9 CIF Information for Compound 104a 
Identification code feng6080 
Chemical formula C28H21N3O9S 
Formula weight 575.54 g/mol 
Temperature 230(2) K 
Wavelength 1.54178 Å 
Crystal size 0.020 x 0.020 x 0.180 mm 
Crystal system orthorhombic 
Space group P 21 21 21 
Unit cell dimensions a = 7.3390(5) Å α = 90° 
 b = 14.9243(9) Å β = 90° 
 c = 24.6171(13) Å γ = 90° 
Volume 2696.3(3) Å3  
Z 4 
Density (calculated) 1.418 g/cm3 
Absorption 
coefficient 
1.596 mm-1 
F(000) 1192 
Diffractometer Bruker Apex II CCD 
Radiation source IMuS micro-focus source, Cu 
Theta range for data 
collection 
3.46 to 68.59° 
Index ranges -8<=h<=8, -17<=k<=17, -28<=l<=29 
Reflections collected 21453 
Independent 
reflections 
4941 [R(int) = 0.2124] 
Absorption 
correction 
multi-scan 
Max. and min. 
transmission 
0.9700 and 0.7600 
Structure solution 
technique 
direct methods 
Structure solution 
program 
SHELXS-97 (Sheldrick, 2008) 
Refinement method Full-matrix least-squares on F2 
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Refinement program SHELXL-97 (Sheldrick, 2008) 
Function minimized Σ w(Fo2 - Fc2)2 
Data / restraints / 
parameters 
4941 / 0 / 371 
Goodness-of-fit on F2 0.980 
Δ/σmax 0.003 
Final R indices 
2518 data; 
I>2σ(I) 
R1 = 0.1074, wR2 
= 0.2321 
 all data 
R1 = 0.1834, wR2 
= 0.2909 
Weighting scheme 
w=1/[σ2(Fo2)+(0.1204P)2] 
where P=(Fo2+2Fc2)/3 
Absolute structure 
parameter 
-0.0(1) 
Extinction 
coefficient 
0.0085(16) 
Largest diff. peak 
and hole 
0.555 and -0.891 eÅ-3 
R.M.S. deviation 
from mean 
0.138 eÅ-3 
 
Table 10 Atomic Coordinates and Equivalent Isotropic Atomic Displacement Parameters (Å2) for 104a. 
 x/a y/b z/c U(eq) 
S1 0.1358(4) 0.4945(2) 0.51824(10) 0.0650(9) 
O1 0.1908(11) 0.4539(5) 0.4680(3) 0.075(2) 
O2 0.9533(10) 0.5249(5) 0.5259(3) 0.072(2) 
O3 0.8204(16) 0.7690(7) 0.5691(4) 0.110(3) 
O4 0.5965(16) 0.8522(8) 0.5938(5) 0.128(4) 
O5 0.0914(9) 0.3065(5) 0.6255(3) 0.063(2) 
O6 0.4624(10) 0.3781(5) 0.5475(3) 0.0610(19) 
O7 0.1467(11) 0.2329(5) 0.5242(3) 0.079(2) 
O8 0.8376(19) 0.8901(8) 0.6918(4) 0.115(4) 
O9 0.0907(18) 0.8208(8) 0.6718(5) 0.122(4) 
N1 0.656(2) 0.7816(8) 0.5766(5) 0.094(3) 
N2 0.1693(12) 0.4176(5) 0.5680(3) 0.057(2) 
125 
 
 x/a y/b z/c U(eq) 
N3 0.992(2) 0.8876(9) 0.6723(5) 0.092(4) 
C1 0.4639(17) 0.5772(8) 0.5150(5) 0.070(3) 
C2 0.5868(15) 0.6426(7) 0.5289(5) 0.070(3) 
C3 0.5313(18) 0.7095(8) 0.5612(5) 0.074(3) 
C4 0.354(2) 0.7159(8) 0.5826(5) 0.083(4) 
C5 0.2313(17) 0.6490(8) 0.5688(5) 0.076(3) 
C6 0.2889(16) 0.5793(7) 0.5348(5) 0.063(3) 
C7 0.0167(14) 0.3839(7) 0.6008(4) 0.059(3) 
C8 0.2695(14) 0.2852(7) 0.6059(4) 0.055(2) 
C9 0.3199(14) 0.3643(6) 0.5695(4) 0.050(2) 
C10 0.079(2) 0.4865(8) 0.6788(5) 0.080(4) 
C11 0.023(3) 0.5495(11) 0.7170(6) 0.106(5) 
C12 0.849(3) 0.5733(13) 0.7204(7) 0.132(7) 
C13 0.720(3) 0.5400(12) 0.6842(9) 0.134(7) 
C14 0.7743(18) 0.4775(10) 0.6443(6) 0.092(4) 
C15 0.9552(16) 0.4507(8) 0.6441(5) 0.065(3) 
C16 0.3443(16) 0.2817(8) 0.7061(4) 0.068(3) 
C17 0.4666(19) 0.2669(9) 0.7482(6) 0.088(4) 
C18 0.6398(18) 0.2430(9) 0.7384(5) 0.081(3) 
C19 0.7030(16) 0.2360(10) 0.6842(5) 0.079(3) 
C20 0.5794(14) 0.2484(8) 0.6427(5) 0.070(3) 
C21 0.4033(13) 0.2713(7) 0.6515(4) 0.054(2) 
C22 0.2622(15) 0.2027(7) 0.5673(4) 0.061(3) 
C23 0.3055(18) 0.0545(8) 0.6139(5) 0.073(3) 
C24 0.2413(19) 0.9792(7) 0.6381(5) 0.077(3) 
C25 0.0639(18) 0.9695(8) 0.6454(4) 0.069(3) 
C26 0.9402(17) 0.0318(8) 0.6291(5) 0.071(3) 
C27 0.0019(15) 0.1074(8) 0.6021(4) 0.070(3) 
C28 0.1887(15) 0.1197(7) 0.5955(4) 0.059(3) 
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Table 11 Bond Lengths (Å) for 104a. 
S1-O2 1.427(8) S1-O1 1.434(7) 
S1-N2 1.697(8) S1-C6 1.741(12) 
O3-N1 1.232(16) O4-N1 1.218(15) 
O5-C7 1.416(12) O5-C8 1.430(11) 
O6-C9 1.196(11) O7-C22 1.431(12) 
O7-H7B 0.83 O8-N3 1.233(15) 
O9-N3 1.230(16) N1-C3 1.465(17) 
N2-C9 1.362(13) N2-C7 1.469(12) 
N3-C25 1.486(16) C1-C6 1.374(15) 
C1-C2 1.372(16) C1-H1A 0.94 
C2-C3 1.340(16) C2-H2A 0.94 
C3-C4 1.405(18) C4-C5 1.388(17) 
C4-H4A 0.94 C5-C6 1.400(16) 
C5-H5A 0.94 C7-C15 1.528(15) 
C7-H7A 0.99 C8-C21 1.506(14) 
C8-C9 1.527(14) C8-C22 1.555(13) 
C10-C15 1.357(17) C10-C11 1.392(19) 
C10-H10A 0.94 C11-C12 1.33(2) 
C11-H11A 0.94 C12-C13 1.39(3) 
C12-H12A 0.94 C13-C14 1.41(2) 
C13-H13A 0.94 C14-C15 1.387(16) 
C14-H14A 0.94 C16-C17 1.390(16) 
C16-C21 1.421(13) C16-H16A 0.94 
C17-C18 1.342(16) C17-H17A 0.94 
C18-C19 1.416(17) C18-H18A 0.94 
C19-C20 1.379(15) C19-H19A 0.94 
C20-C21 1.354(14) C20-H20A 0.94 
C22-C28 1.520(15) C22-H22A 0.99 
C23-C24 1.356(16) C23-C28 1.373(16) 
C23-H23A 0.94 C24-C25 1.323(16) 
C24-H24A 0.94 C25-C26 1.360(17) 
C26-C27 1.386(15) C26-H26A 0.94 
C27-C28 1.392(15) C27-H27A 0.94 
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Table 12 Bond Angles (°) for 104a. 
O2-S1-O1 120.9(5) O2-S1-N2 104.8(5) 
O1-S1-N2 107.2(5) O2-S1-C6 110.1(5) 
O1-S1-C6 109.1(5) N2-S1-C6 103.2(5) 
C7-O5-C8 112.9(8) C22-O7-H7B 109.5 
O4-N1-O3 122.5(14) O4-N1-C3 119.9(15) 
O3-N1-C3 117.5(13) C9-N2-C7 113.8(8) 
C9-N2-S1 122.1(7) C7-N2-S1 121.2(7) 
O8-N3-O9 124.7(13) O8-N3-C25 118.3(14) 
O9-N3-C25 117.0(13) C6-C1-C2 120.6(12) 
C6-C1-H1A 119.7 C2-C1-H1A 119.7 
C3-C2-C1 118.6(12) C3-C2-H2A 120.7 
C1-C2-H2A 120.7 C2-C3-C4 123.7(12) 
C2-C3-N1 120.7(13) C4-C3-N1 115.7(12) 
C5-C4-C3 117.4(11) C5-C4-H4A 121.3 
C3-C4-H4A 121.3 C4-C5-C6 119.0(12) 
C4-C5-H5A 120.5 C6-C5-H5A 120.5 
C1-C6-C5 120.7(12) C1-C6-S1 120.2(9) 
C5-C6-S1 119.0(9) O5-C7-N2 102.8(7) 
O5-C7-C15 110.2(8) N2-C7-C15 112.6(9) 
O5-C7-H7A 110.3 N2-C7-H7A 110.3 
C15-C7-H7A 110.3 O5-C8-C21 112.0(8) 
O5-C8-C9 104.4(8) C21-C8-C9 112.7(8) 
O5-C8-C22 110.6(8) C21-C8-C22 111.6(8) 
C9-C8-C22 105.2(8) O6-C9-N2 126.7(9) 
O6-C9-C8 127.6(9) N2-C9-C8 105.7(8) 
C15-C10-C11 119.7(13) C15-C10-H10A 120.2 
C11-C10-H10A 120.2 C12-C11-C10 120.3(16) 
C12-C11-H11A 119.8 C10-C11-H11A 119.8 
C11-C12-C13 121.3(16) C11-C12-H12A 119.4 
C13-C12-H12A 119.4 C12-C13-C14 119.1(17) 
C12-C13-H13A 120.4 C14-C13-H13A 120.4 
C15-C14-C13 117.8(15) C15-C14-H14A 121.1 
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C13-C14-H14A 121.1 C10-C15-C14 121.6(12) 
C10-C15-C7 119.9(11) C14-C15-C7 118.3(11) 
C17-C16-C21 119.5(11) C17-C16-H16A 120.2 
C21-C16-H16A 120.2 C18-C17-C16 121.3(12) 
C18-C17-H17A 119.4 C16-C17-H17A 119.4 
C17-C18-C19 119.9(11) C17-C18-H18A 120.0 
C19-C18-H18A 120.0 C20-C19-C18 118.2(11) 
C20-C19-H19A 120.9 C18-C19-H19A 120.9 
C21-C20-C19 122.9(11) C21-C20-H20A 118.5 
C19-C20-H20A 118.5 C20-C21-C16 118.0(10) 
C20-C21-C8 122.6(9) C16-C21-C8 119.4(9) 
O7-C22-C28 112.6(9) O7-C22-C8 102.9(8) 
C28-C22-C8 112.3(8) O7-C22-H22A 109.6 
C28-C22-H22A 109.6 C8-C22-H22A 109.6 
C24-C23-C28 121.0(12) C24-C23-H23A 119.5 
C28-C23-H23A 119.5 C25-C24-C23 119.5(12) 
C25-C24-H24A 120.3 C23-C24-H24A 120.3 
C24-C25-C26 122.8(12) C24-C25-N3 119.9(12) 
C26-C25-N3 117.3(12) C25-C26-C27 118.8(11) 
C25-C26-H26A 120.6 C27-C26-H26A 120.6 
C26-C27-C28 119.0(11) C26-C27-H27A 120.5 
C28-C27-H27A 120.5 C23-C28-C27 118.9(11) 
C23-C28-C22 120.4(10) C27-C28-C22 120.7(10) 
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Table 13 Anisotropic Atomic Displacement Parameters (Å2) for 104a. 
The anisotropic atomic displacement factor exponent takes the form: -2π2[ h2 a*2 U11 + ... + 2 h 
k a* b* U12 ] 
 U11 U22 U33 U23 U13 U12 
S1 0.0763(18) 0.0650(17) 0.0537(15) 0.0032(14) -0.0001(13) 0.0061(14) 
O1 0.096(5) 0.080(5) 0.050(4) -0.011(4) 0.017(4) 0.008(4) 
O2 0.076(5) 0.079(5) 0.062(4) 0.006(4) 0.000(4) 0.007(4) 
O3 0.109(8) 0.112(8) 0.110(8) 0.022(6) -0.027(7) -0.018(6) 
O4 0.149(10) 0.087(7) 0.148(10) -0.024(8) -0.004(8) -0.024(7) 
O5 0.070(5) 0.062(4) 0.057(4) -0.004(4) 0.010(3) -0.003(3) 
O6 0.068(5) 0.066(5) 0.049(4) -0.003(3) 0.011(4) 0.004(4) 
O7 0.120(6) 0.062(5) 0.056(4) 0.000(4) -0.026(5) -0.010(4) 
O8 0.140(9) 0.119(9) 0.085(7) 0.017(6) 0.016(7) -0.041(7) 
O9 0.159(10) 0.086(7) 0.122(8) 0.054(7) -0.031(7) -0.015(7) 
N1 0.129(10) 0.074(8) 0.080(7) 0.007(6) -0.024(8) -0.005(8) 
N2 0.070(5) 0.056(5) 0.044(5) 0.010(4) 0.001(4) -0.002(4) 
N3 0.121(11) 0.087(9) 0.067(7) 0.025(6) -0.025(7) -0.028(8) 
C1 0.088(8) 0.066(7) 0.055(7) 0.011(6) 0.010(6) 0.006(6) 
C2 0.080(8) 0.057(7) 0.073(8) 0.000(6) -0.005(6) -0.002(6) 
C3 0.089(9) 0.061(8) 0.072(8) 0.011(6) -0.018(7) -0.006(6) 
C4 0.120(11) 0.067(8) 0.061(7) 0.001(6) -0.001(8) 0.002(8) 
C5 0.082(8) 0.079(8) 0.067(8) 0.002(7) 0.004(6) 0.006(7) 
C6 0.081(8) 0.047(6) 0.063(7) 0.006(5) 0.009(6) 0.004(5) 
C7 0.061(6) 0.063(7) 0.054(6) -0.007(5) -0.002(5) 0.003(5) 
C8 0.065(6) 0.050(6) 0.049(6) -0.009(5) 0.006(5) -0.001(5) 
C9 0.062(6) 0.046(5) 0.043(5) -0.003(4) -0.001(5) 0.004(5) 
C10 0.110(10) 0.067(8) 0.064(7) -0.010(7) 0.002(7) 0.007(7) 
C11 0.154(15) 0.081(10) 0.084(10) -0.015(9) -0.009(10) 0.001(10) 
C12 0.19(2) 0.120(15) 0.088(12) -0.032(11) 0.050(14) 0.025(15) 
C13 0.149(18) 0.101(13) 0.152(17) -0.026(12) 0.062(14) 0.031(12) 
C14 0.085(9) 0.109(12) 0.082(9) -0.003(8) 0.018(7) 0.021(8) 
C15 0.076(8) 0.056(6) 0.063(7) -0.007(6) 0.018(6) -0.001(6) 
C16 0.071(7) 0.081(8) 0.051(6) -0.014(6) 0.004(6) 0.014(6) 
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 U11 U22 U33 U23 U13 U12 
C17 0.111(10) 0.087(9) 0.066(7) -0.022(7) -0.016(8) 0.020(8) 
C18 0.095(9) 0.086(9) 0.062(7) -0.002(7) -0.013(7) 0.010(7) 
C19 0.063(7) 0.096(9) 0.078(9) 0.005(7) -0.002(6) 0.002(6) 
C20 0.063(7) 0.083(8) 0.063(7) 0.001(6) 0.003(6) 0.004(6) 
C21 0.067(7) 0.051(5) 0.044(5) -0.007(5) 0.007(4) -0.007(5) 
C22 0.078(7) 0.052(6) 0.054(6) -0.010(5) -0.007(5) 0.000(5) 
C23 0.090(9) 0.063(7) 0.065(7) -0.007(6) 0.001(6) 0.005(6) 
C24 0.104(10) 0.049(7) 0.079(9) 0.004(6) -0.001(7) 0.002(6) 
C25 0.090(9) 0.070(8) 0.046(6) 0.004(6) 0.010(6) -0.017(6) 
C26 0.073(7) 0.078(8) 0.063(7) 0.001(6) -0.009(6) -0.011(6) 
C27 0.074(8) 0.068(7) 0.067(7) -0.001(6) -0.006(6) -0.014(6) 
C28 0.072(7) 0.053(6) 0.051(6) -0.008(5) 0.001(5) 0.000(5) 
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Table 14 Hydrogen Atomic Coordinates and Isotropic Atomic Displacement Parameters (Å2) for 
104a. 
 x/a y/b z/c U(eq) 
H7B 0.1055 0.1889 0.5076 0.119 
H1A 0.4998 0.5305 0.4917 0.084 
H2A 0.7073 0.6406 0.5160 0.084 
H4A 0.3204 0.7637 0.6053 0.099 
H5A 0.1112 0.6505 0.5821 0.091 
H7A -0.0869 0.3673 0.5770 0.071 
H10A 0.2018 0.4688 0.6771 0.096 
H11A 0.1092 0.5754 0.7406 0.128 
H12A -0.1882 0.6134 0.7477 0.159 
H13A -0.4025 0.5589 0.6863 0.161 
H14A -0.3091 0.4549 0.6188 0.11 
H16A 0.2235 0.2985 0.7136 0.081 
H17A 0.4273 0.2738 0.7843 0.106 
H18A 0.7191 0.2308 0.7675 0.097 
H19A 0.8259 0.2232 0.6768 0.095 
H20A 0.6191 0.2406 0.6067 0.083 
H22A 0.3856 0.1903 0.5529 0.073 
H23A 0.4318 0.0622 0.6097 0.087 
H24A 0.3224 -0.0658 0.6495 0.093 
H26A -0.1847 0.0236 0.6359 0.086 
H27A -0.0811 0.1498 0.5885 0.084 
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